,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,596274,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9576,SPAG6,https://ctdbase.org/detail.go?type=gene&acc=9576,,,9576.0,SPAG6,8090.0,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of SPAG6 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
1,627255,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,3295,HSD17B4,https://ctdbase.org/detail.go?type=gene&acc=3295,,,3295.0,HSD17B4,10116.0,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of HSD17B4 mrna]|carbon tetrachloride results in decreased expression of HSD17B4 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
2,627256,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,3295,HSD17B4,https://ctdbase.org/detail.go?type=gene&acc=3295,,,3295.0,HSD17B4,10116.0,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of HSD17B4 mRNA,,,PMID:16239168,https://www.ncbi.nlm.nih.gov/pubmed/16239168,16239168,,
3,800999,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,54465,ETAA1,https://ctdbase.org/detail.go?type=gene&acc=54465,,,54465.0,ETAA1,9606.0,Homo sapiens (human),Testosterone results in decreased expression of ETAA1 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
4,801000,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,254013,ETFBKMT,https://ctdbase.org/detail.go?type=gene&acc=254013,,,254013.0,ETFBKMT,10090.0,Mus musculus (house mouse),"Testosterone deficiency results in increased expression of ETFBKMT mrna|1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in increased expression of ETFBKMT mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
5,801001,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,100144434,ETL4,https://ctdbase.org/detail.go?type=gene&acc=100144434,,,100144434.0,ETL4,10090.0,Mus musculus (house mouse),Testosterone deficiency results in increased expression of ETL4 mRNA,,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
6,801002,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,55194,EVA1B,https://ctdbase.org/detail.go?type=gene&acc=55194,,,55194.0,EVA1B,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of EVA1B mrna|testosterone results in increased expression of EVA1B mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
7,801003,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,59271,EVA1C,https://ctdbase.org/detail.go?type=gene&acc=59271,,,59271.0,EVA1C,9606.0,Homo sapiens (human),Testosterone results in decreased expression of EVA1C mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
8,801004,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2121,EVC,https://ctdbase.org/detail.go?type=gene&acc=2121,,,2121.0,EVC,9606.0,Homo sapiens (human),Testosterone results in decreased expression of EVC mrna|[testosterone co-treated with calcitriol] results in decreased expression of EVC mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
9,801005,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2123,EVI2A,https://ctdbase.org/detail.go?type=gene&acc=2123,,,2123.0,EVI2A,10116.0,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of EVI2A mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
10,800550,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,64359,NXN,https://ctdbase.org/detail.go?type=gene&acc=64359,,,64359.0,NXN,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in increased methylation of NXN gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
11,800551,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,30010,NXPH1,https://ctdbase.org/detail.go?type=gene&acc=30010,,,30010.0,NXPH1,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in decreased methylation of NXPH1 gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
12,800552,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,4946,OAZ1,https://ctdbase.org/detail.go?type=gene&acc=4946,,,4946.0,OAZ1,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in decreased methylation of OAZ1 gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
13,800553,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,23363,OBSL1,https://ctdbase.org/detail.go?type=gene&acc=23363,,,23363.0,OBSL1,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in decreased methylation of OBSL1 gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
14,800554,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,100506658,OCLN,https://ctdbase.org/detail.go?type=gene&acc=100506658,,,100506658.0,OCLN,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in decreased methylation of and results in increased expression of ocln|[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in increased methylation of OCLN gene,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
15,800555,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,4952,OCRL,https://ctdbase.org/detail.go?type=gene&acc=4952,,,4952.0,OCRL,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in increased expression of OCRL mRNA,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
16,800556,6137,Comparative Toxicogenomics Database (CTD),Methionine,D008715,Methionine,https://ctdbase.org/detail.go?type=chem&acc=D008715,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,10090.0,Mus musculus (house mouse),[methionine deficiency co-treated with choline deficiency co-treated with folic acid deficiency] results in increased expression of ODC1 mRNA,,,PMID:20938992,https://www.ncbi.nlm.nih.gov/pubmed/20938992,20938992,,
17,799944,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,72045,MFSD4B2,https://ctdbase.org/detail.go?type=gene&acc=72045,,,72045.0,Mfsd4b2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MFSD4B2 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
18,799945,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84975,MFSD5,https://ctdbase.org/detail.go?type=gene&acc=84975,,,84975.0,MFSD5,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MFSD5 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
19,799946,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,54842,MFSD6,https://ctdbase.org/detail.go?type=gene&acc=54842,,,54842.0,MFSD6,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of MFSD6 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
20,799947,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100034426,MFSD6A,https://ctdbase.org/detail.go?type=gene&acc=100034426,,,100034426.0,mfsd6a,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of MFSD6A mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
21,800236,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of EMC3 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
22,800237,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,7227.0,Drosophila melanogaster (fruit fly),Bisphenol A results in increased expression of EMC3 mRNA,,,PMID:35041872,https://www.ncbi.nlm.nih.gov/pubmed/35041872,35041872,,
23,800238,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of EMC3 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
24,800239,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of EMC3 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
25,800240,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,442075,EMC3-AS1,https://ctdbase.org/detail.go?type=gene&acc=442075,,,442075.0,EMC3-AS1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of EMC3-AS1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
26,800241,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,51234,EMC4,https://ctdbase.org/detail.go?type=gene&acc=51234,,,51234.0,EMC4,9606.0,Homo sapiens (human),Bisphenol A results in increased expression of EMC4 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
27,800396,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased expression of ALDH1B1 mRNA,,,PMID:30245210,https://www.ncbi.nlm.nih.gov/pubmed/30245210,30245210,,
28,800397,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of ALDH1B1 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
29,800398,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10090.0,Mus musculus (house mouse),"[tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with diethylhexyl phthalate co-treated with bisphenol A] results in decreased expression of ALDH1B1 mRNA",,,PMID:28433925,https://www.ncbi.nlm.nih.gov/pubmed/28433925,28433925,,
30,800399,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ALDH1B1 protein|bisphenol A affects the expression of ALDH1B1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
31,800400,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with butter] affects the expression of ALDH1B1 mRNA,,,PMID:28487351,https://www.ncbi.nlm.nih.gov/pubmed/28487351,28487351,,
32,800401,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of ALDH1B1 mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
33,800402,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,7955.0,Danio rerio (zebrafish),Bisphenol A affects the methylation of ALDH1L1 intron|bisphenol A results in increased methylation of ALDH1L1 exon|bisphenol A results in increased methylation of ALDH1L1 3' UTR,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
34,800403,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of ALDH1L1 mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
35,800404,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,9606.0,Homo sapiens (human),Bisphenol A affects the expression of ALDH1L1 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
36,800405,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of ALDH1L1 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
37,800406,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3483,IGFALS,https://ctdbase.org/detail.go?type=gene&acc=3483,,,3483.0,IGFALS,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of IGFALS mRNA,,,PMID:30903817|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/30903817|https://www.ncbi.nlm.nih.gov/pubmed/32145629,30903817|32145629,,
38,800684,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11320,MGAT4A,https://ctdbase.org/detail.go?type=gene&acc=11320,,,11320.0,MGAT4A,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of MGAT4A gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
39,800685,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of MGAT4B mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
40,800686,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,7955.0,Danio rerio (zebrafish),Bisphenol A affects the methylation of MGAT4B intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
41,800687,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,143606.0,Gobiocypris rarus,Bisphenol A results in decreased expression of MGAT4B mRNA,,,PMID:26364221,https://www.ncbi.nlm.nih.gov/pubmed/26364221,26364221,,
42,800688,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,9606.0,Homo sapiens (human),Bisphenol A affects the expression of MGAT4B mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
43,800689,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of MGAT4B mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
44,800690,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MGAT4B mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
45,800691,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of MGAT4B mRNA,,,PMID:35192832,https://www.ncbi.nlm.nih.gov/pubmed/35192832,35192832,,
46,800692,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,11282,MGAT4B,https://ctdbase.org/detail.go?type=gene&acc=11282,,,11282.0,MGAT4B,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of MGAT4B mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
47,800833,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,81552,VOPP1,https://ctdbase.org/detail.go?type=gene&acc=81552,,,81552.0,VOPP1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of VOPP1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
48,800834,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7441,VPREB1,https://ctdbase.org/detail.go?type=gene&acc=7441,,,7441.0,VPREB1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of VPREB1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
49,800835,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,22363,VPREB1B,https://ctdbase.org/detail.go?type=gene&acc=22363,,,22363.0,Vpreb1b,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of VPREB1B mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
50,800836,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55823,VPS11,https://ctdbase.org/detail.go?type=gene&acc=55823,,,55823.0,VPS11,7955.0,Danio rerio (zebrafish),Bisphenol A affects the expression of VPS11 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
51,801158,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7247,TSN,https://ctdbase.org/detail.go?type=gene&acc=7247,,,7247.0,TSN,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of TSN mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
52,801159,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7247,TSN,https://ctdbase.org/detail.go?type=gene&acc=7247,,,7247.0,TSN,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of TSN mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
53,801160,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7247,TSN,https://ctdbase.org/detail.go?type=gene&acc=7247,,,7247.0,TSN,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of TSN mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
54,801161,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,203062,TSNARE1,https://ctdbase.org/detail.go?type=gene&acc=203062,,,203062.0,TSNARE1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] affects the methylation of TSNARE1 gene|bisphenol A affects the methylation of TSNARE1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
55,799407,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,54221,SNTG2,https://ctdbase.org/detail.go?type=gene&acc=54221,,,54221.0,SNTG2,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in decreased methylation of SNTG2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
56,799408,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,132203,SNTN,https://ctdbase.org/detail.go?type=gene&acc=132203,,,132203.0,SNTN,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased expression of SNTN mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
57,800995,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,5630,PRPH,https://ctdbase.org/detail.go?type=gene&acc=5630,,,5630.0,PRPH,9606.0,Homo sapiens (human),Pentanal results in increased expression of PRPH mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
58,800996,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,79170,PRR15L,https://ctdbase.org/detail.go?type=gene&acc=79170,,,79170.0,PRR15L,9606.0,Homo sapiens (human),Pentanal results in decreased expression of PRR15L mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
59,800997,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,401399,PRRT4,https://ctdbase.org/detail.go?type=gene&acc=401399,,,401399.0,PRRT4,9606.0,Homo sapiens (human),Pentanal results in increased expression of PRRT4 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
60,800998,8063,Comparative Toxicogenomics Database (CTD),Valeraldehyde,C046012,pentanal,https://ctdbase.org/detail.go?type=chem&acc=C046012,51450,PRRX2,https://ctdbase.org/detail.go?type=gene&acc=51450,,,51450.0,PRRX2,9606.0,Homo sapiens (human),Pentanal results in increased expression of PRRX2 mRNA,,,PMID:26079696,https://www.ncbi.nlm.nih.gov/pubmed/26079696,26079696,,
61,799556,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1349,COX7B,https://ctdbase.org/detail.go?type=gene&acc=1349,,,1349.0,COX7B,10090.0,Mus musculus (house mouse),Diethylhexyl phthalate results in increased expression of COX7B mrna|ppara protein promotes the reaction [diethylhexyl phthalate results in increased expression of COX7B mrna],,,PMID:19850644,https://www.ncbi.nlm.nih.gov/pubmed/19850644,19850644,,
62,799557,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,7955.0,Danio rerio (zebrafish),[dietary fats co-treated with ethanol co-treated with diethylhexyl phthalate] affects the expression of CP mRNA,,,PMID:33022287,https://www.ncbi.nlm.nih.gov/pubmed/33022287,33022287,,
63,799558,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1357,CPA1,https://ctdbase.org/detail.go?type=gene&acc=1357,,,1357.0,CPA1,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in decreased expression of CPA1 mRNA,,,PMID:28412506,https://www.ncbi.nlm.nih.gov/pubmed/28412506,28412506,,
64,799559,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,57094,CPA6,https://ctdbase.org/detail.go?type=gene&acc=57094,,,57094.0,CPA6,10090.0,Mus musculus (house mouse),Diethylhexyl phthalate results in decreased expression of CPA6 mRNA,,,PMID:28085963,https://www.ncbi.nlm.nih.gov/pubmed/28085963,28085963,,
65,799560,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,27151,CPAMD8,https://ctdbase.org/detail.go?type=gene&acc=27151,,,27151.0,CPAMD8,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in decreased expression of CPAMD8 mRNA,,,PMID:31163220,https://www.ncbi.nlm.nih.gov/pubmed/31163220,31163220,,
66,799742,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10090.0,Mus musculus (house mouse),"[tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with diethylhexyl phthalate co-treated with bisphenol A] results in increased expression of CPT1A mRNA",,,PMID:28433925,https://www.ncbi.nlm.nih.gov/pubmed/28433925,28433925,,
67,799743,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10116.0,Rattus norvegicus (Norway rat),Diethylhexyl phthalate results in increased expression of CPT1A mRNA,,,PMID:22672789,https://www.ncbi.nlm.nih.gov/pubmed/22672789,22672789,,
68,799744,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1375,CPT1B,https://ctdbase.org/detail.go?type=gene&acc=1375,,,1375.0,CPT1B,10090.0,Mus musculus (house mouse),"[tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with diethylhexyl phthalate co-treated with bisphenol A] results in increased expression of CPT1B mRNA",,,PMID:28433925,https://www.ncbi.nlm.nih.gov/pubmed/28433925,28433925,,
69,799745,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1375,CPT1B,https://ctdbase.org/detail.go?type=gene&acc=1375,,,1375.0,CPT1B,10116.0,Rattus norvegicus (Norway rat),Diethylhexyl phthalate results in increased expression of CPT1B mRNA,,,PMID:22672789,https://www.ncbi.nlm.nih.gov/pubmed/22672789,22672789,,
70,799746,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1376,CPT2,https://ctdbase.org/detail.go?type=gene&acc=1376,,,1376.0,CPT2,10090.0,Mus musculus (house mouse),Diethylhexyl phthalate results in increased expression of CPT2 mRNA,,,PMID:19245819,https://www.ncbi.nlm.nih.gov/pubmed/19245819,19245819,,
71,799747,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1376,CPT2,https://ctdbase.org/detail.go?type=gene&acc=1376,,,1376.0,CPT2,10116.0,Rattus norvegicus (Norway rat),[diethylhexyl phthalate co-treated with dietary fats] results in increased expression of CPT2 mRNA,,,PMID:33166671,https://www.ncbi.nlm.nih.gov/pubmed/33166671,33166671,,
72,799748,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,54504,CPVL,https://ctdbase.org/detail.go?type=gene&acc=54504,,,54504.0,CPVL,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in increased expression of CPVL mRNA,,,PMID:31163220,https://www.ncbi.nlm.nih.gov/pubmed/31163220,31163220,,
73,799937,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1384,CRAT,https://ctdbase.org/detail.go?type=gene&acc=1384,,,1384.0,CRAT,10090.0,Mus musculus (house mouse),Diethylhexyl phthalate results in increased expression of CRAT mrna|ppara protein promotes the reaction [diethylhexyl phthalate results in increased expression of CRAT mrna],,,PMID:19850644,https://www.ncbi.nlm.nih.gov/pubmed/19850644,19850644,,
74,799938,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,286204,CRB2,https://ctdbase.org/detail.go?type=gene&acc=286204,,,286204.0,CRB2,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in decreased expression of CRB2 mRNA,,,PMID:31163220,https://www.ncbi.nlm.nih.gov/pubmed/31163220,31163220,,
75,799939,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),CSNK2B protein inhibits the reaction [diethylhexyl phthalate results in decreased phosphorylation of CREB1 protein]|mir93 inhibits the reaction [diethylhexyl phthalate results in decreased phosphorylation of CREB1 protein],,,PMID:37302538,https://www.ncbi.nlm.nih.gov/pubmed/37302538,37302538,,
76,799940,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),Diethylhexyl phthalate results in decreased phosphorylation of CREB1 protein,,,PMID:35259346|PMID:37302538,https://www.ncbi.nlm.nih.gov/pubmed/35259346|https://www.ncbi.nlm.nih.gov/pubmed/37302538,35259346|37302538,,
77,799941,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),Icariin inhibits the reaction [diethylhexyl phthalate results in decreased phosphorylation of CREB1 protein],,,PMID:35259346,https://www.ncbi.nlm.nih.gov/pubmed/35259346,35259346,,
78,799942,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116.0,Rattus norvegicus (Norway rat),[diethylhexyl phthalate co-treated with diethylnitrosamine] results in increased expression of and results in increased phosphorylation of CREB1 protein|bisphenol A promotes the reaction [[diethylhexyl phthalate co-treated with diethylnitrosamine] results in increased expression of CREB1 protein]|[bisphenol A co-treated with diethylhexyl phthalate co-treated with diethylnitrosamine] results in increased phosphorylation of CREB1 protein|[bisphenol A co-treated with diethylhexyl phthalate co-treated with diethylnitrosamine] results in increased expression of CREB1 mrna|[diethylhexyl phthalate co-treated with diethylnitrosamine] results in increased expression of CREB1 mRNA,,,PMID:36608567,https://www.ncbi.nlm.nih.gov/pubmed/36608567,36608567,,
79,799943,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,55118,CRTAC1,https://ctdbase.org/detail.go?type=gene&acc=55118,,,55118.0,CRTAC1,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in decreased expression of CRTAC1 mRNA,,,PMID:31163220,https://www.ncbi.nlm.nih.gov/pubmed/31163220,31163220,,
80,800098,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with diethylhexyl phthalate] promotes the reaction [[diethylnitrosamine co-treated with methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein]|[diethylhexyl phthalate co-treated with diethylnitrosamine co-treated with methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein|[bisphenol A co-treated with diethylhexyl phthalate] results in increased phosphorylation of CREB1 protein,,,PMID:34186418,https://www.ncbi.nlm.nih.gov/pubmed/34186418,34186418,,
81,800837,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1470,CST2,https://ctdbase.org/detail.go?type=gene&acc=1470,,,1470.0,CST2,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in increased expression of CST2 mRNA,,,PMID:31163220,https://www.ncbi.nlm.nih.gov/pubmed/31163220,31163220,,
82,800838,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1471,CST3,https://ctdbase.org/detail.go?type=gene&acc=1471,,,1471.0,CST3,10090.0,Mus musculus (house mouse),Diethylhexyl phthalate results in increased expression of CST3 mrna|ppara protein promotes the reaction [diethylhexyl phthalate results in increased expression of CST3 mrna],,,PMID:19850644,https://www.ncbi.nlm.nih.gov/pubmed/19850644,19850644,,
83,800839,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1473,CST5,https://ctdbase.org/detail.go?type=gene&acc=1473,,,1473.0,CST5,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in increased expression of CST5 mRNA,,,PMID:31163220,https://www.ncbi.nlm.nih.gov/pubmed/31163220,31163220,,
84,800840,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1474,CST6,https://ctdbase.org/detail.go?type=gene&acc=1474,,,1474.0,CST6,9606.0,Homo sapiens (human),Diethylhexyl phthalate results in increased expression of CST6 mRNA,,,PMID:31163220,https://www.ncbi.nlm.nih.gov/pubmed/31163220,31163220,,
85,800841,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1475,CSTA,https://ctdbase.org/detail.go?type=gene&acc=1475,,,1475.0,CSTA,10116.0,Rattus norvegicus (Norway rat),Diethylhexyl phthalate results in increased expression of CSTA mRNA,,,PMID:29945229,https://www.ncbi.nlm.nih.gov/pubmed/29945229,29945229,,
86,800842,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,100034684,CSTDC5,https://ctdbase.org/detail.go?type=gene&acc=100034684,,,100034684.0,Cstdc5,10090.0,Mus musculus (house mouse),Diethylhexyl phthalate inhibits the reaction [[streptozocin co-treated with dietary fats] results in increased expression of CSTDC5 mrna],,,PMID:33484791,https://www.ncbi.nlm.nih.gov/pubmed/33484791,33484791,,
87,800843,8343,Comparative Toxicogenomics Database (CTD),Bis(2-ethylhexyl) phthalate,D004051,Diethylhexyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D004051,1479,CSTF3,https://ctdbase.org/detail.go?type=gene&acc=1479,,,1479.0,CSTF3,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate] affects the methylation of CSTF3 promoter,,,PMID:23359474,https://www.ncbi.nlm.nih.gov/pubmed/23359474,23359474,,
88,799550,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC3A2 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
89,799551,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,6541,SLC7A1,https://ctdbase.org/detail.go?type=gene&acc=6541,,,6541.0,SLC7A1,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mrna|sb 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
90,799552,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657.0,SLC7A11,10090.0,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mrna]|[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
91,799553,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in increased expression of SMAD3 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
92,799554,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,10116.0,Rattus norvegicus (Norway rat),[benzo(a)pyrene co-treated with fluoranthene] affects the expression of SMAD3 mRNA,,,PMID:18711122,https://www.ncbi.nlm.nih.gov/pubmed/18711122,18711122,,
93,799555,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,4091,SMAD6,https://ctdbase.org/detail.go?type=gene&acc=4091,,,4091.0,SMAD6,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMAD6 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
94,800242,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,6659,SOX4,https://ctdbase.org/detail.go?type=gene&acc=6659,,,6659.0,SOX4,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in increased expression of SOX4 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
95,800243,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,6670,SP3,https://ctdbase.org/detail.go?type=gene&acc=6670,,,6670.0,SP3,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in increased expression of SP3 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
96,800244,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606.0,Homo sapiens (human),[benzo(a)pyrene co-treated with fluoranthene] affects the expression of SPP1 mRNA,,,PMID:17690111,https://www.ncbi.nlm.nih.gov/pubmed/17690111,17690111,,
97,800245,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in increased expression of SPP1 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
98,800246,9154,Comparative Toxicogenomics Database (CTD),Fluoranthene,C007738,fluoranthene,https://ctdbase.org/detail.go?type=chem&acc=C007738,161742,SPRED1,https://ctdbase.org/detail.go?type=gene&acc=161742,,,161742.0,SPRED1,10090.0,Mus musculus (house mouse),[1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRED1 mRNA,,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
99,799749,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10090.0,Mus musculus (house mouse),[1-naphthylisothiocyanate co-treated with allopurinol] results in increased expression of GSTA1 mrna|1-naphthylisothiocyanate results in increased expression of GSTA1 mRNA,,,PMID:33749747,https://www.ncbi.nlm.nih.gov/pubmed/33749747,33749747,,
100,799750,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of GSTA1 mRNA,,,PMID:20551477,https://www.ncbi.nlm.nih.gov/pubmed/20551477,20551477,,
101,799751,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10090.0,Mus musculus (house mouse),[1-naphthylisothiocyanate co-treated with uric acid] results in increased expression of GSTA2 mRNA,,,PMID:33749747,https://www.ncbi.nlm.nih.gov/pubmed/33749747,33749747,,
102,799752,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10090.0,Mus musculus (house mouse),1-naphthylisothiocyanate results in increased expression of GSTA2 mRNA,,,PMID:15913567|PMID:33749747,https://www.ncbi.nlm.nih.gov/pubmed/15913567|https://www.ncbi.nlm.nih.gov/pubmed/33749747,15913567|33749747,,
103,800088,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of GSTT1 mRNA,,,PMID:12883083,https://www.ncbi.nlm.nih.gov/pubmed/12883083,12883083,,
104,800089,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,51512,GTSE1,https://ctdbase.org/detail.go?type=gene&acc=51512,,,51512.0,GTSE1,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of GTSE1 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
105,800090,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2974,GUCY1B2,https://ctdbase.org/detail.go?type=gene&acc=2974,,,2974.0,GUCY1B2,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of GUCY1B2 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
106,800091,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2984,GUCY2C,https://ctdbase.org/detail.go?type=gene&acc=2984,,,2984.0,GUCY2C,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of GUCY2C mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
107,800092,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,2986,GUCY2F,https://ctdbase.org/detail.go?type=gene&acc=2986,,,2986.0,GUCY2F,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of GUCY2F mRNA,,,PMID:12832660,https://www.ncbi.nlm.nih.gov/pubmed/12832660,12832660,,
108,800093,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,73707,GUCY2G,https://ctdbase.org/detail.go?type=gene&acc=73707,,,73707.0,Gucy2g,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of GUCY2G mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
109,800094,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,51454,GULP1,https://ctdbase.org/detail.go?type=gene&acc=51454,,,51454.0,GULP1,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of GULP1 mRNA,,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
110,800095,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,3001,GZMA,https://ctdbase.org/detail.go?type=gene&acc=3001,,,3001.0,GZMA,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of GZMA mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
111,800096,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,3001,GZMA,https://ctdbase.org/detail.go?type=gene&acc=3001,,,3001.0,GZMA,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in increased expression of GZMA mRNA,,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
112,800097,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,3003,GZMK,https://ctdbase.org/detail.go?type=gene&acc=3003,,,3003.0,GZMK,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of GZMK mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
113,800693,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,9606.0,Homo sapiens (human),[1-naphthylisothiocyanate co-treated with cholic acids] affects the expression of HERPUD1 mRNA,,,PMID:27344345,https://www.ncbi.nlm.nih.gov/pubmed/27344345,27344345,,
114,800694,11080,Comparative Toxicogenomics Database (CTD),1-Naphthyl isothiocyanate,D015058,1-Naphthylisothiocyanate,https://ctdbase.org/detail.go?type=chem&acc=D015058,10614,HEXIM1,https://ctdbase.org/detail.go?type=gene&acc=10614,,,10614.0,HEXIM1,10116.0,Rattus norvegicus (Norway rat),1-naphthylisothiocyanate results in decreased expression of HEXIM1 mRNA,,,PMID:25380136,https://www.ncbi.nlm.nih.gov/pubmed/25380136,25380136,,
115,800546,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,205147,AMER3,https://ctdbase.org/detail.go?type=gene&acc=205147,,,205147.0,AMER3,10090.0,Mus musculus (house mouse),Bisphenol F results in increased expression of AMER3 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
116,800547,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,386724,AMIGO3,https://ctdbase.org/detail.go?type=gene&acc=386724,,,386724.0,AMIGO3,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of AMIGO3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
117,800548,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,81693,AMN,https://ctdbase.org/detail.go?type=gene&acc=81693,,,81693.0,AMN,10090.0,Mus musculus (house mouse),Bisphenol F affects the expression of AMN mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
118,800549,12111,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenediphenol",C000611646,bisphenol F,https://ctdbase.org/detail.go?type=chem&acc=C000611646,196394,AMN1,https://ctdbase.org/detail.go?type=gene&acc=196394,,,196394.0,AMN1,7955.0,Danio rerio (zebrafish),Bisphenol F results in increased expression of AMN1 mRNA,,,PMID:30265984,https://www.ncbi.nlm.nih.gov/pubmed/30265984,30265984,,
119,1739334,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Piperine inhibits the reaction [curcumin results in decreased expression of CCND1 protein]|vitamin E inhibits the reaction [curcumin results in decreased expression of CCND1 protein],,,PMID:30935902,https://www.ncbi.nlm.nih.gov/pubmed/30935902,30935902,,
120,1739335,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),TNFSF10 protein promotes the reaction [curcumin results in decreased expression of CCND1 protein],,,PMID:18226269,https://www.ncbi.nlm.nih.gov/pubmed/18226269,18226269,,
121,1739336,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),[curcumin co-treated with gemcitabine] results in decreased expression of CCND1 protein,,,PMID:17440100,https://www.ncbi.nlm.nih.gov/pubmed/17440100,17440100,,
122,1739337,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),Curcumin results in decreased expression of CCND1,,,PMID:15738001,https://www.ncbi.nlm.nih.gov/pubmed/15738001,15738001,,
123,1739338,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),Curcumin results in decreased expression of CCND1 protein,,,PMID:17885582|PMID:18829502|PMID:19501152,https://www.ncbi.nlm.nih.gov/pubmed/17885582|https://www.ncbi.nlm.nih.gov/pubmed/18829502|https://www.ncbi.nlm.nih.gov/pubmed/19501152,17885582|18829502|19501152,,
124,1739339,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),Curcumin results in increased expression of CCND1 mRNA,,,PMID:25822711,https://www.ncbi.nlm.nih.gov/pubmed/25822711,25822711,,
125,1739340,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),2-chloro-5-nitrobenzanilide inhibits the reaction [curcumin results in decreased expression of CCND1 mrna]|curcumin results in decreased expression of CCND1 mRNA,,,PMID:17531121,https://www.ncbi.nlm.nih.gov/pubmed/17531121,17531121,,
126,1739341,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),Buthionine sulfoximine inhibits the reaction [curcumin results in decreased expression of CCND1 protein]|curcumin results in decreased expression of CCND1 protein,,,PMID:17602960,https://www.ncbi.nlm.nih.gov/pubmed/17602960,17602960,,
127,1739534,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [bisphenol A results in increased expression of CCND3 protein]|curcumin results in decreased expression of CCND3 protein,,,PMID:23222814,https://www.ncbi.nlm.nih.gov/pubmed/23222814,23222814,,
128,1739535,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),"Curcumin inhibits the reaction [4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine results in increased expression of CCNE1 protein]|curcumin inhibits the reaction [sirolimus results in increased expression of CCNE1 protein]",,,PMID:36640941,https://www.ncbi.nlm.nih.gov/pubmed/36640941,36640941,,
129,1739536,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Curcumin results in decreased expression of CCNE1 protein,,,PMID:17148446|PMID:36640941,https://www.ncbi.nlm.nih.gov/pubmed/17148446|https://www.ncbi.nlm.nih.gov/pubmed/36640941,17148446|36640941,,
130,1739537,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Curcumin results in increased degradation of CCNE1 protein|lactacystin inhibits the reaction [curcumin results in increased degradation of CCNE1 protein],,,PMID:18156803,https://www.ncbi.nlm.nih.gov/pubmed/18156803,18156803,,
131,1739538,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,10116.0,Rattus norvegicus (Norway rat),Curcumin results in decreased expression of CCNE1 mRNA,,,PMID:18299980,https://www.ncbi.nlm.nih.gov/pubmed/18299980,18299980,,
132,1739539,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,9236,CCPG1,https://ctdbase.org/detail.go?type=gene&acc=9236,,,9236.0,CCPG1,9606.0,Homo sapiens (human),Curcumin results in increased expression of CCPG1 mRNA,,,PMID:17198877,https://www.ncbi.nlm.nih.gov/pubmed/17198877,17198877,,
133,1739987,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [trichloroethylene results in increased expression of CDH2 protein],,,PMID:34233590,https://www.ncbi.nlm.nih.gov/pubmed/34233590,34233590,,
134,1739988,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [tobacco smoke pollution results in increased expression of CDH2 mrna]|curcumin inhibits the reaction [tobacco smoke pollution results in increased expression of CDH2 protein],,,PMID:26191140,https://www.ncbi.nlm.nih.gov/pubmed/26191140,26191140,,
135,1739989,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,10116.0,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [lipopolysaccharides results in increased expression of CDH2 protein]|icam1 protein affects the reaction [curcumin inhibits the reaction [lipopolysaccharides results in increased expression of CDH2 protein]],,,PMID:35549587,https://www.ncbi.nlm.nih.gov/pubmed/35549587,35549587,,
136,1740423,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1025,CDK9,https://ctdbase.org/detail.go?type=gene&acc=1025,,,1025.0,CDK9,9606.0,Homo sapiens (human),Curcumin analog results in decreased expression of CDK9 mRNA,,,PMID:26409325,https://www.ncbi.nlm.nih.gov/pubmed/26409325,26409325,,
137,1740424,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),AR protein affects the reaction [[curcumin co-treated with quercetin] results in increased expression of CDKN1A protein]|[curcumin co-treated with quercetin] results in increased expression of CDKN1A protein|dihydrotestosterone inhibits the reaction [[curcumin co-treated with quercetin] results in increased expression of CDKN1A protein]|[bicalutamide co-treated with curcumin co-treated with quercetin] results in increased expression of CDKN1A protein,,,PMID:27132804,https://www.ncbi.nlm.nih.gov/pubmed/27132804,27132804,,
138,1740425,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[arsenic trioxide co-treated with curcumin] results in increased expression of CDKN1A protein,,,PMID:27430728,https://www.ncbi.nlm.nih.gov/pubmed/27430728,27430728,,
139,1740426,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[curcumin binds to and results in increased activity of VDR protein] which results in increased expression of CDKN1A mRNA,,,PMID:20153625,https://www.ncbi.nlm.nih.gov/pubmed/20153625,20153625,,
140,1740427,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Curcumin inhibits the reaction [bisphenol A results in decreased expression of CDKN1A protein],,,PMID:23222814,https://www.ncbi.nlm.nih.gov/pubmed/23222814,23222814,,
141,1740428,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Curcumin results in decreased expression of CDKN1A protein,,,PMID:17148446|PMID:17332326|PMID:18593936|PMID:30935902,https://www.ncbi.nlm.nih.gov/pubmed/17148446|https://www.ncbi.nlm.nih.gov/pubmed/17332326|https://www.ncbi.nlm.nih.gov/pubmed/18593936|https://www.ncbi.nlm.nih.gov/pubmed/30935902,17148446|17332326|18593936|30935902,,
142,1740648,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090.0,Mus musculus (house mouse),Curcumin results in increased expression of CDKN1A,,,PMID:15738001,https://www.ncbi.nlm.nih.gov/pubmed/15738001,15738001,,
143,1740649,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090.0,Mus musculus (house mouse),Curcumin results in increased expression of CDKN1A mRNA,,,PMID:25822711,https://www.ncbi.nlm.nih.gov/pubmed/25822711,25822711,,
144,1740650,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10116.0,Rattus norvegicus (Norway rat),Buthionine sulfoximine inhibits the reaction [curcumin results in increased expression of CDKN1A protein],,,PMID:17602960,https://www.ncbi.nlm.nih.gov/pubmed/17602960,17602960,,
145,1740651,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10116.0,Rattus norvegicus (Norway rat),Curcumin results in increased expression of CDKN1A protein,,,PMID:17602960|PMID:18316600,https://www.ncbi.nlm.nih.gov/pubmed/17602960|https://www.ncbi.nlm.nih.gov/pubmed/18316600,17602960|18316600,,
146,1740652,969516,Comparative Toxicogenomics Database (CTD),Curcumin,D003474,Curcumin,https://ctdbase.org/detail.go?type=chem&acc=D003474,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),AR protein affects the reaction [[curcumin co-treated with quercetin] results in increased expression of CDKN1B protein]|dihydrotestosterone inhibits the reaction [[curcumin co-treated with quercetin] results in increased expression of CDKN1B protein]|[curcumin co-treated with quercetin] results in increased expression of CDKN1B protein,,,PMID:27132804,https://www.ncbi.nlm.nih.gov/pubmed/27132804,27132804,,
147,1738590,1285941,Comparative Toxicogenomics Database (CTD),"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,811,CALR,https://ctdbase.org/detail.go?type=gene&acc=811,,,811.0,CALR,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in decreased expression of CALR mRNA",,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
148,1738591,1285941,Comparative Toxicogenomics Database (CTD),"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,813,CALU,https://ctdbase.org/detail.go?type=gene&acc=813,,,813.0,CALU,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in decreased expression of CALU mRNA",,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
149,1738592,1285941,Comparative Toxicogenomics Database (CTD),"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,55450,CAMK2N1,https://ctdbase.org/detail.go?type=gene&acc=55450,,,55450.0,CAMK2N1,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in decreased expression of CAMK2N1 mRNA",,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
150,1738593,1285941,Comparative Toxicogenomics Database (CTD),"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,124583,CANT1,https://ctdbase.org/detail.go?type=gene&acc=124583,,,124583.0,CANT1,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in decreased expression of CANT1 mRNA",,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
151,1738594,1285941,Comparative Toxicogenomics Database (CTD),"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,822,CAPG,https://ctdbase.org/detail.go?type=gene&acc=822,,,822.0,CAPG,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in increased expression of CAPG mRNA",,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
152,1738595,1285941,Comparative Toxicogenomics Database (CTD),"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,823,CAPN1,https://ctdbase.org/detail.go?type=gene&acc=823,,,823.0,CAPN1,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in increased expression of CAPN1 mRNA",,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
153,1738596,1285941,Comparative Toxicogenomics Database (CTD),"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",C584509,"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid",https://ctdbase.org/detail.go?type=chem&acc=C584509,147968,CAPN12,https://ctdbase.org/detail.go?type=gene&acc=147968,,,147968.0,CAPN12,9606.0,Homo sapiens (human),"4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid results in increased expression of CAPN12 mRNA",,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
154,1738750,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,26502,NARF,https://ctdbase.org/detail.go?type=gene&acc=26502,,,26502.0,NARF,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of NARF mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
155,1738751,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,51471,NAT8B,https://ctdbase.org/detail.go?type=gene&acc=51471,,,51471.0,NAT8B,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of NAT8B mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
156,1738752,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,339983,NAT8L,https://ctdbase.org/detail.go?type=gene&acc=339983,,,339983.0,NAT8L,10116.0,Rattus norvegicus (Norway rat),Methimazole results in decreased expression of NAT8L mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
157,1738753,1349907,Comparative Toxicogenomics Database (CTD),Methimazole,D008713,Methimazole,https://ctdbase.org/detail.go?type=chem&acc=D008713,51594,NBAS,https://ctdbase.org/detail.go?type=gene&acc=51594,,,51594.0,NBAS,10116.0,Rattus norvegicus (Norway rat),Methimazole results in increased expression of NBAS mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
158,1748184,1475682,BindingDB,"Methyl 5-(4-fluorobenzyl)-4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate",43831,"5-(4-fluorobenzyl)-4-keto-6,7-dihydropyrazolo[1,5-a]pyrazine-2-carboxylic acid methyl ester",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=43831,4600,Phosphotransferase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4600,,,,,,,,Ki (nM),1.14e+5,PMID:12144928|DOI:10.1016/S1074-5521(02)00169-2,https://www.ncbi.nlm.nih.gov/pubmed/12144928|https://doi.org/10.1016/S1074-5521(02)00169-2,12144928,10.1016/S1074-5521(02)00169-2,
159,1740121,1489267,Drug Gene Interaction database (DGIdb),"3-(3-chloro-4-methoxybenzyl)-6,7-dimethoxy-2-[(4-methylbenzyl)sulfanyl]-4(3H)-quinazolinimine",,CHEMBL:CHEMBL532160,https://www.dgidb.org/drugs/chembl:CHEMBL532160,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
160,1740122,1489267,Drug Gene Interaction database (DGIdb),"3-(3-chloro-4-methoxybenzyl)-6,7-dimethoxy-2-[(4-methylbenzyl)sulfanyl]-4(3H)-quinazolinimine",,CHEMBL:CHEMBL532160,https://www.dgidb.org/drugs/chembl:CHEMBL532160,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
161,1740123,1489267,Drug Gene Interaction database (DGIdb),"3-(3-chloro-4-methoxybenzyl)-6,7-dimethoxy-2-[(4-methylbenzyl)sulfanyl]-4(3H)-quinazolinimine",,CHEMBL:CHEMBL532160,https://www.dgidb.org/drugs/chembl:CHEMBL532160,,ATXN2,https://www.dgidb.org/genes/hgnc:10555,,,6311.0,ATXN2,9606.0,Homo sapiens (human),,,,,,,,
162,1740124,1540283,BindingDB,1-(4-methylphenyl)-1H-benzimidazole,3821,"1-(4-methylphenyl)-1H-1,3-benzodiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3821,575,Platelet-derived growth factor receptor beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=575,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),,IC50 (nM),>50000,PMID:9876115|DOI:10.1021/jm9804681,https://www.ncbi.nlm.nih.gov/pubmed/9876115|https://doi.org/10.1021/jm9804681,9876115,10.1021/jm9804681,
163,1740125,1540283,BindingDB,1-(4-methylphenyl)-1H-benzimidazole,3821,"1-(4-methylphenyl)-1H-1,3-benzodiazole",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3821,694,Fibroblast growth factor receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=694,P11362,Fibroblast growth factor receptor 1,2260.0,FGFR1,9606.0,Homo sapiens (human),,IC50 (nM),>50000,PMID:9876115|DOI:10.1021/jm9804681,https://www.ncbi.nlm.nih.gov/pubmed/9876115|https://doi.org/10.1021/jm9804681,9876115,10.1021/jm9804681,
164,1740126,1540545,Drug Gene Interaction database (DGIdb),4-methoxy-N-[(4-methylpyridin-2-yl)carbamoyl]benzamide,,CHEMBL:CHEMBL259784,https://www.dgidb.org/drugs/chembl:CHEMBL259784,,ALDH1A1,https://www.dgidb.org/genes/hgnc:402,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),,,,,,,,
165,1748516,1548953,Drug Gene Interaction database (DGIdb),Enclomiphene,,ENCLOMIPHENE,https://www.dgidb.org/drugs/ncit:C28211,,GLP1R,https://www.dgidb.org/genes/hgnc:4324,,,2740.0,GLP1R,9606.0,Homo sapiens (human),,,,,,,,
166,1748517,1548953,Drug Gene Interaction database (DGIdb),Enclomiphene,,ENCLOMIPHENE,https://www.dgidb.org/drugs/ncit:C28211,,ESR1,https://www.dgidb.org/genes/hgnc:3467,,,2099.0,ESR1,9606.0,Homo sapiens (human),Modulator,,,,,,,
167,1748518,1548992,IUPHAR/BPS Guide to PHARMACOLOGY,Metiamide,1233,metiamide,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1233,263,H2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=263,P25102,Histamine H2 receptor,,,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,5.8,PMID:9384502,https://www.ncbi.nlm.nih.gov/pubmed/9384502,9384502,,
168,1748755,1548992,IUPHAR/BPS Guide to PHARMACOLOGY,Metiamide,1233,metiamide,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1233,263,H2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=263,,,25461.0,Hrh2,10116.0,Rattus norvegicus (Norway rat),Antagonist,pKi,5.8,PMID:9384502,https://www.ncbi.nlm.nih.gov/pubmed/9384502,9384502,,
169,1748756,1549000,IUPHAR/BPS Guide to PHARMACOLOGY,Levocetirizine,1214,(R)-cetirizine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1214,262,H1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=262,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Inverse agonist,pKi,8.5,PMID:15206929,https://www.ncbi.nlm.nih.gov/pubmed/15206929,15206929,,
170,1748757,1549026,Comparative Toxicogenomics Database (CTD),Geranyl acetate,C432872,geranyl acetate,https://ctdbase.org/detail.go?type=chem&acc=C432872,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Geranyl acetate results in increased expression of BAX protein,,,PMID:29745075,https://www.ncbi.nlm.nih.gov/pubmed/29745075,29745075,,
171,1748758,1549026,Comparative Toxicogenomics Database (CTD),Geranyl acetate,C432872,geranyl acetate,https://ctdbase.org/detail.go?type=chem&acc=C432872,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Geranyl acetate results in decreased expression of BCL2 protein,,,PMID:29745075,https://www.ncbi.nlm.nih.gov/pubmed/29745075,29745075,,
172,1748759,1549026,Comparative Toxicogenomics Database (CTD),Geranyl acetate,C432872,geranyl acetate,https://ctdbase.org/detail.go?type=chem&acc=C432872,693052,GOBP2,https://ctdbase.org/detail.go?type=gene&acc=693052,,,693052.0,GOBP2,7130.0,Manduca sexta (tobacco hornworm),"Geranyl acetate binds to GOBP2 protein|geranyl acetate inhibits the reaction [6,11-hexadecadienyl diazoacetate analog binds to GOBP2 protein]",,,PMID:9219366,https://www.ncbi.nlm.nih.gov/pubmed/9219366,9219366,,
173,1740268,1594503,BindingDB,Monosubstituted aryl-Me ATX inhibitor 6,103968,Monosubstituted aryl-Me ATX inhibitor 6,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103968,5705,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5705,Q9R1E6,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18606.0,Enpp2,10090.0,Mus musculus (house mouse),,IC50 (nM),450,PMID:23688339|DOI:10.1021/cb400150c,https://www.ncbi.nlm.nih.gov/pubmed/23688339|https://doi.org/10.1021/cb400150c,23688339,10.1021/cb400150c,
174,1740269,1611207,BindingDB,Monosubstituted aryl-Me ATX inhibitor 3,103965,Monosubstituted aryl-Me ATX inhibitor 3,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103965,5705,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5705,Q9R1E6,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18606.0,Enpp2,10090.0,Mus musculus (house mouse),,IC50 (nM),20000,PMID:23688339|DOI:10.1021/cb400150c,https://www.ncbi.nlm.nih.gov/pubmed/23688339|https://doi.org/10.1021/cb400150c,23688339,10.1021/cb400150c,
175,1744972,2247078,Toxin and Toxin Target Database (T3DB),2-[(2Z)-2-(nitromethylidene)pyrrolidin-1-yl]acetonitrile,T3D1064,[2-(Nitromethylene)-1-pyrrolidinyl]acetonitrile,http://www.t3db.ca/toxins/T3D1064,BE0003586,Neuronal acetylcholine receptor subunit alpha-5,http://www.t3db.ca/biodb/bio_entities/BE0003586,P30532,Neuronal acetylcholine receptor subunit alpha-5,1138.0,CHRNA5,9606.0,Homo sapiens (human),"It acts as a neurotransmitter mimic , having both excitatory and depressant ieffects, eventually blocking postsynaptic nicotinic receptors. (T10)",,,,,,,
176,1753469,2258991,Drug Gene Interaction database (DGIdb),"2-Ethylsulfanyl-7-methyl-3-phenyl-5,6,7,8-tetrahydro-3H-9-thia-1,3,7-triaza-fluoren-4-one",,CHEMBL:CHEMBL547656,https://www.dgidb.org/drugs/chembl:CHEMBL547656,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606.0,Homo sapiens (human),,,,,,,,
177,1744973,2261002,BindingDB,Disubstituted aryl-Me ATX inhibitor 2,103974,Disubstituted aryl-Me ATX inhibitor 2,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=103974,5705,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5705,Q9R1E6,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18606.0,Enpp2,10090.0,Mus musculus (house mouse),,IC50 (nM),3000,PMID:23688339|DOI:10.1021/cb400150c,https://www.ncbi.nlm.nih.gov/pubmed/23688339|https://doi.org/10.1021/cb400150c,23688339,10.1021/cb400150c,
178,1753470,2278569,BindingDB,N-Cyclopropyl-2-((N-(4-methoxyphenyl)-4-methylphenyl)sulfonamido)acetamide,23424,"ChemBridge CNS-Set 6382507, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23424,2395,Ubiquitin carboxyl-terminal hydrolase isozyme L3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2395,P15374,Ubiquitin carboxyl-terminal hydrolase isozyme L3,7347.0,UCHL3,9606.0,Homo sapiens (human),,IC50 (nM),>334000,PMID:17761421|DOI:10.1016/j.bmc.2007.07.016,https://www.ncbi.nlm.nih.gov/pubmed/17761421|https://doi.org/10.1016/j.bmc.2007.07.016,17761421,10.1016/j.bmc.2007.07.016,
179,1744975,2280259,BindingDB,"(5Z)-5-[[4-[(2,4-dichlorophenyl)methoxy]phenyl]methylidene]imidazolidine-2,4-dione",106798,"(5Z)&#8208;5&#8208;({4&#8208;[(2,4&#8208; dichlorophenyl)methoxy]phenyl}methylidene)imidazolidine&#8208; 2,4&#8208;dione (comp#j)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106798,2622,Tyrosine-protein phosphatase non-receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2622,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),5.0e+3,PMID:23848232|DOI:10.1111/cbdd.12189,https://www.ncbi.nlm.nih.gov/pubmed/23848232|https://doi.org/10.1111/cbdd.12189,23848232,10.1111/cbdd.12189,
180,1744974,2286675,BindingDB,"(5Z)-5-{4-[(3,4-dichlorobenzyl)oxy]benzylidene}imidazolidine-2,4-dione",106799,"(5Z)&#8208;5&#8208;({4&#8208;[(3,4&#8208; dichlorophenyl)methoxy]phenyl}methylidene)imidazolidine&#8208; 2,4&#8208;dione (comp#k)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106799,2622,Tyrosine-protein phosphatase non-receptor type 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2622,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770.0,PTPN1,9606.0,Homo sapiens (human),,IC50 (nM),1.10e+4,PMID:23848232|DOI:10.1111/cbdd.12189,https://www.ncbi.nlm.nih.gov/pubmed/23848232|https://doi.org/10.1111/cbdd.12189,23848232,10.1111/cbdd.12189,
181,1753471,2302435,BindingDB,"2-(Chloromethyl)-1,1-dioxo-1,2-benzothiazol-3-one",50282865,"2-Chloromethyl-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[d]isothiazol-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50282865,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),>20000,DOI:10.1101/2020.12.16.422677,https://doi.org/10.1101/2020.12.16.422677,,10.1101/2020.12.16.422677,
182,1753472,2302435,BindingDB,"2-(Chloromethyl)-1,1-dioxo-1,2-benzothiazol-3-one",50282865,"2-Chloromethyl-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[d]isothiazol-3-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50282865,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),>20000,DOI:10.1101/2020.12.16.422677,https://doi.org/10.1101/2020.12.16.422677,,10.1101/2020.12.16.422677,
183,1753473,2307681,Therapeutic Target Database (TTD),1-Methyl-1H-indole-3-carbonitrile,D06FSR,1-methyl-1H-indole-3-carbonitrile,https://idrblab.net/ttd/data/drug/details/D06FSR,T89360,Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2),https://idrblab.net/ttd/data/target/details/T89360,P12268,Inosine-5'-monophosphate dehydrogenase 2,3615.0,IMPDH2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
184,1745660,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,50813,COPS7A,https://ctdbase.org/detail.go?type=gene&acc=50813,,,50813.0,COPS7A,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of COPS7A mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
185,1745661,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,22818,COPZ1,https://ctdbase.org/detail.go?type=gene&acc=22818,,,22818.0,COPZ1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of COPZ1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
186,1745662,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51226,COPZ2,https://ctdbase.org/detail.go?type=gene&acc=51226,,,51226.0,COPZ2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of COPZ2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
187,1746167,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1355,COX15,https://ctdbase.org/detail.go?type=gene&acc=1355,,,1355.0,COX15,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of COX15 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
188,1746168,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,51241,COX16,https://ctdbase.org/detail.go?type=gene&acc=51241,,,51241.0,COX16,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of COX16 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
189,1746169,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,4513,COX2,https://ctdbase.org/detail.go?type=gene&acc=4513,,,4513.0,COX2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of COX2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
190,1746170,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,4514,COX3,https://ctdbase.org/detail.go?type=gene&acc=4514,,,4514.0,COX3,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of COX3 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
191,1746171,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1327,COX4I1,https://ctdbase.org/detail.go?type=gene&acc=1327,,,1327.0,COX4I1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of COX4I1 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
192,1746172,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1327,COX4I1,https://ctdbase.org/detail.go?type=gene&acc=1327,,,1327.0,COX4I1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of COX4I1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
193,1746173,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,554101,COX5AA,https://ctdbase.org/detail.go?type=gene&acc=554101,,,554101.0,cox5aa,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of COX5AA mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
194,1746174,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1345,COX6C,https://ctdbase.org/detail.go?type=gene&acc=1345,,,1345.0,COX6C,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of COX6C mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
195,1747021,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,54544,CRCT1,https://ctdbase.org/detail.go?type=gene&acc=54544,,,54544.0,CRCT1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of CRCT1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
196,1747022,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of CREB1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
197,1747023,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),Tadalafil inhibits the reaction [thioacetamide results in decreased phosphorylation of CREB1 protein]|thioacetamide results in decreased phosphorylation of CREB1 protein,,,PMID:31323263,https://www.ncbi.nlm.nih.gov/pubmed/31323263,31323263,,
198,1747024,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,90993,CREB3L1,https://ctdbase.org/detail.go?type=gene&acc=90993,,,90993.0,CREB3L1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of CREB3L1 mrna|thioacetamide results in decreased expression of CREB3L1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
199,1748987,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of CTSB mRNA,,,PMID:16297948,https://www.ncbi.nlm.nih.gov/pubmed/16297948,16297948,,
200,1748988,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,569298,CTSBB,https://ctdbase.org/detail.go?type=gene&acc=569298,,,569298.0,ctsbb,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of CTSBB mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
201,1748989,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1075,CTSC,https://ctdbase.org/detail.go?type=gene&acc=1075,,,1075.0,CTSC,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of CTSC mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
202,1748990,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of CTSD mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
203,1749379,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,2017,CTTN,https://ctdbase.org/detail.go?type=gene&acc=2017,,,2017.0,CTTN,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of CTTN mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
204,1749380,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,83992,CTTNBP2,https://ctdbase.org/detail.go?type=gene&acc=83992,,,83992.0,CTTNBP2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of CTTNBP2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
205,1749381,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55917,CTTNBP2NL,https://ctdbase.org/detail.go?type=gene&acc=55917,,,55917.0,CTTNBP2NL,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of CTTNBP2NL mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
206,1749382,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,348180,CTU2,https://ctdbase.org/detail.go?type=gene&acc=348180,,,348180.0,CTU2,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of CTU2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
207,1749383,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,348180,CTU2,https://ctdbase.org/detail.go?type=gene&acc=348180,,,348180.0,CTU2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of CTU2 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
208,1749384,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8029,CUBN,https://ctdbase.org/detail.go?type=gene&acc=8029,,,8029.0,CUBN,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of CUBN mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
209,1749385,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,8029,CUBN,https://ctdbase.org/detail.go?type=gene&acc=8029,,,8029.0,CUBN,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of CUBN mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
210,1749386,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,404093,CUEDC1,https://ctdbase.org/detail.go?type=gene&acc=404093,,,404093.0,CUEDC1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of CUEDC1 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
211,1749387,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,79004,CUEDC2,https://ctdbase.org/detail.go?type=gene&acc=79004,,,79004.0,CUEDC2,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of CUEDC2 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
212,1754239,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,10926,DBF4,https://ctdbase.org/detail.go?type=gene&acc=10926,,,10926.0,DBF4,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DBF4 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
213,1754240,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1622,DBI,https://ctdbase.org/detail.go?type=gene&acc=1622,,,1622.0,DBI,10116.0,Rattus norvegicus (Norway rat),Thioacetamide affects the expression of DBI mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
214,1754241,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1622,DBI,https://ctdbase.org/detail.go?type=gene&acc=1622,,,1622.0,DBI,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of DBI mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
215,1754242,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,13168,DBIL5,https://ctdbase.org/detail.go?type=gene&acc=13168,,,13168.0,Dbil5,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in decreased expression of DBIL5 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
216,1754243,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1627,DBN1,https://ctdbase.org/detail.go?type=gene&acc=1627,,,1627.0,DBN1,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in increased expression of DBN1 mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
217,1754244,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1627,DBN1,https://ctdbase.org/detail.go?type=gene&acc=1627,,,1627.0,DBN1,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DBN1 mRNA,,,PMID:23411599|PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/23411599|https://www.ncbi.nlm.nih.gov/pubmed/34492290,23411599|34492290,,
218,1754245,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,55861,DBNDD2,https://ctdbase.org/detail.go?type=gene&acc=55861,,,55861.0,DBNDD2,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DBNDD2 mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
219,1754246,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,553729,DBNLB,https://ctdbase.org/detail.go?type=gene&acc=553729,,,553729.0,dbnlb,7955.0,Danio rerio (zebrafish),Thioacetamide affects the expression of DBNLB mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
220,1754247,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1628,DBP,https://ctdbase.org/detail.go?type=gene&acc=1628,,,1628.0,DBP,10141.0,Cavia porcellus (domestic guinea pig),Thioacetamide results in decreased expression of DBP mRNA,,,PMID:34492290,https://www.ncbi.nlm.nih.gov/pubmed/34492290,34492290,,
221,1754248,2723949,Comparative Toxicogenomics Database (CTD),Thioacetamide,D013853,Thioacetamide,https://ctdbase.org/detail.go?type=chem&acc=D013853,1628,DBP,https://ctdbase.org/detail.go?type=gene&acc=1628,,,1628.0,DBP,10116.0,Rattus norvegicus (Norway rat),Thioacetamide results in increased expression of DBP mRNA,,,PMID:23411599,https://www.ncbi.nlm.nih.gov/pubmed/23411599,23411599,,
222,1746166,2725924,BindingDB,"6-(6-chloro-2H-chromen-3-yl)-1,3,5-triazine-2,4-diamine",6642,"6-(6-chloro-2H-chromen-3-yl)-1,3,5-triazine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=6642,98,Cyclin-dependent kinase 4/G1/S-specific cyclin-D1 [L188C],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=98,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),,IC50 (nM),450000,PMID:11741479|DOI:10.1021/jm0103256,https://www.ncbi.nlm.nih.gov/pubmed/11741479|https://doi.org/10.1021/jm0103256,11741479,10.1021/jm0103256,
223,1746164,2746741,BindingDB,LON-WEI-4d77710c-69,496305,LON-WEI-4d77710c-69,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496305,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),219,,,,,
224,1746165,2761171,Comparative Toxicogenomics Database (CTD),Ethionamide,D005000,Ethionamide,https://ctdbase.org/detail.go?type=chem&acc=D005000,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606.0,Homo sapiens (human),KEAP1 mRNA inhibits the reaction [ethionamide results in increased susceptibility to arsenic trioxide],,,PMID:26708503,https://www.ncbi.nlm.nih.gov/pubmed/26708503,26708503,,
225,1738587,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of and results in increased activity of TP53 protein]|cobaltous chloride results in increased expression of and results in increased activity of TP53 protein|ditiocarb inhibits the reaction [cobaltous chloride results in increased expression of and results in increased activity of TP53 protein],,,PMID:10951577,https://www.ncbi.nlm.nih.gov/pubmed/10951577,10951577,,
226,1738588,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),[cobaltous chloride co-treated with TP53 gene mutant form] results in decreased expression of and results in decreased phosphorylation of TP53 protein,,,PMID:21687937,https://www.ncbi.nlm.nih.gov/pubmed/21687937,21687937|21687937,,
227,1738589,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of and results in increased phosphorylation of TP53 protein|[cobaltous chloride co-treated with TP53 gene mutant form] results in decreased expression of BBC3 protein|[cobaltous chloride co-treated with TP53 gene mutant form] results in increased expression of CDKN1A protein|[tp53 protein co-treated with cobaltous chloride] affects the localization of AIFM1 protein|[cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CASP3 protein|tp53 protein promotes the reaction [cobaltous chloride results in increased activity of CASP3 protein],,,PMID:21687937,https://www.ncbi.nlm.nih.gov/pubmed/21687937,21687937,,
228,1740926,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,150465,TTL,https://ctdbase.org/detail.go?type=gene&acc=150465,,,150465.0,TTL,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of TTL mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
229,1740927,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,23170,TTLL12,https://ctdbase.org/detail.go?type=gene&acc=23170,,,23170.0,TTLL12,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of TTLL12 mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
230,1740928,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,9654,TTLL4,https://ctdbase.org/detail.go?type=gene&acc=9654,,,9654.0,TTLL4,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of TTLL4 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
231,1740929,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,79739,TTLL7,https://ctdbase.org/detail.go?type=gene&acc=79739,,,79739.0,TTLL7,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of TTLL7 mRNA,,,PMID:20105288,https://www.ncbi.nlm.nih.gov/pubmed/20105288,20105288,,
232,1740930,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7276,TTR,https://ctdbase.org/detail.go?type=gene&acc=7276,,,7276.0,TTR,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of TTR mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
233,1740931,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,80727,TTYH3,https://ctdbase.org/detail.go?type=gene&acc=80727,,,80727.0,TTYH3,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of TTYH3 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
234,1740932,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7277,TUBA4A,https://ctdbase.org/detail.go?type=gene&acc=7277,,,7277.0,TUBA4A,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of TUBA4A mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
235,1743335,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7372,UMPS,https://ctdbase.org/detail.go?type=gene&acc=7372,,,7372.0,UMPS,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of UMPS mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
236,1743336,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7372,UMPS,https://ctdbase.org/detail.go?type=gene&acc=7372,,,7372.0,UMPS,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of UMPS mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
237,1743337,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,55898,UNC45A,https://ctdbase.org/detail.go?type=gene&acc=55898,,,55898.0,UNC45A,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of UNC45A mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
238,1743338,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,222643,UNC5CL,https://ctdbase.org/detail.go?type=gene&acc=222643,,,222643.0,UNC5CL,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of UNC5CL mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
239,1743339,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7374,UNG,https://ctdbase.org/detail.go?type=gene&acc=7374,,,7374.0,UNG,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of UNG mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
240,1743340,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,64718,UNKL,https://ctdbase.org/detail.go?type=gene&acc=64718,,,64718.0,UNKL,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of UNKL mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
241,1743341,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,391051,UOX,https://ctdbase.org/detail.go?type=gene&acc=391051,,,391051.0,UOX,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of UOX mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
242,1743342,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,65109,UPF3B,https://ctdbase.org/detail.go?type=gene&acc=65109,,,65109.0,UPF3B,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of UPF3B mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
243,1743524,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,84300,UQCC2,https://ctdbase.org/detail.go?type=gene&acc=84300,,,84300.0,UQCC2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of UQCC2 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
244,1749640,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,50804,MYEF2,https://ctdbase.org/detail.go?type=gene&acc=50804,,,50804.0,MYEF2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of MYEF2 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
245,1749641,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4628,MYH10,https://ctdbase.org/detail.go?type=gene&acc=4628,,,4628.0,MYH10,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of MYH10 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
246,1749642,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,79784,MYH14,https://ctdbase.org/detail.go?type=gene&acc=79784,,,79784.0,MYH14,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of MYH14 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
247,1749643,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4627,MYH9,https://ctdbase.org/detail.go?type=gene&acc=4627,,,4627.0,MYH9,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of MYH9 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
248,1749644,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4636,MYL5,https://ctdbase.org/detail.go?type=gene&acc=4636,,,4636.0,MYL5,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of MYL5 mRNA,,,PMID:26314263,https://www.ncbi.nlm.nih.gov/pubmed/26314263,26314263,,
249,1749645,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4638,MYLK,https://ctdbase.org/detail.go?type=gene&acc=4638,,,4638.0,MYLK,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of MYLK mrna|cobaltous chloride results in decreased expression of MYLK protein,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
250,1749646,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4651,MYO10,https://ctdbase.org/detail.go?type=gene&acc=4651,,,4651.0,MYO10,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of MYO10 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
251,1749647,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,23026,MYO16,https://ctdbase.org/detail.go?type=gene&acc=23026,,,23026.0,MYO16,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of MYO16 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
252,1750909,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,10787,NCKAP1,https://ctdbase.org/detail.go?type=gene&acc=10787,,,10787.0,NCKAP1,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of NCKAP1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
253,1751290,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,65009,NDRG4,https://ctdbase.org/detail.go?type=gene&acc=65009,,,65009.0,NDRG4,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NDRG4 mRNA,,,PMID:17553155,https://www.ncbi.nlm.nih.gov/pubmed/17553155,17553155,,
254,1751291,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,8509,NDST2,https://ctdbase.org/detail.go?type=gene&acc=8509,,,8509.0,NDST2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NDST2 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
255,1751292,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4694,NDUFA1,https://ctdbase.org/detail.go?type=gene&acc=4694,,,4694.0,NDUFA1,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NDUFA1 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
256,1751293,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,51079,NDUFA13,https://ctdbase.org/detail.go?type=gene&acc=51079,,,51079.0,NDUFA13,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NDUFA13 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
257,1751294,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4695,NDUFA2,https://ctdbase.org/detail.go?type=gene&acc=4695,,,4695.0,NDUFA2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NDUFA2 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
258,1751689,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4723,NDUFV1,https://ctdbase.org/detail.go?type=gene&acc=4723,,,4723.0,NDUFV1,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NDUFV1 mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
259,1751690,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,10529,NEBL,https://ctdbase.org/detail.go?type=gene&acc=10529,,,10529.0,NEBL,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of NEBL mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
260,1751691,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,25945,NECTIN3,https://ctdbase.org/detail.go?type=gene&acc=25945,,,25945.0,NECTIN3,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of NECTIN3 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
261,1751692,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4738,NEDD8,https://ctdbase.org/detail.go?type=gene&acc=4738,,,4738.0,NEDD8,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NEDD8 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
262,1751693,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4739,NEDD9,https://ctdbase.org/detail.go?type=gene&acc=4739,,,4739.0,NEDD9,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NEDD9 mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
263,1751694,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4739,NEDD9,https://ctdbase.org/detail.go?type=gene&acc=4739,,,4739.0,NEDD9,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of NEDD9 mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
264,1751695,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4747,NEFL,https://ctdbase.org/detail.go?type=gene&acc=4747,,,4747.0,NEFL,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of NEFL mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
265,1752353,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4779,NFE2L1,https://ctdbase.org/detail.go?type=gene&acc=4779,,,4779.0,NFE2L1,10116.0,Rattus norvegicus (Norway rat),[cobaltous chloride co-treated with oxygen deficiency] results in increased expression of NFE2L1 protein|cobaltous chloride results in increased expression of NFE2L1 protein,,,PMID:19278353,https://www.ncbi.nlm.nih.gov/pubmed/19278353,19278353,,
266,1752354,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of NFE2L2 protein]|nfe2l2 protein promotes the reaction [cobaltous chloride results in increased expression of HMOX1 mrna]|nfe2l2 protein promotes the reaction [cobaltous chloride results in increased expression of NQO1 mrna]|nfe2l2 protein affects the susceptibility to cobaltous chloride|nfe2l2 protein promotes the reaction [cobaltous chloride results in increased expression of GCLC mrna]|cobaltous chloride results in increased expression of and affects the localization of NFE2L2 protein|nfe2l2 protein promotes the reaction [cobaltous chloride results in increased expression of GCLM mrna],,,PMID:29966676,https://www.ncbi.nlm.nih.gov/pubmed/29966676,29966676,,
267,1752355,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mrna]],,,PMID:27297870,https://www.ncbi.nlm.nih.gov/pubmed/27297870,27297870,,
268,1752356,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4774,NFIA,https://ctdbase.org/detail.go?type=gene&acc=4774,,,4774.0,NFIA,10116.0,Rattus norvegicus (Norway rat),Cobaltous chloride results in decreased expression of NFIA mRNA,,,PMID:24386269,https://www.ncbi.nlm.nih.gov/pubmed/24386269,24386269,,
269,1752357,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4781,NFIB,https://ctdbase.org/detail.go?type=gene&acc=4781,,,4781.0,NFIB,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NFIB mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
270,1752358,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,7955.0,Danio rerio (zebrafish),Cobaltous chloride results in increased expression of NFIL3 mRNA,,,PMID:24612858,https://www.ncbi.nlm.nih.gov/pubmed/24612858,24612858,,
271,1752359,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,9606.0,Homo sapiens (human),Cobaltous chloride results in increased expression of NFIL3 mRNA,,,PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19376846,19376846,,
272,1752360,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NFKB1 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
273,1752361,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),"2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with phloretin] results in increased expression of NFKB1 mrna]|[2,2-bis(4-glycidyloxyphenyl)propane co-treated with cobaltous chloride] affects the expression of NFKB1 mrna|[cobaltous chloride co-treated with lipopolysaccharide, E coli O55-B5 co-treated with phloretin] results in increased expression of NFKB1 mrna|2,2-bis(4-glycidyloxyphenyl)propane affects the reaction [[cobaltous chloride co-treated with phloretin] affects the expression of NFKB1 mrna]|[cobaltous chloride co-treated with phloretin] affects the expression of NFKB1 mrna|[phlorhizin co-treated with 2,2-bis(4-glycidyloxyphenyl)propane co-treated with cobaltous chloride] affects the expression of NFKB1 mRNA",,,PMID:32408695,https://www.ncbi.nlm.nih.gov/pubmed/32408695,32408695,,
274,1754839,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,8828,NRP2,https://ctdbase.org/detail.go?type=gene&acc=8828,,,8828.0,NRP2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NRP2 mRNA,,,PMID:19320972,https://www.ncbi.nlm.nih.gov/pubmed/19320972,19320972,,
275,1754840,3032536,Comparative Toxicogenomics Database (CTD),Cobaltous Chloride,C018021,cobaltous chloride,https://ctdbase.org/detail.go?type=chem&acc=C018021,7468,NSD2,https://ctdbase.org/detail.go?type=gene&acc=7468,,,7468.0,NSD2,9606.0,Homo sapiens (human),Cobaltous chloride results in decreased expression of NSD2 mRNA,,,PMID:19320972|PMID:19376846,https://www.ncbi.nlm.nih.gov/pubmed/19320972|https://www.ncbi.nlm.nih.gov/pubmed/19376846,19320972|19376846,,
276,1745787,3035594,Comparative Toxicogenomics Database (CTD),"6-Oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-1(6H)-pyridazinebutyric acid",C102861,FK 838,https://ctdbase.org/detail.go?type=chem&acc=C102861,134,ADORA1,https://ctdbase.org/detail.go?type=gene&acc=134,,,134.0,ADORA1,9606.0,Homo sapiens (human),FK 838 binds to and results in decreased activity of ADORA1 protein,,,PMID:12922924,https://www.ncbi.nlm.nih.gov/pubmed/12922924,12922924,,
277,1745788,3035714,Drug Gene Interaction database (DGIdb),Abt-751,,ABT-751,https://www.dgidb.org/drugs/drugbank:DB12254,,TUBB2B,https://www.dgidb.org/genes/hgnc:30829,,,347733.0,TUBB2B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
278,1745789,3035714,Drug Gene Interaction database (DGIdb),Abt-751,,ABT-751,https://www.dgidb.org/drugs/drugbank:DB12254,,TUBB4B,https://www.dgidb.org/genes/hgnc:20771,,,10383.0,TUBB4B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
279,1745790,3035842,Comparative Toxicogenomics Database (CTD),Immepip,C085755,4-(1H-imidazol-4-ylmethyl)piperidine,https://ctdbase.org/detail.go?type=chem&acc=C085755,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),4-(1H-imidazol-4-ylmethyl)piperidine promotes the reaction [isoproterenol results in increased activity of ADRB2 protein],,,PMID:17196553,https://www.ncbi.nlm.nih.gov/pubmed/17196553,17196553,,
280,1745791,3035842,Comparative Toxicogenomics Database (CTD),Immepip,C085755,4-(1H-imidazol-4-ylmethyl)piperidine,https://ctdbase.org/detail.go?type=chem&acc=C085755,11255,HRH3,https://ctdbase.org/detail.go?type=gene&acc=11255,,,11255.0,HRH3,7955.0,Danio rerio (zebrafish),4-(1H-imidazol-4-ylmethyl)piperidine promotes the reaction [guanosine 5'-O-(3-thiotriphosphate) binds to HRH3 protein],,,PMID:10899947,https://www.ncbi.nlm.nih.gov/pubmed/10899947,10899947,,
281,1745792,3035842,Comparative Toxicogenomics Database (CTD),Immepip,C085755,4-(1H-imidazol-4-ylmethyl)piperidine,https://ctdbase.org/detail.go?type=chem&acc=C085755,11255,HRH3,https://ctdbase.org/detail.go?type=gene&acc=11255,,,11255.0,HRH3,9031.0,Gallus gallus (chicken),4-(1H-imidazol-4-ylmethyl)piperidine binds to and results in increased activity of HRH3 protein,,,PMID:12065605,https://www.ncbi.nlm.nih.gov/pubmed/12065605,12065605,,
282,1745793,3035842,Comparative Toxicogenomics Database (CTD),Immepip,C085755,4-(1H-imidazol-4-ylmethyl)piperidine,https://ctdbase.org/detail.go?type=chem&acc=C085755,11255,HRH3,https://ctdbase.org/detail.go?type=gene&acc=11255,,,11255.0,HRH3,10090.0,Mus musculus (house mouse),4-(1H-imidazol-4-ylmethyl)piperidine binds to and results in increased activity of HRH3 protein|[4-(1H-imidazol-4-ylmethyl)piperidine binds to and results in increased activity of HRH3 protein] which results in increased transport of calcium,,,PMID:12706455,https://www.ncbi.nlm.nih.gov/pubmed/12706455,12706455,,
283,1745794,3035842,Comparative Toxicogenomics Database (CTD),Immepip,C085755,4-(1H-imidazol-4-ylmethyl)piperidine,https://ctdbase.org/detail.go?type=chem&acc=C085755,11255,HRH3,https://ctdbase.org/detail.go?type=gene&acc=11255,,,11255.0,HRH3,10090.0,Mus musculus (house mouse),4-(1H-imidazol-4-ylmethyl)piperidine results in increased activity of HRH3 protein,,,PMID:15735960,https://www.ncbi.nlm.nih.gov/pubmed/15735960,15735960,,
284,1741372,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,9837,GINS1,https://ctdbase.org/detail.go?type=gene&acc=9837,,,9837.0,GINS1,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of GINS1 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
285,1741373,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,51659,GINS2,https://ctdbase.org/detail.go?type=gene&acc=51659,,,51659.0,GINS2,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of GINS2 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
286,1741374,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,84296,GINS4,https://ctdbase.org/detail.go?type=gene&acc=84296,,,84296.0,GINS4,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of GINS4 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
287,1741375,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10116.0,Rattus norvegicus (Norway rat),Dasatinib promotes the reaction [lead acetate results in decreased expression of GJA1 protein],,,PMID:26926986,https://www.ncbi.nlm.nih.gov/pubmed/26926986,26926986,,
288,1741526,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,3018,H2BC3,https://ctdbase.org/detail.go?type=gene&acc=3018,,,3018.0,H2BC3,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of H2BC3 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
289,1741527,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,8345,H2BC9,https://ctdbase.org/detail.go?type=gene&acc=8345,,,8345.0,H2BC9,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of H2BC9 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
290,1741528,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,145864,HAPLN3,https://ctdbase.org/detail.go?type=gene&acc=145864,,,145864.0,HAPLN3,9606.0,Homo sapiens (human),Dasatinib results in increased expression of HAPLN3 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
291,1741529,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,3037,HAS2,https://ctdbase.org/detail.go?type=gene&acc=3037,,,3037.0,HAS2,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of HAS2 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
292,1741530,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,1839,HBEGF,https://ctdbase.org/detail.go?type=gene&acc=1839,,,1839.0,HBEGF,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of HBEGF mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
293,1741531,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,3055,HCK,https://ctdbase.org/detail.go?type=gene&acc=3055,,,3055.0,HCK,9606.0,Homo sapiens (human),Dasatinib results in decreased phosphorylation of HCK protein,,,PMID:18180381,https://www.ncbi.nlm.nih.gov/pubmed/18180381,18180381,,
294,1742014,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,3655,ITGA6,https://ctdbase.org/detail.go?type=gene&acc=3655,,,3655.0,ITGA6,9606.0,Homo sapiens (human),Dasatinib results in decreased expression of ITGA6 mRNA,,,PMID:20579391,https://www.ncbi.nlm.nih.gov/pubmed/20579391,20579391,,
295,1742015,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,9606.0,Homo sapiens (human),Dasatinib results in decreased activity of LCK protein,,,PMID:18550857,https://www.ncbi.nlm.nih.gov/pubmed/18550857,18550857,,
296,1745222,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),[oxygen deficiency co-treated with dasatinib] results in decreased phosphorylation of SRC protein,,,PMID:34717917,https://www.ncbi.nlm.nih.gov/pubmed/34717917,34717917,,
297,1745223,3062316,Comparative Toxicogenomics Database (CTD),Dasatinib,D000069439,Dasatinib,https://ctdbase.org/detail.go?type=chem&acc=D000069439,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),Pinocembrin promotes the reaction [dasatinib inhibits the reaction [benzo(a)pyrene results in increased phosphorylation of SRC protein]],,,PMID:33393179,https://www.ncbi.nlm.nih.gov/pubmed/33393179,33393179,,
298,1746614,3081185,Drug Gene Interaction database (DGIdb),Nerispirdine,,NERISPIRDINE,https://www.dgidb.org/drugs/ncit:C80997,,KCNG3,https://www.dgidb.org/genes/hgnc:18306,,,170850.0,KCNG3,9606.0,Homo sapiens (human),Blocker,,,,,,,
299,1746615,3081185,Drug Gene Interaction database (DGIdb),Nerispirdine,,NERISPIRDINE,https://www.dgidb.org/drugs/ncit:C80997,,KCNB2,https://www.dgidb.org/genes/hgnc:6232,,,9312.0,KCNB2,9606.0,Homo sapiens (human),Blocker,,,,,,,
300,1746616,3081185,Drug Gene Interaction database (DGIdb),Nerispirdine,,NERISPIRDINE,https://www.dgidb.org/drugs/ncit:C80997,,KCNH7,https://www.dgidb.org/genes/hgnc:18863,,,90134.0,KCNH7,9606.0,Homo sapiens (human),Blocker,,,,,,,
301,1746617,3081185,Drug Gene Interaction database (DGIdb),Nerispirdine,,NERISPIRDINE,https://www.dgidb.org/drugs/ncit:C80997,,KCND2,https://www.dgidb.org/genes/hgnc:6238,,,3751.0,KCND2,9606.0,Homo sapiens (human),Blocker,,,,,,,
302,1747014,3081385,Comparative Toxicogenomics Database (CTD),"Cyclic 3',5'-uridine monophosphate",C045338,"cyclic 3',5'-uridine monophosphate",https://ctdbase.org/detail.go?type=chem&acc=C045338,343069,HNRNPCL1,https://ctdbase.org/detail.go?type=gene&acc=343069,,,343069.0,HNRNPCL1,9606.0,Homo sapiens (human),"HNRNPCL1 protein binds to cyclic 3',5'-uridine monophosphate",,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
303,1747015,3081385,Comparative Toxicogenomics Database (CTD),"Cyclic 3',5'-uridine monophosphate",C045338,"cyclic 3',5'-uridine monophosphate",https://ctdbase.org/detail.go?type=chem&acc=C045338,3184,HNRNPD,https://ctdbase.org/detail.go?type=gene&acc=3184,,,3184.0,HNRNPD,9606.0,Homo sapiens (human),"HNRNPD protein binds to cyclic 3',5'-uridine monophosphate",,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
304,1747016,3081385,Comparative Toxicogenomics Database (CTD),"Cyclic 3',5'-uridine monophosphate",C045338,"cyclic 3',5'-uridine monophosphate",https://ctdbase.org/detail.go?type=chem&acc=C045338,9987,HNRNPDL,https://ctdbase.org/detail.go?type=gene&acc=9987,,,9987.0,HNRNPDL,9606.0,Homo sapiens (human),"HNRNPDL protein binds to cyclic 3',5'-uridine monophosphate",,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
305,1747017,3081385,Comparative Toxicogenomics Database (CTD),"Cyclic 3',5'-uridine monophosphate",C045338,"cyclic 3',5'-uridine monophosphate",https://ctdbase.org/detail.go?type=chem&acc=C045338,3187,HNRNPH1,https://ctdbase.org/detail.go?type=gene&acc=3187,,,3187.0,HNRNPH1,9606.0,Homo sapiens (human),"HNRNPH1 protein binds to cyclic 3',5'-uridine monophosphate",,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
306,1747018,3081385,Comparative Toxicogenomics Database (CTD),"Cyclic 3',5'-uridine monophosphate",C045338,"cyclic 3',5'-uridine monophosphate",https://ctdbase.org/detail.go?type=chem&acc=C045338,3190,HNRNPK,https://ctdbase.org/detail.go?type=gene&acc=3190,,,3190.0,HNRNPK,9606.0,Homo sapiens (human),"HNRNPK protein binds to cyclic 3',5'-uridine monophosphate",,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
307,1747019,3081385,Comparative Toxicogenomics Database (CTD),"Cyclic 3',5'-uridine monophosphate",C045338,"cyclic 3',5'-uridine monophosphate",https://ctdbase.org/detail.go?type=chem&acc=C045338,3191,HNRNPL,https://ctdbase.org/detail.go?type=gene&acc=3191,,,3191.0,HNRNPL,9606.0,Homo sapiens (human),"HNRNPL protein binds to cyclic 3',5'-uridine monophosphate",,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
308,1747020,3081385,Comparative Toxicogenomics Database (CTD),"Cyclic 3',5'-uridine monophosphate",C045338,"cyclic 3',5'-uridine monophosphate",https://ctdbase.org/detail.go?type=chem&acc=C045338,4670,HNRNPM,https://ctdbase.org/detail.go?type=gene&acc=4670,,,4670.0,HNRNPM,9606.0,Homo sapiens (human),"HNRNPM protein binds to cyclic 3',5'-uridine monophosphate",,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
309,1747830,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090.0,Mus musculus (house mouse),Ginsenosides results in decreased expression of PCNA protein,,,PMID:36641037,https://www.ncbi.nlm.nih.gov/pubmed/36641037,36641037,,
310,1747831,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,10090.0,Mus musculus (house mouse),Ginsenosides results in decreased phosphorylation of PIK3R1 protein,,,PMID:36641037,https://www.ncbi.nlm.nih.gov/pubmed/36641037,36641037,,
311,1747832,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),PPARA protein affects the reaction [ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mrna]]|ginsenosides inhibits the reaction [pirinixic acid results in increased activity of PPARA protein]|ppara protein affects the reaction [ginsenosides results in increased expression of APOA1 mrna]|ppara protein affects the reaction [ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOC3 mrna]]|ginsenosides inhibits the reaction [pirinixic acid results in increased expression of PPARA mrna]|ppara protein affects the reaction [ginsenosides results in increased expression of APOC3 mrna]|ginsenosides results in decreased expression of PPARA mRNA,,,PMID:16297877,https://www.ncbi.nlm.nih.gov/pubmed/16297877,16297877,,
312,1747833,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),Ginsenosides metabolite results in increased expression of SIRT1 protein,,,PMID:30965081,https://www.ncbi.nlm.nih.gov/pubmed/30965081,30965081,,
313,1747834,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,10090.0,Mus musculus (house mouse),Ginsenosides results in decreased expression of SNAI1 protein,,,PMID:36641037,https://www.ncbi.nlm.nih.gov/pubmed/36641037,36641037,,
314,1747835,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),Ginsenosides inhibits the reaction [chlorpyrifos results in decreased expression of SOD1 protein],,,PMID:36152060,https://www.ncbi.nlm.nih.gov/pubmed/36152060,36152060,,
315,1747836,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10090.0,Mus musculus (house mouse),Ginsenosides inhibits the reaction [chlorpyrifos results in increased expression of TIMP1 mrna],,,PMID:36152060,https://www.ncbi.nlm.nih.gov/pubmed/36152060,36152060,,
316,1747837,3086007,Comparative Toxicogenomics Database (CTD),Ginsenosides,D036145,Ginsenosides,https://ctdbase.org/detail.go?type=chem&acc=D036145,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116.0,Rattus norvegicus (Norway rat),[paeonol co-treated with icariin co-treated with nobiletin co-treated with ginsenosides co-treated with astragaloside A] affects the secretion of TIMP1 protein,,,PMID:32344236,https://www.ncbi.nlm.nih.gov/pubmed/32344236,32344236,,
317,1751131,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,84962,AJUBA,https://ctdbase.org/detail.go?type=gene&acc=84962,,,84962.0,AJUBA,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of AJUBA mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
318,1751132,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of AKT1 mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
319,1751133,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,218,ALDH3A1,https://ctdbase.org/detail.go?type=gene&acc=218,,,218.0,ALDH3A1,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [particulate matter results in increased expression of ALDH3A1 mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [vehicle emissions results in increased expression of ALDH3A1 mrna],,,PMID:28655636,https://www.ncbi.nlm.nih.gov/pubmed/28655636,28655636,,
320,1752362,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,8537,BCAS1,https://ctdbase.org/detail.go?type=gene&acc=8537,,,8537.0,BCAS1,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of BCAS1 mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
321,1752363,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased expression of BCL2 protein,,,PMID:35123993,https://www.ncbi.nlm.nih.gov/pubmed/35123993,35123993,,
322,1752364,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,604,BCL6,https://ctdbase.org/detail.go?type=gene&acc=604,,,604.0,BCL6,10090.0,Mus musculus (house mouse),"2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [indeno(1,2,3-cd)pyrene promotes the reaction [antigens, dermatophagoides results in increased expression of BCL6 mrna]]",,,PMID:36975775,https://www.ncbi.nlm.nih.gov/pubmed/36975775,36975775,,
323,1752365,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,55814,BDP1,https://ctdbase.org/detail.go?type=gene&acc=55814,,,55814.0,BDP1,9606.0,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of BDP1 mRNA,,,PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/29704546,29704546,,
324,1752366,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alpinetin co-treated with TNF protein] results in increased expression of BECN1 protein]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[dextran sulfate co-treated with alpinetin] results in increased expression of BECN1 protein],,,PMID:31676321,https://www.ncbi.nlm.nih.gov/pubmed/31676321,31676321,,
325,1752367,3091786,Comparative Toxicogenomics Database (CTD),CH-223191,C511621,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide,https://ctdbase.org/detail.go?type=chem&acc=C511621,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [particulate matter results in decreased expression of BIRC5 mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [vehicle emissions results in decreased expression of BIRC5 mrna],,,PMID:28655636,https://www.ncbi.nlm.nih.gov/pubmed/28655636,28655636,,
326,1748991,3125888,Drug Gene Interaction database (DGIdb),"1-Cyclohexylamino-3-(3,6-dibromo-carbazol-9-yl)-propan-2-ol",,CHEMBL:CHEMBL530733,https://www.dgidb.org/drugs/chembl:CHEMBL530733,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,,,,,
327,1748992,3125888,Drug Gene Interaction database (DGIdb),"1-Cyclohexylamino-3-(3,6-dibromo-carbazol-9-yl)-propan-2-ol",,CHEMBL:CHEMBL530733,https://www.dgidb.org/drugs/chembl:CHEMBL530733,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
328,1748993,3129754,Drug Gene Interaction database (DGIdb),"6-(2-furyl)-6H-indeno[2,1-c][1,5]benzothiazepin-7-ol",,CHEMBL:CHEMBL606166,https://www.dgidb.org/drugs/chembl:CHEMBL606166,,TSHR,https://www.dgidb.org/genes/hgnc:12373,,,7253.0,TSHR,9606.0,Homo sapiens (human),,,,,,,,
329,1748994,3129754,Drug Gene Interaction database (DGIdb),"6-(2-furyl)-6H-indeno[2,1-c][1,5]benzothiazepin-7-ol",,CHEMBL:CHEMBL606166,https://www.dgidb.org/drugs/chembl:CHEMBL606166,,GMNN,https://www.dgidb.org/genes/hgnc:17493,,,51053.0,GMNN,9606.0,Homo sapiens (human),,,,,,,,
330,1748995,3129754,Drug Gene Interaction database (DGIdb),"6-(2-furyl)-6H-indeno[2,1-c][1,5]benzothiazepin-7-ol",,CHEMBL:CHEMBL606166,https://www.dgidb.org/drugs/chembl:CHEMBL606166,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606.0,Homo sapiens (human),,,,,,,,
331,1748996,3130863,Drug Gene Interaction database (DGIdb),"2,7-bis(4-Hydroxybutyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone",,CHEMBL:CHEMBL581225,https://www.dgidb.org/drugs/chembl:CHEMBL581225,,HTT,https://www.dgidb.org/genes/hgnc:4851,,,3064.0,HTT,9606.0,Homo sapiens (human),,,,,,,,
332,1753474,3140491,BindingDB,N-(4-chlorophenyl)-2-phenoxypropanamide,50294184,CHEMBL561640,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50294184,1988,Inosine-5'-monophosphate dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1988,P20839,Inosine-5'-monophosphate dehydrogenase 1 ,3614.0,IMPDH1,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:18215774|DOI:10.1016/j.chembiol.2007.12.010,https://www.ncbi.nlm.nih.gov/pubmed/18215774|https://doi.org/10.1016/j.chembiol.2007.12.010,18215774,10.1016/j.chembiol.2007.12.010,
333,1753475,3140491,BindingDB,N-(4-chlorophenyl)-2-phenoxypropanamide,50294184,CHEMBL561640,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50294184,1989,Inosine-5'-monophosphate dehydrogenase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1989,P12268,Inosine-5'-monophosphate dehydrogenase 2,3615.0,IMPDH2,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:18215774|DOI:10.1016/j.chembiol.2007.12.010,https://www.ncbi.nlm.nih.gov/pubmed/18215774|https://doi.org/10.1016/j.chembiol.2007.12.010,18215774,10.1016/j.chembiol.2007.12.010,
334,1753476,3140491,BindingDB,N-(4-chlorophenyl)-2-phenoxypropanamide,50294184,CHEMBL561640,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50294184,4874,Inosine-5-monophosphate dehydrogenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4874,,,,,,,,IC50 (nM),3.3e+3,PMID:18215774|DOI:10.1016/j.chembiol.2007.12.010,https://www.ncbi.nlm.nih.gov/pubmed/18215774|https://doi.org/10.1016/j.chembiol.2007.12.010,18215774,10.1016/j.chembiol.2007.12.010,
335,1748997,3147878,Drug Gene Interaction database (DGIdb),"2-Anilino-3-piperidin-1-ylnaphthalene-1,4-dione",,CHEMBL:CHEMBL578905,https://www.dgidb.org/drugs/chembl:CHEMBL578905,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
336,1753477,3151867,BindingDB,"6-[(2,3-Dioxo-1,4-dihydroquinoxalin-6-yl)oxy]-1,4-dihydroquinoxaline-2,3-dione",81327,"Tetrahydroquinoxalin analog, J",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81327,1988,Inosine-5'-monophosphate dehydrogenase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1988,P20839,Inosine-5'-monophosphate dehydrogenase 1 ,3614.0,IMPDH1,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:18215774|DOI:10.1016/j.chembiol.2007.12.010,https://www.ncbi.nlm.nih.gov/pubmed/18215774|https://doi.org/10.1016/j.chembiol.2007.12.010,18215774,10.1016/j.chembiol.2007.12.010,
337,1753478,3151867,BindingDB,"6-[(2,3-Dioxo-1,4-dihydroquinoxalin-6-yl)oxy]-1,4-dihydroquinoxaline-2,3-dione",81327,"Tetrahydroquinoxalin analog, J",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81327,1989,Inosine-5'-monophosphate dehydrogenase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1989,P12268,Inosine-5'-monophosphate dehydrogenase 2,3615.0,IMPDH2,9606.0,Homo sapiens (human),,IC50 (nM),>5.0e+4,PMID:18215774|DOI:10.1016/j.chembiol.2007.12.010,https://www.ncbi.nlm.nih.gov/pubmed/18215774|https://doi.org/10.1016/j.chembiol.2007.12.010,18215774,10.1016/j.chembiol.2007.12.010,
338,1753479,3151867,BindingDB,"6-[(2,3-Dioxo-1,4-dihydroquinoxalin-6-yl)oxy]-1,4-dihydroquinoxaline-2,3-dione",81327,"Tetrahydroquinoxalin analog, J",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=81327,4874,Inosine-5-monophosphate dehydrogenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4874,,,,,,,,IC50 (nM),5.9e+3,PMID:18215774|DOI:10.1016/j.chembiol.2007.12.010,https://www.ncbi.nlm.nih.gov/pubmed/18215774|https://doi.org/10.1016/j.chembiol.2007.12.010,18215774,10.1016/j.chembiol.2007.12.010,
339,1738442,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,94122,SYTL5,https://ctdbase.org/detail.go?type=gene&acc=94122,,,94122.0,SYTL5,9606.0,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL5 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
340,1738443,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,23118,TAB2,https://ctdbase.org/detail.go?type=gene&acc=23118,,,23118.0,TAB2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAB2 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAB2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
341,1738444,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,6863,TAC1,https://ctdbase.org/detail.go?type=gene&acc=6863,,,6863.0,TAC1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAC1 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAC1 mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAC1 mrna|[nog protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAC1 mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAC1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
342,1739320,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,54906,TASOR2,https://ctdbase.org/detail.go?type=gene&acc=54906,,,54906.0,TASOR2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TASOR2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
343,1739321,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,412,STS,https://ctdbase.org/detail.go?type=gene&acc=412,,,412.0,STS,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STS mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STS mrna|[nog protein co-treated with p-chloromercuribenzoic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STS mrna|[nog protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STS mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
344,1739322,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,201595,STT3B,https://ctdbase.org/detail.go?type=gene&acc=201595,,,201595.0,STT3B,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STT3B mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STT3B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
345,1753088,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of TBX2 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of TXNRD1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of TFAP2B mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of VGLL1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HSD3B1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DNAJB1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of RARA mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of MPZL1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of VTN mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HMGCS2 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of FAH mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of SEMA3C mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of GPR183 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of SPTSSB mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of SQSTM1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of HMOX1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of ELAVL3 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of SRXN1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of GSTA1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of CYP24A1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of NR2F2 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of SFRP2 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DCN mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of SH3BP5 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of SERPINA1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of TFAP2A mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of AFP mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of GSTA2 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of SLCO2B1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DCX mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of NQO1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of CDC20 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of MLIP mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of COL3A1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HOXA5 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of ELAVL4 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of APOA1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of VCAM1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of RBM20 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of GSTP1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of EBF3 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of FLRT3 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of NR2F1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of NEUROG2 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of UGT2A3 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of STMN2 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of MMP1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of GSTO1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of FOXG1 mrna|[ldn 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FG",,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
346,1753089,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,10148,EBI3,https://ctdbase.org/detail.go?type=gene&acc=10148,,,10148.0,EBI3,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBI3 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBI3 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBI3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
347,1753090,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,10969,EBNA1BP2,https://ctdbase.org/detail.go?type=gene&acc=10969,,,10969.0,EBNA1BP2,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EBNA1BP2 protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
348,1753091,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,10969,EBNA1BP2,https://ctdbase.org/detail.go?type=gene&acc=10969,,,10969.0,EBNA1BP2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBNA1BP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
349,1753092,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,10682,EBP,https://ctdbase.org/detail.go?type=gene&acc=10682,,,10682.0,EBP,9606.0,Homo sapiens (human),"[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EBP protein",,,PMID:37664457,https://www.ncbi.nlm.nih.gov/pubmed/37664457,37664457,,
350,1753093,4521392,Comparative Toxicogenomics Database (CTD),"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",C459179,"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",https://ctdbase.org/detail.go?type=chem&acc=C459179,1889,ECE1,https://ctdbase.org/detail.go?type=gene&acc=1889,,,1889.0,ECE1,9606.0,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECE1 mrna|[nog protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ECE1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
351,1741177,4799939,BindingDB,5-methyl-N-[2-(morpholin-4-yl)-5-(trifluoromethyl)phenyl]furan-2-carboxamide,221070,SPHINX,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=221070,5413,SRSF protein kinase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5413,Q96SB4,SRSF protein kinase 1,6732.0,SRPK1,9606.0,Homo sapiens (human),,IC50 (nM),880,PMID:28135068|DOI:10.1021/acschembio.6b01048,https://www.ncbi.nlm.nih.gov/pubmed/28135068|https://doi.org/10.1021/acschembio.6b01048,28135068,10.1021/acschembio.6b01048,
352,1741178,5005498,Drug Gene Interaction database (DGIdb),Alsterpaullone,,ALSTERPAULLONE,https://www.dgidb.org/drugs/drugbank:DB04014,,PIM1,https://www.dgidb.org/genes/hgnc:8986,,,5292.0,PIM1,9606.0,Homo sapiens (human),,,,,,,,
353,1741179,5005498,Drug Gene Interaction database (DGIdb),Alsterpaullone,,ALSTERPAULLONE,https://www.dgidb.org/drugs/drugbank:DB04014,,IKBKB,https://www.dgidb.org/genes/hgnc:5960,,,3551.0,IKBKB,9606.0,Homo sapiens (human),,,,,,,,
354,1741180,5005498,Drug Gene Interaction database (DGIdb),Alsterpaullone,,ALSTERPAULLONE,https://www.dgidb.org/drugs/drugbank:DB04014,,PDPK1,https://www.dgidb.org/genes/hgnc:8816,,,5170.0,PDPK1,9606.0,Homo sapiens (human),,,,,,,,
355,1741181,5005498,Drug Gene Interaction database (DGIdb),Alsterpaullone,,ALSTERPAULLONE,https://www.dgidb.org/drugs/drugbank:DB04014,,CDK1,https://www.dgidb.org/genes/hgnc:1722,,,983.0,CDK1,9606.0,Homo sapiens (human),,,,,,,,
356,1741182,5005498,Drug Gene Interaction database (DGIdb),Alsterpaullone,,ALSTERPAULLONE,https://www.dgidb.org/drugs/drugbank:DB04014,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
357,1741183,5005498,Drug Gene Interaction database (DGIdb),Alsterpaullone,,ALSTERPAULLONE,https://www.dgidb.org/drugs/drugbank:DB04014,,ROCK2,https://www.dgidb.org/genes/hgnc:10252,,,9475.0,ROCK2,9606.0,Homo sapiens (human),,,,,,,,
358,1741184,5018304,Drug Gene Interaction database (DGIdb),Diclofenac sodium,,DICLOFENAC SODIUM,https://www.dgidb.org/drugs/rxcui:203214,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,,,,,
359,1741185,5018304,Drug Gene Interaction database (DGIdb),Diclofenac sodium,,DICLOFENAC SODIUM,https://www.dgidb.org/drugs/rxcui:203214,,PLCG1,https://www.dgidb.org/genes/hgnc:9065,,,5335.0,PLCG1,9606.0,Homo sapiens (human),,,,,,,,
360,1741186,5040063,Therapeutic Target Database (TTD),Propyl pyrazole triol,D0Y8UF,propylpyrazoletriol,https://idrblab.net/ttd/data/drug/details/D0Y8UF,T89534,Estrogen receptor (ESR),https://idrblab.net/ttd/data/target/details/T89534,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Agonist,,,,,,,
361,1739529,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,10379,IRF9,https://ctdbase.org/detail.go?type=gene&acc=10379,,,10379.0,IRF9,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in decreased expression of IRF9 mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
362,1739530,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,345611,IRGM,https://ctdbase.org/detail.go?type=gene&acc=345611,,,345611.0,IRGM,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in decreased expression of IRGM mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
363,1739531,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3683,ITGAL,https://ctdbase.org/detail.go?type=gene&acc=3683,,,3683.0,ITGAL,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in decreased expression of ITGAL mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
364,1739532,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3699,ITIH3,https://ctdbase.org/detail.go?type=gene&acc=3699,,,3699.0,ITIH3,10090.0,Mus musculus (house mouse),Diethyl maleate results in decreased expression of ITIH3 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
365,1739533,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3700,ITIH4,https://ctdbase.org/detail.go?type=gene&acc=3700,,,3700.0,ITIH4,10090.0,Mus musculus (house mouse),Diethyl maleate results in decreased expression of ITIH4 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
366,1739715,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,83700,JAM3,https://ctdbase.org/detail.go?type=gene&acc=83700,,,83700.0,JAM3,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in decreased expression of JAM3 mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
367,1739716,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [diethyl maleate results in increased expression of JUN protein modified form]|diethyl maleate results in increased expression of JUN protein modified form,,,PMID:30261343,https://www.ncbi.nlm.nih.gov/pubmed/30261343,30261343,,
368,1739717,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090.0,Mus musculus (house mouse),Diethyl maleate results in increased expression of JUN mRNA,,,PMID:10915739|PMID:12774022,https://www.ncbi.nlm.nih.gov/pubmed/10915739|https://www.ncbi.nlm.nih.gov/pubmed/12774022,10915739|12774022,,
369,1739718,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090.0,Mus musculus (house mouse),Diethyl maleate results in increased phosphorylation of JUN protein|pyrazolanthrone inhibits the reaction [TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein]]|tnf protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein],,,PMID:12774022,https://www.ncbi.nlm.nih.gov/pubmed/12774022,12774022,,
370,1739719,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,10008,KCNE3,https://ctdbase.org/detail.go?type=gene&acc=10008,,,10008.0,KCNE3,10090.0,Mus musculus (house mouse),Diethyl maleate results in decreased expression of KCNE3 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
371,1739720,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606.0,Homo sapiens (human),Diethyl maleate results in increased expression of KEAP1 mRNA,,,PMID:33545341|PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/33545341|https://www.ncbi.nlm.nih.gov/pubmed/34480604,33545341|34480604,,
372,1739721,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606.0,Homo sapiens (human),Diethyl maleate results in increased expression of KEAP1 protein,,,PMID:27358234,https://www.ncbi.nlm.nih.gov/pubmed/27358234,27358234,,
373,1739722,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,10656,KHDRBS3,https://ctdbase.org/detail.go?type=gene&acc=10656,,,10656.0,KHDRBS3,9606.0,Homo sapiens (human),Diethyl maleate results in increased expression of KHDRBS3 mRNA,,,PMID:33545341,https://www.ncbi.nlm.nih.gov/pubmed/33545341,33545341,,
374,1739723,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3833,KIFC1,https://ctdbase.org/detail.go?type=gene&acc=3833,,,3833.0,KIFC1,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in increased expression of KIFC1 mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
375,1739724,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071.0,KLF10,10090.0,Mus musculus (house mouse),Diethyl maleate results in decreased expression of KLF10 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
376,1740418,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606.0,Homo sapiens (human),Diethyl maleate results in decreased activity of MGMT protein,,,PMID:16950796,https://www.ncbi.nlm.nih.gov/pubmed/16950796,16950796,,
377,1740419,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in increased expression of MKI67 mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
378,1740420,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,2872,MKNK2,https://ctdbase.org/detail.go?type=gene&acc=2872,,,2872.0,MKNK2,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in decreased expression of MKNK2 mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
379,1740421,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606.0,Homo sapiens (human),Diethyl maleate results in increased expression of MMP1 mRNA,,,PMID:33545341,https://www.ncbi.nlm.nih.gov/pubmed/33545341,33545341,,
380,1740422,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,4321,MMP12,https://ctdbase.org/detail.go?type=gene&acc=4321,,,4321.0,MMP12,10090.0,Mus musculus (house mouse),Diethyl maleate results in increased expression of MMP12 mRNA,,,PMID:10216232,https://www.ncbi.nlm.nih.gov/pubmed/10216232,10216232,,
381,1742672,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,10993,SDS,https://ctdbase.org/detail.go?type=gene&acc=10993,,,10993.0,SDS,10116.0,Rattus norvegicus (Norway rat),Diethyl maleate results in decreased expression of SDS mRNA,,,PMID:21161181,https://www.ncbi.nlm.nih.gov/pubmed/21161181,21161181,,
382,1742673,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,6414,SELENOP,https://ctdbase.org/detail.go?type=gene&acc=6414,,,6414.0,SELENOP,9606.0,Homo sapiens (human),Diethyl maleate results in decreased expression of SELENOP mRNA,,,PMID:30261343,https://www.ncbi.nlm.nih.gov/pubmed/30261343,30261343,,
383,1742674,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,20708,SERPINB6B,https://ctdbase.org/detail.go?type=gene&acc=20708,,,20708.0,Serpinb6b,10090.0,Mus musculus (house mouse),Diethyl maleate results in decreased expression of SERPINB6B mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
384,1742675,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,3053,SERPIND1,https://ctdbase.org/detail.go?type=gene&acc=3053,,,3053.0,SERPIND1,10090.0,Mus musculus (house mouse),Diethyl maleate results in decreased expression of SERPIND1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
385,1742676,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,29950,SERTAD1,https://ctdbase.org/detail.go?type=gene&acc=29950,,,29950.0,SERTAD1,9606.0,Homo sapiens (human),Diethyl maleate results in increased expression of SERTAD1 mRNA,,,PMID:33545341,https://www.ncbi.nlm.nih.gov/pubmed/33545341,33545341,,
386,1742677,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,94081,SFXN1,https://ctdbase.org/detail.go?type=gene&acc=94081,,,94081.0,SFXN1,10090.0,Mus musculus (house mouse),Diethyl maleate results in decreased expression of SFXN1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
387,1742678,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,9606.0,Homo sapiens (human),Diethyl maleate affects the expression of SH3BP5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
388,1742679,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,9606.0,Homo sapiens (human),Diethyl maleate results in increased expression of SH3BP5 mRNA,,,PMID:33545341,https://www.ncbi.nlm.nih.gov/pubmed/33545341,33545341,,
389,1742680,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,51804,SIX4,https://ctdbase.org/detail.go?type=gene&acc=51804,,,51804.0,SIX4,10090.0,Mus musculus (house mouse),Diethyl maleate results in increased expression of SIX4 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
390,1742681,5271566,Comparative Toxicogenomics Database (CTD),Diethyl maleate,C014476,diethyl maleate,https://ctdbase.org/detail.go?type=chem&acc=C014476,177343,SKN-1,https://ctdbase.org/detail.go?type=gene&acc=177343,,,177343.0,skn-1,6239.0,Caenorhabditis elegans,Diethyl maleate results in increased activity of SKN-1 protein,,,PMID:30261343,https://www.ncbi.nlm.nih.gov/pubmed/30261343,30261343,,
391,1739323,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6432,SRSF7,https://ctdbase.org/detail.go?type=gene&acc=6432,,,6432.0,SRSF7,9606.0,Homo sapiens (human),Quercetin results in decreased expression of SRSF7 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
392,1739324,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,10929,SRSF8,https://ctdbase.org/detail.go?type=gene&acc=10929,,,10929.0,SRSF8,9606.0,Homo sapiens (human),Quercetin results in decreased expression of SRSF8 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
393,1739325,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809.0,SRXN1,10116.0,Rattus norvegicus (Norway rat),Quercetin affects the expression of SRXN1 mRNA,,,PMID:18178720,https://www.ncbi.nlm.nih.gov/pubmed/18178720,18178720,,
394,1739326,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6742,SSBP1,https://ctdbase.org/detail.go?type=gene&acc=6742,,,6742.0,SSBP1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of SSBP1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
395,1739327,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6747,SSR3,https://ctdbase.org/detail.go?type=gene&acc=6747,,,6747.0,SSR3,9606.0,Homo sapiens (human),Quercetin results in increased expression of SSR3 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
396,1739328,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,51066,SSUH2,https://ctdbase.org/detail.go?type=gene&acc=51066,,,51066.0,SSUH2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of SSUH2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
397,1739329,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6767,ST13,https://ctdbase.org/detail.go?type=gene&acc=6767,,,6767.0,ST13,9606.0,Homo sapiens (human),ST13 protein modified form affects the reaction [quercetin results in increased ubiquitination of ERBB2 protein]|quercetin promotes the reaction [ST13 protein modified form binds to and results in increased ubiquitination of ERBB2 protein],,,PMID:18655187,https://www.ncbi.nlm.nih.gov/pubmed/18655187,18655187,,
398,1739330,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6480,ST6GAL1,https://ctdbase.org/detail.go?type=gene&acc=6480,,,6480.0,ST6GAL1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of ST6GAL1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
399,1739331,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,54879,ST7L,https://ctdbase.org/detail.go?type=gene&acc=54879,,,54879.0,ST7L,9606.0,Homo sapiens (human),Quercetin results in increased expression of ST7L mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
400,1739332,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,10274,STAG1,https://ctdbase.org/detail.go?type=gene&acc=10274,,,10274.0,STAG1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of STAG1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
401,1739333,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,10735,STAG2,https://ctdbase.org/detail.go?type=gene&acc=10735,,,10735.0,STAG2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of STAG2 mRNA,,,PMID:23727915,https://www.ncbi.nlm.nih.gov/pubmed/23727915,23727915,,
402,1739854,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [levetiracetam results in increased expression of GJA1 protein],,,PMID:37098359,https://www.ncbi.nlm.nih.gov/pubmed/37098359,37098359,,
403,1739855,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2702,GJA5,https://ctdbase.org/detail.go?type=gene&acc=2702,,,2702.0,GJA5,10116.0,Rattus norvegicus (Norway rat),Quercetin affects the expression of GJA5 mRNA,,,PMID:18178720,https://www.ncbi.nlm.nih.gov/pubmed/18178720,18178720,,
404,1739856,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2705,GJB1,https://ctdbase.org/detail.go?type=gene&acc=2705,,,2705.0,GJB1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of GJB1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
405,1739857,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2717,GLA,https://ctdbase.org/detail.go?type=gene&acc=2717,,,2717.0,GLA,9606.0,Homo sapiens (human),Quercetin results in increased expression of GLA mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
406,1741053,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6783,SULT1E1,https://ctdbase.org/detail.go?type=gene&acc=6783,,,6783.0,SULT1E1,9606.0,Homo sapiens (human),SULT1E1 protein results in increased sulfation of and results in decreased activity of quercetin,,,PMID:17293380,https://www.ncbi.nlm.nih.gov/pubmed/17293380,17293380,,
407,1741054,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,9606.0,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of SULT2A1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
408,1741055,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of SULT2A1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
409,1741227,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,9052,GPRC5A,https://ctdbase.org/detail.go?type=gene&acc=9052,,,9052.0,GPRC5A,9606.0,Homo sapiens (human),Quercetin results in increased expression of GPRC5A mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
410,1741228,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,55890,GPRC5C,https://ctdbase.org/detail.go?type=gene&acc=55890,,,55890.0,GPRC5C,9606.0,Homo sapiens (human),Quercetin results in decreased expression of GPRC5C mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
411,1741229,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,29899,GPSM2,https://ctdbase.org/detail.go?type=gene&acc=29899,,,29899.0,GPSM2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of GPSM2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
412,1741230,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,8855.0,Cairina moschata (Muscovy duck),Quercetin inhibits the reaction [gliotoxin results in increased expression of GPT protein],,,PMID:36990423,https://www.ncbi.nlm.nih.gov/pubmed/36990423,36990423,,
413,1741231,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [isoniazid results in increased expression of GPT protein],,,PMID:31332904,https://www.ncbi.nlm.nih.gov/pubmed/31332904,31332904,,
414,1741232,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [carbon tetrachloride results in increased activity of GPT protein],,,PMID:26218279,https://www.ncbi.nlm.nih.gov/pubmed/26218279,26218279,,
415,1741233,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [perfluorooctanoic acid results in increased expression of GPT protein],,,PMID:26054880,https://www.ncbi.nlm.nih.gov/pubmed/26054880,26054880,,
416,1741234,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [cyclosporine results in increased activity of GPT protein]|[quercetin co-treated with vitamin E] inhibits the reaction [cyclosporine results in increased activity of GPT protein],,,PMID:17927767,https://www.ncbi.nlm.nih.gov/pubmed/17927767,17927767,,
417,1742692,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [atrazine results in increased expression of GSR mrna],,,PMID:23070809|PMID:23132811,https://www.ncbi.nlm.nih.gov/pubmed/23070809|https://www.ncbi.nlm.nih.gov/pubmed/23132811,23070809|23132811,,
418,1742693,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606.0,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TF mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
419,1742694,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [lipopolysaccharides results in increased activity of TF protein],,,PMID:16507316,https://www.ncbi.nlm.nih.gov/pubmed/16507316,16507316,,
420,1742695,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [erastin results in increased expression of TF protein]|quercetin inhibits the reaction [erastin results in increased expression of TF mrna],,,PMID:37230155,https://www.ncbi.nlm.nih.gov/pubmed/37230155,37230155,,
421,1742696,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7019,TFAM,https://ctdbase.org/detail.go?type=gene&acc=7019,,,7019.0,TFAM,9606.0,Homo sapiens (human),Quercetin results in increased expression of TFAM protein,,,PMID:21051700,https://www.ncbi.nlm.nih.gov/pubmed/21051700,21051700,,
422,1742697,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7019,TFAM,https://ctdbase.org/detail.go?type=gene&acc=7019,,,7019.0,TFAM,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [aluminum lactate results in decreased expression of TFAM protein]|quercetin inhibits the reaction [aluminum lactate results in decreased expression of TFAM mrna],,,PMID:26493151,https://www.ncbi.nlm.nih.gov/pubmed/26493151,26493151,,
423,1742698,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,51106,TFB1M,https://ctdbase.org/detail.go?type=gene&acc=51106,,,51106.0,TFB1M,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TFB1M mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
424,1742699,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7027,TFDP1,https://ctdbase.org/detail.go?type=gene&acc=7027,,,7027.0,TFDP1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TFDP1 mRNA,,,PMID:23727915,https://www.ncbi.nlm.nih.gov/pubmed/23727915,23727915,,
425,1742700,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7029,TFDP2,https://ctdbase.org/detail.go?type=gene&acc=7029,,,7029.0,TFDP2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TFDP2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
426,1742701,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),Quercetin results in increased expression of TFF1 mRNA,,,PMID:14706564|PMID:15090535|PMID:21632981|PMID:32530119,https://www.ncbi.nlm.nih.gov/pubmed/14706564|https://www.ncbi.nlm.nih.gov/pubmed/15090535|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/32530119,14706564|15090535|21632981|32530119,,
427,1742702,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7031,TFF1,https://ctdbase.org/detail.go?type=gene&acc=7031,,,7031.0,TFF1,9606.0,Homo sapiens (human),Tamoxifen inhibits the reaction [quercetin results in increased expression of TFF1 mrna],,,PMID:32530119,https://www.ncbi.nlm.nih.gov/pubmed/32530119,32530119,,
428,1744006,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,29087,THYN1,https://ctdbase.org/detail.go?type=gene&acc=29087,,,29087.0,THYN1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of THYN1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
429,1744007,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7072,TIA1,https://ctdbase.org/detail.go?type=gene&acc=7072,,,7072.0,TIA1,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TIA1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
430,1744008,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,148022,TICAM1,https://ctdbase.org/detail.go?type=gene&acc=148022,,,148022.0,TICAM1,9606.0,Homo sapiens (human),Quercetin results in increased expression of TICAM1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
431,1744009,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,353376,TICAM2,https://ctdbase.org/detail.go?type=gene&acc=353376,,,353376.0,TICAM2,9606.0,Homo sapiens (human),Quercetin results in increased expression of TICAM2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
432,1744010,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,92610,TIFA,https://ctdbase.org/detail.go?type=gene&acc=92610,,,92610.0,TIFA,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TIFA mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
433,1744011,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,57103,TIGAR,https://ctdbase.org/detail.go?type=gene&acc=57103,,,57103.0,TIGAR,9606.0,Homo sapiens (human),Quercetin results in increased expression of TIGAR mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
434,1744012,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,166815,TIGD2,https://ctdbase.org/detail.go?type=gene&acc=166815,,,166815.0,TIGD2,9606.0,Homo sapiens (human),Quercetin results in decreased expression of TIGD2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
435,1744013,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,8914,TIMELESS,https://ctdbase.org/detail.go?type=gene&acc=8914,,,8914.0,TIMELESS,9606.0,Homo sapiens (human),Quercetin results in increased expression of TIMELESS mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
436,1746388,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [dietary fats results in increased expression of TNF mrna]|quercetin inhibits the reaction [dietary fats results in increased expression of TNF protein],,,PMID:24465016|PMID:25614714,https://www.ncbi.nlm.nih.gov/pubmed/24465016|https://www.ncbi.nlm.nih.gov/pubmed/25614714,24465016|25614714,,
437,1746389,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Quercetin results in increased phosphorylation of and results in increased activity of TP53 protein,,,PMID:25078064,https://www.ncbi.nlm.nih.gov/pubmed/25078064,25078064,,
438,1746390,5280343,Comparative Toxicogenomics Database (CTD),Quercetin,D011794,Quercetin,https://ctdbase.org/detail.go?type=chem&acc=D011794,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Quercetin results in increased phosphorylation of TP53 protein,,,PMID:22983795,https://www.ncbi.nlm.nih.gov/pubmed/22983795,22983795,,
439,1746789,5280378,Comparative Toxicogenomics Database (CTD),Formononetin,C007768,formononetin,https://ctdbase.org/detail.go?type=chem&acc=C007768,5563,PRKAA2,https://ctdbase.org/detail.go?type=gene&acc=5563,,,5563.0,PRKAA2,10090.0,Mus musculus (house mouse),Lipopolysaccharides promotes the reaction [formononetin results in increased phosphorylation of PRKAA2 protein]|formononetin results in increased phosphorylation of PRKAA2 protein,,,PMID:37269934,https://www.ncbi.nlm.nih.gov/pubmed/37269934,37269934,,
440,1746790,5280378,Comparative Toxicogenomics Database (CTD),Formononetin,C007768,formononetin,https://ctdbase.org/detail.go?type=chem&acc=C007768,5567,PRKACB,https://ctdbase.org/detail.go?type=gene&acc=5567,,,5567.0,PRKACB,10090.0,Mus musculus (house mouse),[lipopolysaccharides co-treated with formononetin] results in increased phosphorylation of PRKACB protein,,,PMID:37269934,https://www.ncbi.nlm.nih.gov/pubmed/37269934,37269934,,
441,1747162,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606.0,Homo sapiens (human),Luteolin results in increased activity of CASP7 protein,,,PMID:21074525,https://www.ncbi.nlm.nih.gov/pubmed/21074525,21074525,,
442,1747163,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),[luteolin co-treated with paclitaxel] results in increased cleavage of CASP8 protein,,,PMID:24525192,https://www.ncbi.nlm.nih.gov/pubmed/24525192,24525192,,
443,1747164,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Luteolin promotes the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP8 protein],,,PMID:15334063,https://www.ncbi.nlm.nih.gov/pubmed/15334063,15334063,,
444,1747165,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein],,,PMID:16140950,https://www.ncbi.nlm.nih.gov/pubmed/16140950,16140950,,
445,1747166,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116.0,Rattus norvegicus (Norway rat),Luteolin inhibits the reaction [hydrogen peroxide results in increased expression of CASP8 protein],,,PMID:27525270,https://www.ncbi.nlm.nih.gov/pubmed/27525270,27525270,,
446,1747167,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),"Luteolin inhibits the reaction [metals, heavy results in increased cleavage of CASP9 protein]|luteolin inhibits the reaction [[lead co-treated with cadmium co-treated with mercury co-treated with copper co-treated with zinc co-treated with manganese co-treated with chromium co-treated with nickel] results in increased cleavage of CASP9 protein]",,,PMID:29115570,https://www.ncbi.nlm.nih.gov/pubmed/29115570,29115570,,
447,1747168,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Luteolin results in increased activity of CASP9 protein,,,PMID:21601631|PMID:27489195,https://www.ncbi.nlm.nih.gov/pubmed/21601631|https://www.ncbi.nlm.nih.gov/pubmed/27489195,21601631|27489195,,
448,1747169,5280445,Comparative Toxicogenomics Database (CTD),Luteolin,D047311,Luteolin,https://ctdbase.org/detail.go?type=chem&acc=D047311,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Luteolin results in increased cleavage of CASP9 protein,,,PMID:18331776|PMID:19397994|PMID:27474067,https://www.ncbi.nlm.nih.gov/pubmed/18331776|https://www.ncbi.nlm.nih.gov/pubmed/19397994|https://www.ncbi.nlm.nih.gov/pubmed/27474067,18331776|19397994|27474067,,
449,1744301,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,10090.0,Mus musculus (house mouse),Calcitriol results in decreased expression of ODC1 protein,,,PMID:9224728,https://www.ncbi.nlm.nih.gov/pubmed/9224728,9224728,,
450,1744302,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,11339,OIP5,https://ctdbase.org/detail.go?type=gene&acc=11339,,,11339.0,OIP5,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of OIP5 mrna|[testosterone co-treated with calcitriol] results in decreased expression of OIP5 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
451,1744303,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,55301,OLAH,https://ctdbase.org/detail.go?type=gene&acc=55301,,,55301.0,OLAH,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of OLAH mrna|calcitriol results in increased expression of OLAH mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
452,1744613,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,56957,OTUD7B,https://ctdbase.org/detail.go?type=gene&acc=56957,,,56957.0,OTUD7B,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of OTUD7B mrna|calcitriol results in increased expression of OTUD7B mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
453,1744614,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,90268,OTULIN,https://ctdbase.org/detail.go?type=gene&acc=90268,,,90268.0,OTULIN,9606.0,Homo sapiens (human),Calcitriol results in increased expression of OTULIN mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
454,1744615,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,54491,OTULINL,https://ctdbase.org/detail.go?type=gene&acc=54491,,,54491.0,OTULINL,9606.0,Homo sapiens (human),Calcitriol results in increased expression of OTULINL mrna|[testosterone co-treated with calcitriol] results in increased expression of OTULINL mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
455,1744616,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,144203,OVOS2,https://ctdbase.org/detail.go?type=gene&acc=144203,,,144203.0,OVOS2,9606.0,Homo sapiens (human),Calcitriol results in increased expression of OVOS2 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
456,1746380,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,113026,PLCD3,https://ctdbase.org/detail.go?type=gene&acc=113026,,,113026.0,PLCD3,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of PLCD3 mrna|calcitriol results in increased expression of PLCD3 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
457,1746381,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,23007,PLCH1,https://ctdbase.org/detail.go?type=gene&acc=23007,,,23007.0,PLCH1,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of PLCH1 mrna|[testosterone co-treated with calcitriol] results in decreased expression of PLCH1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
458,1746382,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,257068,PLCXD2,https://ctdbase.org/detail.go?type=gene&acc=257068,,,257068.0,PLCXD2,9606.0,Homo sapiens (human),Calcitriol results in increased expression of PLCXD2 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
459,1746383,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,5338,PLD2,https://ctdbase.org/detail.go?type=gene&acc=5338,,,5338.0,PLD2,9606.0,Homo sapiens (human),Calcitriol results in increased expression of PLD2 mrna|[testosterone co-treated with calcitriol] results in increased expression of PLD2 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
460,1746384,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,59339,PLEKHA2,https://ctdbase.org/detail.go?type=gene&acc=59339,,,59339.0,PLEKHA2,9606.0,Homo sapiens (human),Calcitriol results in increased expression of PLEKHA2 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
461,1746385,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,22874,PLEKHA6,https://ctdbase.org/detail.go?type=gene&acc=22874,,,22874.0,PLEKHA6,9606.0,Homo sapiens (human),Calcitriol results in increased expression of PLEKHA6 mRNA,,,PMID:21592394|PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/21592394|https://www.ncbi.nlm.nih.gov/pubmed/26485663,21592394|26485663,,
462,1746386,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,22874,PLEKHA6,https://ctdbase.org/detail.go?type=gene&acc=22874,,,22874.0,PLEKHA6,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of PLEKHA6 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
463,1746387,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,144100,PLEKHA7,https://ctdbase.org/detail.go?type=gene&acc=144100,,,144100.0,PLEKHA7,9606.0,Homo sapiens (human),Calcitriol results in increased expression of PLEKHA7 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
464,1746894,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,10721,POLQ,https://ctdbase.org/detail.go?type=gene&acc=10721,,,10721.0,POLQ,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of POLQ mrna|calcitriol results in decreased expression of POLQ mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
465,1747939,5280453,DrugBank,Calcitriol,DB00136,Calcitriol,https://www.drugbank.ca/drugs/DB00136,BE0001141,Vitamin D-binding protein,https://www.drugbank.ca/bio_entities/BE0001141,P02774,Vitamin D-binding protein,2638.0,GC,9606.0,Homo sapiens (human),Binder,,,PMID:27742848|PMID:8370586,https://www.ncbi.nlm.nih.gov/pubmed/27742848|https://www.ncbi.nlm.nih.gov/pubmed/8370586,27742848|8370586,,
466,1749637,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,494115,RBMXL1,https://ctdbase.org/detail.go?type=gene&acc=494115,,,494115.0,RBMXL1,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of RBMXL1 mrna|[testosterone co-treated with calcitriol] results in decreased expression of RBMXL1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
467,1749638,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,116362,RBP7,https://ctdbase.org/detail.go?type=gene&acc=116362,,,116362.0,RBP7,9606.0,Homo sapiens (human),Calcitriol results in increased expression of RBP7 mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
468,1749639,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,1827,RCAN1,https://ctdbase.org/detail.go?type=gene&acc=1827,,,1827.0,RCAN1,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of RCAN1 mrna|calcitriol results in increased expression of RCAN1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
469,1749772,5280453,Drug Gene Interaction database (DGIdb),Calcitriol,,CALCITRIOL,https://www.dgidb.org/drugs/rxcui:1894,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606.0,Homo sapiens (human),,,,,,,,
470,1751993,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,6278,S100A7,https://ctdbase.org/detail.go?type=gene&acc=6278,,,6278.0,S100A7,9606.0,Homo sapiens (human),Calcitriol results in increased expression of S100A7 mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
471,1751994,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,6279,S100A8,https://ctdbase.org/detail.go?type=gene&acc=6279,,,6279.0,S100A8,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of S100A8 mRNA,,,PMID:16002434|PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/16002434|https://www.ncbi.nlm.nih.gov/pubmed/26485663,16002434|26485663,,
472,1751995,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,6279,S100A8,https://ctdbase.org/detail.go?type=gene&acc=6279,,,6279.0,S100A8,9606.0,Homo sapiens (human),Calcitriol results in increased expression of S100A8 mRNA,,,PMID:1733233|PMID:20089671,https://www.ncbi.nlm.nih.gov/pubmed/1733233|https://www.ncbi.nlm.nih.gov/pubmed/20089671,1733233|20089671,,
473,1751996,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,6279,S100A8,https://ctdbase.org/detail.go?type=gene&acc=6279,,,6279.0,S100A8,9606.0,Homo sapiens (human),Calcitriol results in increased expression of S100A8 protein,,,PMID:20089671,https://www.ncbi.nlm.nih.gov/pubmed/20089671,20089671,,
474,1751997,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,6280,S100A9,https://ctdbase.org/detail.go?type=gene&acc=6280,,,6280.0,S100A9,9606.0,Homo sapiens (human),Calcitriol results in increased expression of S100A9 mRNA,,,PMID:1733233|PMID:20089671,https://www.ncbi.nlm.nih.gov/pubmed/1733233|https://www.ncbi.nlm.nih.gov/pubmed/20089671,1733233|20089671,,
475,1752897,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,5272,SERPINB9,https://ctdbase.org/detail.go?type=gene&acc=5272,,,5272.0,SERPINB9,9606.0,Homo sapiens (human),Calcitriol results in increased expression of SERPINB9 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
476,1752898,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),[benzo(a)pyrene co-treated with calcitriol] results in increased expression of SERPINE1 mrna|[benzo(a)pyrene co-treated with calcitriol] results in increased expression of SERPINE1 protein,,,PMID:29524502,https://www.ncbi.nlm.nih.gov/pubmed/29524502,29524502,,
477,1752899,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),Calcitriol results in increased expression of SERPINE2 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
478,1752900,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,5176,SERPINF1,https://ctdbase.org/detail.go?type=gene&acc=5176,,,5176.0,SERPINF1,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of SERPINF1 mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
479,1752901,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,5274,SERPINI1,https://ctdbase.org/detail.go?type=gene&acc=5274,,,5274.0,SERPINI1,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of SERPINI1 mrna|calcitriol results in decreased expression of SERPINI1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
480,1752902,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,27244,SESN1,https://ctdbase.org/detail.go?type=gene&acc=27244,,,27244.0,SESN1,9606.0,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of SESN1 mrna|calcitriol results in decreased expression of SESN1 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
481,1752903,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,6418,SET,https://ctdbase.org/detail.go?type=gene&acc=6418,,,6418.0,SET,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of SET mRNA,,,PMID:12798352,https://www.ncbi.nlm.nih.gov/pubmed/12798352,12798352,,
482,1752904,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,26470,SEZ6L2,https://ctdbase.org/detail.go?type=gene&acc=26470,,,26470.0,SEZ6L2,9606.0,Homo sapiens (human),Calcitriol results in decreased expression of SEZ6L2 mRNA,,,PMID:16002434,https://www.ncbi.nlm.nih.gov/pubmed/16002434,16002434,,
483,1752905,5280453,Comparative Toxicogenomics Database (CTD),Calcitriol,D002117,Calcitriol,https://ctdbase.org/detail.go?type=chem&acc=D002117,2810,SFN,https://ctdbase.org/detail.go?type=gene&acc=2810,,,2810.0,SFN,9606.0,Homo sapiens (human),Calcitriol results in increased expression of SFN mRNA,,,PMID:26485663,https://www.ncbi.nlm.nih.gov/pubmed/26485663,26485663,,
484,1749773,5280459,Therapeutic Target Database (TTD),Quercitrin,D07DJS,QUERCITRIN,https://idrblab.net/ttd/data/drug/details/D07DJS,T26623,Aldose reductase (AKR1B1),https://idrblab.net/ttd/data/target/details/T26623,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
485,1749774,5280489,Comparative Toxicogenomics Database (CTD),Beta-Carotene,D019207,beta Carotene,https://ctdbase.org/detail.go?type=chem&acc=D019207,28976,ACAD9,https://ctdbase.org/detail.go?type=gene&acc=28976,,,28976.0,ACAD9,10090.0,Mus musculus (house mouse),[BCO1 protein affects the susceptibility to beta carotene] which affects the expression of ACAD9 mRNA,,,PMID:24657404,https://www.ncbi.nlm.nih.gov/pubmed/24657404,24657404,,
486,1749775,5280489,Comparative Toxicogenomics Database (CTD),Beta-Carotene,D019207,beta Carotene,https://ctdbase.org/detail.go?type=chem&acc=D019207,124,ADH1A,https://ctdbase.org/detail.go?type=gene&acc=124,,,124.0,ADH1A,9606.0,Homo sapiens (human),Beta carotene results in increased expression of ADH1A mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
487,1749776,5280489,Comparative Toxicogenomics Database (CTD),Beta-Carotene,D019207,beta Carotene,https://ctdbase.org/detail.go?type=chem&acc=D019207,128,ADH5,https://ctdbase.org/detail.go?type=gene&acc=128,,,128.0,ADH5,9606.0,Homo sapiens (human),Beta carotene results in increased expression of ADH5 mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
488,1749777,5280489,Comparative Toxicogenomics Database (CTD),Beta-Carotene,D019207,beta Carotene,https://ctdbase.org/detail.go?type=chem&acc=D019207,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10090.0,Mus musculus (house mouse),Beta carotene results in decreased expression of ADIPOQ mRNA,,,PMID:21569430,https://www.ncbi.nlm.nih.gov/pubmed/21569430,21569430,,
489,1749778,5280489,Comparative Toxicogenomics Database (CTD),Beta-Carotene,D019207,beta Carotene,https://ctdbase.org/detail.go?type=chem&acc=D019207,165,AEBP1,https://ctdbase.org/detail.go?type=gene&acc=165,,,165.0,AEBP1,10090.0,Mus musculus (house mouse),[BCO1 protein affects the susceptibility to beta carotene] which affects the expression of AEBP1 mRNA,,,PMID:24657404,https://www.ncbi.nlm.nih.gov/pubmed/24657404,24657404,,
490,1747940,5280531,Comparative Toxicogenomics Database (CTD),Vitamin A Palmitate,C014794,retinol palmitate,https://ctdbase.org/detail.go?type=chem&acc=C014794,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Retinol palmitate results in increased activity of CAT protein,,,PMID:20679000,https://www.ncbi.nlm.nih.gov/pubmed/20679000,20679000,,
491,1747941,5280531,Comparative Toxicogenomics Database (CTD),Vitamin A Palmitate,C014794,retinol palmitate,https://ctdbase.org/detail.go?type=chem&acc=C014794,1208,CLPS,https://ctdbase.org/detail.go?type=gene&acc=1208,,,1208.0,CLPS,9796.0,Equus caballus (horse),[PNLIPRP2 protein co-treated with CLPS protein] results in increased hydrolysis of retinol palmitate,,,PMID:16497549,https://www.ncbi.nlm.nih.gov/pubmed/16497549,16497549,,
492,1747942,5280531,Comparative Toxicogenomics Database (CTD),Vitamin A Palmitate,C014794,retinol palmitate,https://ctdbase.org/detail.go?type=chem&acc=C014794,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),Retinol palmitate results in increased expression of CYP3A11 mRNA,,,PMID:19686701,https://www.ncbi.nlm.nih.gov/pubmed/19686701,19686701,,
493,1747943,5280531,Comparative Toxicogenomics Database (CTD),Vitamin A Palmitate,C014794,retinol palmitate,https://ctdbase.org/detail.go?type=chem&acc=C014794,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Retinol palmitate promotes the reaction [[RXRA protein co-treated with NR1I3 protein] results in increased expression of CYP3A4 mrna]|retinol palmitate promotes the reaction [[RXRG protein co-treated with NR1I3 protein] results in increased expression of CYP3A4 mrna],,,PMID:19686701,https://www.ncbi.nlm.nih.gov/pubmed/19686701,19686701,,
494,1747944,5280531,Comparative Toxicogenomics Database (CTD),Vitamin A Palmitate,C014794,retinol palmitate,https://ctdbase.org/detail.go?type=chem&acc=C014794,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,10116.0,Rattus norvegicus (Norway rat),Retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein],,,PMID:17164434,https://www.ncbi.nlm.nih.gov/pubmed/17164434,17164434,,
495,1747945,5280531,Comparative Toxicogenomics Database (CTD),Vitamin A Palmitate,C014794,retinol palmitate,https://ctdbase.org/detail.go?type=chem&acc=C014794,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),Retinol palmitate inhibits the reaction [lipopolysaccharides results in increased secretion of IL10 protein],,,PMID:17377406,https://www.ncbi.nlm.nih.gov/pubmed/17377406,17377406,,
496,1747946,5280531,Comparative Toxicogenomics Database (CTD),Vitamin A Palmitate,C014794,retinol palmitate,https://ctdbase.org/detail.go?type=chem&acc=C014794,3557,IL1RN,https://ctdbase.org/detail.go?type=gene&acc=3557,,,3557.0,IL1RN,9606.0,Homo sapiens (human),Retinol palmitate inhibits the reaction [lipopolysaccharides results in increased secretion of IL1RN protein],,,PMID:17377406,https://www.ncbi.nlm.nih.gov/pubmed/17377406,17377406,,
497,1750578,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606.0,Homo sapiens (human),Senecionine results in decreased expression of ABCB11 mRNA,,,PMID:26100227,https://www.ncbi.nlm.nih.gov/pubmed/26100227,26100227,,
498,1750579,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,10090.0,Mus musculus (house mouse),Senecionine results in decreased expression of ABCB11 mRNA,,,PMID:31606820,https://www.ncbi.nlm.nih.gov/pubmed/31606820,31606820,,
499,1750580,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,18669,ABCB1B,https://ctdbase.org/detail.go?type=gene&acc=18669,,,18669.0,Abcb1b,10116.0,Rattus norvegicus (Norway rat),Senecionine results in increased expression of ABCB1B mRNA,,,PMID:32419051,https://www.ncbi.nlm.nih.gov/pubmed/32419051,32419051,,
500,1753324,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Senecionine results in increased expression of CYP1A2 mRNA,,,PMID:26100227,https://www.ncbi.nlm.nih.gov/pubmed/26100227,26100227,,
501,1753325,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10090.0,Mus musculus (house mouse),Senecionine results in decreased expression of CYP1A2 mRNA,,,PMID:31606820,https://www.ncbi.nlm.nih.gov/pubmed/31606820,31606820,,
502,1753326,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Senecionine results in increased expression of CYP1B1 mRNA,,,PMID:26100227,https://www.ncbi.nlm.nih.gov/pubmed/26100227,26100227,,
503,1753327,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,1553,CYP2A13,https://ctdbase.org/detail.go?type=gene&acc=1553,,,1553.0,CYP2A13,9606.0,Homo sapiens (human),Senecionine results in increased expression of CYP2A13 mRNA,,,PMID:26100227,https://www.ncbi.nlm.nih.gov/pubmed/26100227,26100227,,
504,1753328,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,13086,CYP2A4,https://ctdbase.org/detail.go?type=gene&acc=13086,,,13086.0,Cyp2a4,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of CYP2A4 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
505,1753329,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,13087,CYP2A5,https://ctdbase.org/detail.go?type=gene&acc=13087,,,13087.0,Cyp2a5,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of CYP2A5 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
506,1753330,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090.0,Mus musculus (house mouse),Senecionine affects the expression of CYP2B10 mRNA,,,PMID:31606820,https://www.ncbi.nlm.nih.gov/pubmed/31606820,31606820,,
507,1753331,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,13090,CYP2B19,https://ctdbase.org/detail.go?type=gene&acc=13090,,,13090.0,Cyp2b19,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of CYP2B19 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
508,1754358,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,1969,EPHA2,https://ctdbase.org/detail.go?type=gene&acc=1969,,,1969.0,EPHA2,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of EPHA2 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
509,1754614,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,2162,F13A1,https://ctdbase.org/detail.go?type=gene&acc=2162,,,2162.0,F13A1,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of F13A1 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
510,1754615,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,51011,FAHD2A,https://ctdbase.org/detail.go?type=gene&acc=51011,,,51011.0,FAHD2A,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of FAHD2A protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
511,1754616,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,2177,FANCD2,https://ctdbase.org/detail.go?type=gene&acc=2177,,,2177.0,FANCD2,10116.0,Rattus norvegicus (Norway rat),Senecionine results in increased expression of FANCD2 mRNA,,,PMID:32419051,https://www.ncbi.nlm.nih.gov/pubmed/32419051,32419051,,
512,1754617,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Senecionine metabolite results in increased expression of FAS mRNA,,,PMID:30465738,https://www.ncbi.nlm.nih.gov/pubmed/30465738,30465738,,
513,1754618,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,10116.0,Rattus norvegicus (Norway rat),Senecionine results in increased expression of FAS mRNA,,,PMID:32419051,https://www.ncbi.nlm.nih.gov/pubmed/32419051,32419051,,
514,1754619,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,23014,FBXO21,https://ctdbase.org/detail.go?type=gene&acc=23014,,,23014.0,FBXO21,10090.0,Mus musculus (house mouse),Senecionine results in increased expression of FBXO21 protein,,,PMID:35357534,https://www.ncbi.nlm.nih.gov/pubmed/35357534,35357534,,
515,1754620,5280906,Comparative Toxicogenomics Database (CTD),Senecionine,C009237,senecionine,https://ctdbase.org/detail.go?type=chem&acc=C009237,2214,FCGR3A,https://ctdbase.org/detail.go?type=gene&acc=2214,,,2214.0,FCGR3A,10116.0,Rattus norvegicus (Norway rat),Senecionine results in increased expression of FCGR3A mRNA,,,PMID:34185104,https://www.ncbi.nlm.nih.gov/pubmed/34185104,34185104,,
516,1752522,5280914,Comparative Toxicogenomics Database (CTD),lipoxin A4,C040527,lipoxin A4,https://ctdbase.org/detail.go?type=chem&acc=C040527,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,9606.0,Homo sapiens (human),PDGFB protein promotes the reaction [lipoxin A4 results in decreased phosphorylation of PDGFRB protein]|lipoxin A4 results in decreased phosphorylation of PDGFRB protein,,,PMID:20709806,https://www.ncbi.nlm.nih.gov/pubmed/20709806,20709806,,
517,1752523,5280914,Comparative Toxicogenomics Database (CTD),lipoxin A4,C040527,lipoxin A4,https://ctdbase.org/detail.go?type=chem&acc=C040527,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Lipoxin A4 binds to and results in increased activity of PPARG protein,,,PMID:19321784,https://www.ncbi.nlm.nih.gov/pubmed/19321784,19321784,,
518,1752524,5280914,Comparative Toxicogenomics Database (CTD),lipoxin A4,C040527,lipoxin A4,https://ctdbase.org/detail.go?type=chem&acc=C040527,5724,PTAFR,https://ctdbase.org/detail.go?type=gene&acc=5724,,,5724.0,PTAFR,9606.0,Homo sapiens (human),[WEB 2086 binds to and results in decreased activity of PTAFR protein] which results in decreased susceptibility to lipoxin A4,,,PMID:7602232,https://www.ncbi.nlm.nih.gov/pubmed/7602232,7602232,,
519,1752525,5280914,Comparative Toxicogenomics Database (CTD),lipoxin A4,C040527,lipoxin A4,https://ctdbase.org/detail.go?type=chem&acc=C040527,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Celecoxib inhibits the reaction [PTGS2 protein affects the abundance of lipoxin A4]|PTGS2 protein affects the abundance of lipoxin A4,,,PMID:15326064,https://www.ncbi.nlm.nih.gov/pubmed/15326064,15326064,,
520,1741235,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1134,CHRNA1,https://ctdbase.org/detail.go?type=gene&acc=1134,,,1134.0,CHRNA1,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in decreased expression of CHRNA1 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
521,1741236,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606.0,Homo sapiens (human),5-butyl-6-hydroxy-10-chlorobenzo(c)quinolizinium chloride inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]|6-hydroxy-10-chlorobenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]|3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone inhibits the reaction [[[colforsin co-treated with genistein] results in increased activity of CFTR protein] which results in increased transport of iodides]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|brefeldin A inhibits the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|fenamic acid inhibits the reaction [[[colforsin co-treated with genistein] results in increased activity of CFTR protein] which results in increased transport of iodides]|glyburide inhibits the reaction [[[colforsin co-treated with genistein] results in increased activity of CFTR protein] which results in increased transport of iodides]|geldanamycin promotes the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|brefeldin A inhibits the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|geldanamycin promotes the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|cftr protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]|thapsigargin promotes the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]|thapsigargin promotes the reaction [5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [miglustat inhibits the reaction [CFTR protein mutant form inhibits the reaction [[colforsin co-treated with genistein] results in increased transport of iodides]]]|[[colforsin co-treated with genistein] results in increased activity of CFTR protein] which results in increased transport of iodides|[colforsin co-treated with genistein] results in increased activity of CFTR protein,,,PMID:18230692,https://www.ncbi.nlm.nih.gov/pubmed/18230692,18230692,,
522,1741237,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606.0,Homo sapiens (human),Genistein affects the localization of CFTR protein mutant form,,,PMID:15191910,https://www.ncbi.nlm.nih.gov/pubmed/15191910,15191910,,
523,1742827,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,54102,CLIC6,https://ctdbase.org/detail.go?type=gene&acc=54102,,,54102.0,CLIC6,9606.0,Homo sapiens (human),Genistein results in increased expression of CLIC6 mRNA,,,PMID:16474171,https://www.ncbi.nlm.nih.gov/pubmed/16474171,16474171,,
524,1742828,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,54102,CLIC6,https://ctdbase.org/detail.go?type=gene&acc=54102,,,54102.0,CLIC6,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of CLIC6 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
525,1742829,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7461,CLIP2,https://ctdbase.org/detail.go?type=gene&acc=7461,,,7461.0,CLIP2,9606.0,Homo sapiens (human),Genistein results in decreased expression of CLIP2 mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
526,1742830,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,321857,CLK4A,https://ctdbase.org/detail.go?type=gene&acc=321857,,,321857.0,clk4a,7955.0,Danio rerio (zebrafish),Genistein results in decreased expression of CLK4A mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
527,1742831,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,79789,CLMN,https://ctdbase.org/detail.go?type=gene&acc=79789,,,79789.0,CLMN,9606.0,Homo sapiens (human),Genistein results in decreased expression of CLMN mRNA,,,PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/26865669,26865669,,
528,1742832,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1207,CLNS1A,https://ctdbase.org/detail.go?type=gene&acc=1207,,,1207.0,CLNS1A,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CLNS1A mRNA,,,PMID:16169203,https://www.ncbi.nlm.nih.gov/pubmed/16169203,16169203,,
529,1742833,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1208,CLPS,https://ctdbase.org/detail.go?type=gene&acc=1208,,,1208.0,CLPS,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in decreased expression of CLPS mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
530,1743176,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,23070,CMTR1,https://ctdbase.org/detail.go?type=gene&acc=23070,,,23070.0,CMTR1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in decreased methylation of CMTR1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
531,1743177,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,326846,CNBPA,https://ctdbase.org/detail.go?type=gene&acc=326846,,,326846.0,cnbpa,7955.0,Danio rerio (zebrafish),Genistein results in increased expression of CNBPA mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
532,1743178,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,55748,CNDP2,https://ctdbase.org/detail.go?type=gene&acc=55748,,,55748.0,CNDP2,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CNDP2 mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
533,1743179,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,84518,CNFN,https://ctdbase.org/detail.go?type=gene&acc=84518,,,84518.0,CNFN,9606.0,Homo sapiens (human),Genistein results in decreased expression of CNFN mRNA,,,PMID:19371625,https://www.ncbi.nlm.nih.gov/pubmed/19371625,19371625,,
534,1743180,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,254263,CNIH2,https://ctdbase.org/detail.go?type=gene&acc=254263,,,254263.0,CNIH2,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CNIH2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
535,1743181,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,22866,CNKSR2,https://ctdbase.org/detail.go?type=gene&acc=22866,,,22866.0,CNKSR2,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CNKSR2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
536,1743182,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1264,CNN1,https://ctdbase.org/detail.go?type=gene&acc=1264,,,1264.0,CNN1,9606.0,Homo sapiens (human),Genistein results in decreased expression of CNN1 mRNA,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
537,1743183,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1265,CNN2,https://ctdbase.org/detail.go?type=gene&acc=1265,,,1265.0,CNN2,9606.0,Homo sapiens (human),ESR2 promotes the reaction [genistein results in decreased expression of CNN2 protein]|genistein results in decreased expression of CNN2 protein,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
538,1744293,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1339,COX6A2,https://ctdbase.org/detail.go?type=gene&acc=1339,,,1339.0,COX6A2,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in decreased expression of COX6A2 mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
539,1744294,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9167,COX7A2L,https://ctdbase.org/detail.go?type=gene&acc=9167,,,9167.0,COX7A2L,9606.0,Homo sapiens (human),ESR2 promotes the reaction [genistein results in decreased expression of COX7A2L protein]|genistein results in decreased expression of COX7A2L protein,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
540,1744295,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,9167,COX7A2L,https://ctdbase.org/detail.go?type=gene&acc=9167,,,9167.0,COX7A2L,9606.0,Homo sapiens (human),Genistein results in increased expression of COX7A2L mRNA,,,PMID:17266178,https://www.ncbi.nlm.nih.gov/pubmed/17266178,17266178,,
541,1744296,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of CP mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
542,1744297,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CP mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
543,1744298,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in decreased expression of CP mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
544,1744299,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1357,CPA1,https://ctdbase.org/detail.go?type=gene&acc=1357,,,1357.0,CPA1,9606.0,Homo sapiens (human),Genistein results in decreased expression of CPA1 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
545,1744300,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1357,CPA1,https://ctdbase.org/detail.go?type=gene&acc=1357,,,1357.0,CPA1,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of CPA1 mRNA,,,PMID:15901920,https://www.ncbi.nlm.nih.gov/pubmed/15901920,15901920,,
546,1746003,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1501,CTNND2,https://ctdbase.org/detail.go?type=gene&acc=1501,,,1501.0,CTNND2,9606.0,Homo sapiens (human),Genistein results in increased expression of CTNND2 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
547,1746004,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1503,CTPS1,https://ctdbase.org/detail.go?type=gene&acc=1503,,,1503.0,CTPS1,9606.0,Homo sapiens (human),Genistein results in increased expression of CTPS1 mRNA,,,PMID:16474171,https://www.ncbi.nlm.nih.gov/pubmed/16474171,16474171,,
548,1746005,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1504,CTRB1,https://ctdbase.org/detail.go?type=gene&acc=1504,,,1504.0,CTRB1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in increased methylation of CTRB1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
549,1746006,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,11330,CTRC,https://ctdbase.org/detail.go?type=gene&acc=11330,,,11330.0,CTRC,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased methylation of CTRC gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
550,1746007,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,5476,CTSA,https://ctdbase.org/detail.go?type=gene&acc=5476,,,5476.0,CTSA,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CTSA mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
551,1746008,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CTSB mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
552,1746009,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,10116.0,Rattus norvegicus (Norway rat),[genistein co-treated with methoxychlor] results in increased expression of CTSB mRNA,,,PMID:21782745,https://www.ncbi.nlm.nih.gov/pubmed/21782745,21782745,,
553,1746010,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1075,CTSC,https://ctdbase.org/detail.go?type=gene&acc=1075,,,1075.0,CTSC,9606.0,Homo sapiens (human),Genistein results in increased expression of CTSC mRNA,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
554,1746011,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1075,CTSC,https://ctdbase.org/detail.go?type=gene&acc=1075,,,1075.0,CTSC,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CTSC mRNA,,,PMID:15289156|PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/15289156|https://www.ncbi.nlm.nih.gov/pubmed/32186404,15289156|32186404,,
555,1746012,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,643,CXCR5,https://ctdbase.org/detail.go?type=gene&acc=643,,,643.0,CXCR5,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CXCR5 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
556,1747582,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116.0,Rattus norvegicus (Norway rat),Genistein results in decreased expression of CYP11A1 mRNA,,,PMID:32827888,https://www.ncbi.nlm.nih.gov/pubmed/32827888,32827888,,
557,1747583,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of CYP17A1 mRNA,,,PMID:21624456|PMID:26792615,https://www.ncbi.nlm.nih.gov/pubmed/21624456|https://www.ncbi.nlm.nih.gov/pubmed/26792615,21624456|26792615,,
558,1747584,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10090.0,Mus musculus (house mouse),Genistein results in increased expression of CYP17A1 mRNA,,,PMID:18281260,https://www.ncbi.nlm.nih.gov/pubmed/18281260,18281260,,
559,1752633,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1907,EDN2,https://ctdbase.org/detail.go?type=gene&acc=1907,,,1907.0,EDN2,9606.0,Homo sapiens (human),Genistein results in decreased expression of EDN2 mRNA,,,PMID:16399490|PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/16399490|https://www.ncbi.nlm.nih.gov/pubmed/26865667,16399490|26865667,,
560,1752634,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1907,EDN2,https://ctdbase.org/detail.go?type=gene&acc=1907,,,1907.0,EDN2,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of EDN2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
561,1752635,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of EDNRB mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
562,1752636,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,26098,EDRF1,https://ctdbase.org/detail.go?type=gene&acc=26098,,,26098.0,EDRF1,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of EDRF1 mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
563,1752637,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1915,EEF1A1,https://ctdbase.org/detail.go?type=gene&acc=1915,,,1915.0,EEF1A1,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased methylation of EEF1A1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
564,1752638,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1917,EEF1A2,https://ctdbase.org/detail.go?type=gene&acc=1917,,,1917.0,EEF1A2,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of EEF1A2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
565,1752639,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,1938,EEF2,https://ctdbase.org/detail.go?type=gene&acc=1938,,,1938.0,EEF2,9606.0,Homo sapiens (human),Genistein results in decreased expression of EEF2 mRNA,,,PMID:16705744,https://www.ncbi.nlm.nih.gov/pubmed/16705744,16705744,,
566,1752640,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,399665,EEIG1,https://ctdbase.org/detail.go?type=gene&acc=399665,,,399665.0,EEIG1,9606.0,Homo sapiens (human),Genistein results in increased expression of EEIG1 mRNA,,,PMID:14605097,https://www.ncbi.nlm.nih.gov/pubmed/14605097,14605097,,
567,1752641,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,80820,EEPD1,https://ctdbase.org/detail.go?type=gene&acc=80820,,,80820.0,EEPD1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in increased methylation of EEPD1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
568,1752642,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,388795,EFCAB8,https://ctdbase.org/detail.go?type=gene&acc=388795,,,388795.0,EFCAB8,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of EFCAB8 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
569,1752906,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,6876,TAGLN,https://ctdbase.org/detail.go?type=gene&acc=6876,,,6876.0,TAGLN,9606.0,Homo sapiens (human),Genistein affects the expression of TAGLN mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
570,1752907,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,6887,TAL2,https://ctdbase.org/detail.go?type=gene&acc=6887,,,6887.0,TAL2,10090.0,Mus musculus (house mouse),Genistein results in increased expression of TAL2 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
571,1753094,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,123036,TC2N,https://ctdbase.org/detail.go?type=gene&acc=123036,,,123036.0,TC2N,9606.0,Homo sapiens (human),[daidzein co-treated with daidzin co-treated with genistin co-treated with genistein co-treated with glycitin co-treated with glycitein] results in increased expression of TC2N mRNA,,,PMID:27424125,https://www.ncbi.nlm.nih.gov/pubmed/27424125,27424125,,
572,1753095,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,8557,TCAP,https://ctdbase.org/detail.go?type=gene&acc=8557,,,8557.0,TCAP,7955.0,Danio rerio (zebrafish),Genistein results in increased expression of TCAP mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
573,1753096,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,6917,TCEA1,https://ctdbase.org/detail.go?type=gene&acc=6917,,,6917.0,TCEA1,9606.0,Homo sapiens (human),Genistein results in increased expression of TCEA1 mRNA,,,PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/26865667,26865667,,
574,1753097,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,6943,TCF21,https://ctdbase.org/detail.go?type=gene&acc=6943,,,6943.0,TCF21,9606.0,Homo sapiens (human),Genistein inhibits the reaction [tobacco smoke pollution results in increased methylation of TCF21 promoter],,,PMID:25214829,https://www.ncbi.nlm.nih.gov/pubmed/25214829,25214829,,
575,1753098,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,6943,TCF21,https://ctdbase.org/detail.go?type=gene&acc=6943,,,6943.0,TCF21,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of TCF21 mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
576,1753943,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,8909,ENDOU,https://ctdbase.org/detail.go?type=gene&acc=8909,,,8909.0,ENDOU,10090.0,Mus musculus (house mouse),Genistein results in increased expression of ENDOU mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
577,1753944,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,219670,ENKUR,https://ctdbase.org/detail.go?type=gene&acc=219670,,,219670.0,ENKUR,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of ENKUR mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
578,1753945,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,2023,ENO1,https://ctdbase.org/detail.go?type=gene&acc=2023,,,2023.0,ENO1,10090.0,Mus musculus (house mouse),Genistein results in increased expression of ENO1 mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
579,1753946,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,2023,ENO1,https://ctdbase.org/detail.go?type=gene&acc=2023,,,2023.0,ENO1,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of ENO1 mRNA,,,PMID:12075121,https://www.ncbi.nlm.nih.gov/pubmed/12075121,12075121,,
580,1753947,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,2026,ENO2,https://ctdbase.org/detail.go?type=gene&acc=2026,,,2026.0,ENO2,9606.0,Homo sapiens (human),Genistein results in decreased expression of ENO2 mRNA,,,PMID:15159206,https://www.ncbi.nlm.nih.gov/pubmed/15159206,15159206,,
581,1753948,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,2027,ENO3,https://ctdbase.org/detail.go?type=gene&acc=2027,,,2027.0,ENO3,9606.0,Homo sapiens (human),Genistein results in decreased expression of ENO3 mRNA,,,PMID:15757668,https://www.ncbi.nlm.nih.gov/pubmed/15757668,15757668,,
582,1753949,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,387712,ENO4,https://ctdbase.org/detail.go?type=gene&acc=387712,,,387712.0,ENO4,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of ENO4 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
583,1753950,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,5167,ENPP1,https://ctdbase.org/detail.go?type=gene&acc=5167,,,5167.0,ENPP1,9606.0,Homo sapiens (human),Genistein results in increased expression of ENPP1 mRNA,,,PMID:22228119,https://www.ncbi.nlm.nih.gov/pubmed/22228119,22228119,,
584,1754127,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,326287,EPB41B,https://ctdbase.org/detail.go?type=gene&acc=326287,,,326287.0,epb41b,7955.0,Danio rerio (zebrafish),Genistein results in decreased expression of EPB41B mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
585,1754128,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,2036,EPB41L1,https://ctdbase.org/detail.go?type=gene&acc=2036,,,2036.0,EPB41L1,9606.0,Homo sapiens (human),Genistein results in increased expression of EPB41L1 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
586,1754348,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,74088,THEM7,https://ctdbase.org/detail.go?type=gene&acc=74088,,,74088.0,Them7,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of THEM7 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
587,1754349,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,79896,THNSL1,https://ctdbase.org/detail.go?type=gene&acc=79896,,,79896.0,THNSL1,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of THNSL1 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
588,1754350,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,79905,TMC7,https://ctdbase.org/detail.go?type=gene&acc=79905,,,79905.0,TMC7,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of TMC7 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
589,1754351,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,57187,THOC2,https://ctdbase.org/detail.go?type=gene&acc=57187,,,57187.0,THOC2,9606.0,Homo sapiens (human),ESR1 promotes the reaction [genistein results in decreased expression of THOC2 protein]|genistein results in decreased expression of THOC2 protein,,,PMID:20884965,https://www.ncbi.nlm.nih.gov/pubmed/20884965,20884965,,
590,1754352,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7066,THPO,https://ctdbase.org/detail.go?type=gene&acc=7066,,,7066.0,THPO,10090.0,Mus musculus (house mouse),Genistein results in increased expression of THPO mRNA,,,PMID:21048042,https://www.ncbi.nlm.nih.gov/pubmed/21048042,21048042,,
591,1754353,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7067,THRA,https://ctdbase.org/detail.go?type=gene&acc=7067,,,7067.0,THRA,9606.0,Homo sapiens (human),Genistein binds to THRA protein|genistein promotes the reaction [triiodothyronine results in increased activity of THRA protein],,,PMID:29688519,https://www.ncbi.nlm.nih.gov/pubmed/29688519,29688519,,
592,1754354,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7068,THRB,https://ctdbase.org/detail.go?type=gene&acc=7068,,,7068.0,THRB,9606.0,Homo sapiens (human),[genistein binds to THRB protein] promotes the reaction [NCOA1 protein binds to THRB protein]|genistein promotes the reaction [NCOA1 protein binds to THRB protein]|genistein promotes the reaction [triiodothyronine results in increased activity of THRB protein],,,PMID:29688519,https://www.ncbi.nlm.nih.gov/pubmed/29688519,29688519,,
593,1754355,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7068,THRB,https://ctdbase.org/detail.go?type=gene&acc=7068,,,7068.0,THRB,10090.0,Mus musculus (house mouse),Genistein results in decreased expression of THRB mRNA,,,PMID:24967385,https://www.ncbi.nlm.nih.gov/pubmed/24967385,24967385,,
594,1754356,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,7069,THRSP,https://ctdbase.org/detail.go?type=gene&acc=7069,,,7069.0,THRSP,10116.0,Rattus norvegicus (Norway rat),Genistein results in increased expression of THRSP mRNA,,,PMID:17341692|PMID:24793811,https://www.ncbi.nlm.nih.gov/pubmed/17341692|https://www.ncbi.nlm.nih.gov/pubmed/24793811,17341692|24793811,,
595,1754357,5280961,Comparative Toxicogenomics Database (CTD),Genistein,D019833,Genistein,https://ctdbase.org/detail.go?type=chem&acc=D019833,79875,THSD4,https://ctdbase.org/detail.go?type=gene&acc=79875,,,79875.0,THSD4,10090.0,Mus musculus (house mouse),Genistein results in increased expression of THSD4 mRNA,,,PMID:32186404,https://www.ncbi.nlm.nih.gov/pubmed/32186404,32186404,,
596,1753629,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606.0,Homo sapiens (human),Budesonide results in increased activity of CSF2 protein,,,PMID:11730731,https://www.ncbi.nlm.nih.gov/pubmed/11730731,11730731,,
597,1753630,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10116.0,Rattus norvegicus (Norway rat),"Budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of CXCL1 protein]|budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of CXCL1 mrna]",,,PMID:15734790,https://www.ncbi.nlm.nih.gov/pubmed/15734790,15734790,,
598,1753631,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10116.0,Rattus norvegicus (Norway rat),"Budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of CXCL2 mrna]|budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of CXCL2 protein]",,,PMID:15734790,https://www.ncbi.nlm.nih.gov/pubmed/15734790,15734790,,
599,1753632,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,2921,CXCL3,https://ctdbase.org/detail.go?type=gene&acc=2921,,,2921.0,CXCL3,10116.0,Rattus norvegicus (Norway rat),"Budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of CXCL3 protein]|budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of CXCL3 mrna]",,,PMID:15734790,https://www.ncbi.nlm.nih.gov/pubmed/15734790,15734790,,
600,1753633,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Budesonide inhibits the reaction [TNF protein results in increased secretion of CXCL8 mrna]|budesonide inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein],,,PMID:14643170,https://www.ncbi.nlm.nih.gov/pubmed/14643170,14643170,,
601,1753634,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,10090.0,Mus musculus (house mouse),Budesonide inhibits the reaction [ozone results in increased expression of CXCL8 protein]|progesterone promotes the reaction [budesonide inhibits the reaction [ozone results in increased expression of CXCL8 protein]],,,PMID:28279894,https://www.ncbi.nlm.nih.gov/pubmed/28279894,28279894,,
602,1753835,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),Ketoconazole inhibits the reaction [budesonide results in increased expression of CYP3A5 mrna],,,PMID:24555085,https://www.ncbi.nlm.nih.gov/pubmed/24555085,24555085,,
603,1753836,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606.0,Homo sapiens (human),Mifepristone inhibits the reaction [budesonide results in increased expression of CYP3A5 mrna],,,PMID:12538830,https://www.ncbi.nlm.nih.gov/pubmed/12538830,12538830,,
604,1753837,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,171352,CYP3A9,https://ctdbase.org/detail.go?type=gene&acc=171352,,,171352.0,Cyp3a9,10116.0,Rattus norvegicus (Norway rat),Budesonide results in increased expression of CYP3A9 mRNA,,,PMID:19562681|PMID:20888898,https://www.ncbi.nlm.nih.gov/pubmed/19562681|https://www.ncbi.nlm.nih.gov/pubmed/20888898,19562681|20888898,,
605,1753838,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,8288,EPX,https://ctdbase.org/detail.go?type=gene&acc=8288,,,8288.0,EPX,10116.0,Rattus norvegicus (Norway rat),Budesonide inhibits the reaction [sephadex results in increased expression of EPX protein],,,PMID:10850854,https://www.ncbi.nlm.nih.gov/pubmed/10850854,10850854,,
606,1753839,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641.0,GCG,10116.0,Rattus norvegicus (Norway rat),Budesonide results in decreased expression of GCG mRNA,,,PMID:12524409,https://www.ncbi.nlm.nih.gov/pubmed/12524409,12524409,,
607,1753840,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641.0,GCG,10116.0,Rattus norvegicus (Norway rat),[fatty acids co-treated with budesonide] results in increased expression of GCG mRNA,,,PMID:14705828,https://www.ncbi.nlm.nih.gov/pubmed/14705828,14705828,,
608,1754259,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),"Budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of IL1B protein]|budesonide inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 results in increased expression of IL1B mrna]",,,PMID:15734790,https://www.ncbi.nlm.nih.gov/pubmed/15734790,15734790,,
609,1754260,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Budesonide results in decreased expression of IL4 protein,,,PMID:12406821|PMID:15086961|PMID:7988651,https://www.ncbi.nlm.nih.gov/pubmed/12406821|https://www.ncbi.nlm.nih.gov/pubmed/15086961|https://www.ncbi.nlm.nih.gov/pubmed/7988651,12406821|15086961|7988651,,
610,1754447,5281004,Comparative Toxicogenomics Database (CTD),Budesonide,D019819,Budesonide,https://ctdbase.org/detail.go?type=chem&acc=D019819,4057,LTF,https://ctdbase.org/detail.go?type=gene&acc=4057,,,4057.0,LTF,9606.0,Homo sapiens (human),Budesonide inhibits the reaction [methylcholine results in increased secretion of LTF protein]|budesonide results in decreased secretion of LTF protein,,,PMID:11112886,https://www.ncbi.nlm.nih.gov/pubmed/11112886,11112886,,
611,1739703,5281025,Drug Gene Interaction database (DGIdb),Quetiapine Fumarate,,QUETIAPINE FUMARATE,https://www.dgidb.org/drugs/rxcui:221153,,RABEP1,https://www.dgidb.org/genes/hgnc:17677,,,9135.0,RABEP1,9606.0,Homo sapiens (human),,,,,,,,
612,1739704,5281025,Drug Gene Interaction database (DGIdb),Quetiapine Fumarate,,QUETIAPINE FUMARATE,https://www.dgidb.org/drugs/rxcui:221153,,EPM2A,https://www.dgidb.org/genes/hgnc:3413,,,7957.0,EPM2A,9606.0,Homo sapiens (human),,,,,,,,
613,1739705,5281025,Drug Gene Interaction database (DGIdb),Quetiapine Fumarate,,QUETIAPINE FUMARATE,https://www.dgidb.org/drugs/rxcui:221153,,MIR582,https://www.dgidb.org/genes/hgnc:32838,,,693167.0,MIR582,9606.0,Homo sapiens (human),,,,,,,,
614,1739706,5281033,Drug Gene Interaction database (DGIdb),Pyrantel Pamoate,,PYRANTEL PAMOATE,https://www.dgidb.org/drugs/rxcui:8985,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606.0,Homo sapiens (human),,,,,,,,
615,1739707,5281034,ChEMBL,Oxymetholone,CHEMBL1200585,OXYMETHOLONE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200585/,CHEMBL1871,Androgen Receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1871/,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),Androgen receptor agonist,,,,,,,
616,1739708,5281051,DrugBank,,DB13014,Hypericin,https://www.drugbank.ca/drugs/DB13014,BE0002281,Glutathione S-transferase A1,https://www.drugbank.ca/bio_entities/BE0002281,P08263,Glutathione S-transferase A1,2938.0,GSTA1,9606.0,Homo sapiens (human),,,,PMID:15461448,https://www.ncbi.nlm.nih.gov/pubmed/15461448,15461448,,
617,1739709,5281051,DrugBank,,DB13014,Hypericin,https://www.drugbank.ca/drugs/DB13014,BE0000814,Glutathione S-transferase P,https://www.drugbank.ca/bio_entities/BE0000814,P09211,Glutathione S-transferase P,2950.0,GSTP1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15461448|PMID:22810152,https://www.ncbi.nlm.nih.gov/pubmed/15461448|https://www.ncbi.nlm.nih.gov/pubmed/22810152,15461448|22810152,,
618,1739710,5281051,DrugBank,,DB13014,Hypericin,https://www.drugbank.ca/drugs/DB13014,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),,,,PMID:15461448,https://www.ncbi.nlm.nih.gov/pubmed/15461448,15461448,,
619,1739711,5281068,ChEMBL,Chlorpheniramine Maleate,CHEMBL1659,CHLORPHENIRAMINE MALEATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1659/,CHEMBL231,Histamine H1 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL231/,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Histamine H1 receptor antagonist,,,PMID:10511010|PMID:16413139,https://www.ncbi.nlm.nih.gov/pubmed/10511010|https://www.ncbi.nlm.nih.gov/pubmed/16413139,10511010|16413139,,
620,1739712,5281069,ChEMBL,Clemastine Fumarate,CHEMBL1200795,CLEMASTINE FUMARATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200795/,CHEMBL231,Histamine H1 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL231/,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Histamine H1 receptor antagonist,,,,,,,
621,1739713,5281070,ChEMBL,Dexchlorpheniramine Maleate,CHEMBL1200927,DEXCHLORPHENIRAMINE MALEATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200927/,CHEMBL231,Histamine H1 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL231/,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Histamine H1 receptor antagonist,,,PMID:26515,https://www.ncbi.nlm.nih.gov/pubmed/26515,26515,,
622,1739714,5281070,Drug Gene Interaction database (DGIdb),Dexchlorpheniramine Maleate,,DEXCHLORPHENIRAMINE MALEATE,https://www.dgidb.org/drugs/rxcui:54828,,HRH1,https://www.dgidb.org/genes/hgnc:5182,,,3269.0,HRH1,9606.0,Homo sapiens (human),,,,,,,,
623,1741869,5281104,Comparative Toxicogenomics Database (CTD),Paricalcitol,C084656,paricalcitol,https://ctdbase.org/detail.go?type=chem&acc=C084656,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090.0,Mus musculus (house mouse),[paricalcitol co-treated with enalapril] results in decreased expression of SOD2 protein,,,PMID:20720404,https://www.ncbi.nlm.nih.gov/pubmed/20720404,20720404,,
624,1741870,5281104,Comparative Toxicogenomics Database (CTD),Paricalcitol,C084656,paricalcitol,https://ctdbase.org/detail.go?type=chem&acc=C084656,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090.0,Mus musculus (house mouse),Paricalcitol results in decreased expression of SOD2 protein,,,PMID:20720404|PMID:25037058,https://www.ncbi.nlm.nih.gov/pubmed/20720404|https://www.ncbi.nlm.nih.gov/pubmed/25037058,20720404|25037058,,
625,1741871,5281104,Comparative Toxicogenomics Database (CTD),Paricalcitol,C084656,paricalcitol,https://ctdbase.org/detail.go?type=chem&acc=C084656,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,9606.0,Homo sapiens (human),[phosphorus co-treated with paricalcitol] results in increased expression of SOD3 mRNA,,,PMID:17715259,https://www.ncbi.nlm.nih.gov/pubmed/17715259,17715259,,
626,1741872,5281104,Comparative Toxicogenomics Database (CTD),Paricalcitol,C084656,paricalcitol,https://ctdbase.org/detail.go?type=chem&acc=C084656,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,9913.0,Bos taurus (cattle),Paricalcitol promotes the reaction [beta-glycerophosphoric acid results in decreased expression of SPARC mrna],,,PMID:17171500,https://www.ncbi.nlm.nih.gov/pubmed/17171500,17171500,,
627,1742534,5281222,Comparative Toxicogenomics Database (CTD),Butein,C040918,butein,https://ctdbase.org/detail.go?type=chem&acc=C040918,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Butein results in increased activity of CASP9 protein,,,PMID:35130734,https://www.ncbi.nlm.nih.gov/pubmed/35130734,35130734,,
628,1742535,5281222,Comparative Toxicogenomics Database (CTD),Butein,C040918,butein,https://ctdbase.org/detail.go?type=chem&acc=C040918,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),Butein affects the reaction [IL6 protein affects the expression of CDH1 protein],,,PMID:35130734,https://www.ncbi.nlm.nih.gov/pubmed/35130734,35130734,,
629,1742536,5281222,Comparative Toxicogenomics Database (CTD),Butein,C040918,butein,https://ctdbase.org/detail.go?type=chem&acc=C040918,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,9606.0,Homo sapiens (human),Butein results in decreased activity of DIO2 protein,,,PMID:17327447,https://www.ncbi.nlm.nih.gov/pubmed/17327447,17327447,,
630,1742537,5281222,Comparative Toxicogenomics Database (CTD),Butein,C040918,butein,https://ctdbase.org/detail.go?type=chem&acc=C040918,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,9606.0,Homo sapiens (human),Butein results in decreased expression of GPX4 protein,,,PMID:35130734,https://www.ncbi.nlm.nih.gov/pubmed/35130734,35130734,,
631,1742538,5281222,Comparative Toxicogenomics Database (CTD),Butein,C040918,butein,https://ctdbase.org/detail.go?type=chem&acc=C040918,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Pyrazolanthrone inhibits the reaction [butein results in increased expression of HMOX1 protein]|[butein results in increased expression of HMOX1 protein] inhibits the reaction [hydrogen peroxide results in increased abundance of reactive oxygen species]|[butein results in increased expression of HMOX1 protein] which results in decreased susceptibility to hydrogen peroxide|butein results in increased expression of and results in increased activity of HMOX1 protein|[tin protoporphyrin IX results in decreased expression of and results in decreased activity of HMOX1 protein] inhibits the reaction [butein inhibits the reaction [hydrogen peroxide results in increased abundance of reactive oxygen species]],,,PMID:23318726,https://www.ncbi.nlm.nih.gov/pubmed/23318726,23318726,,
632,1738432,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,100631042,MIR34,https://ctdbase.org/detail.go?type=gene&acc=100631042,,,100631042.0,,9606.0,Homo sapiens (human),Crocin results in decreased expression of MIR34 mRNA,,,PMID:35085590,https://www.ncbi.nlm.nih.gov/pubmed/35085590,35085590,,
633,1738433,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,407040,MIR34A,https://ctdbase.org/detail.go?type=gene&acc=407040,,,407040.0,MIR34A,9606.0,Homo sapiens (human),MIR34A mRNA inhibits the reaction [crocin results in increased expression of PTPN4 protein]|mir34a mRNA inhibits the reaction [crocin results in increased activity of CASP3 protein],,,PMID:35085590,https://www.ncbi.nlm.nih.gov/pubmed/35085590,35085590,,
634,1738434,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,407046,MIR9-1,https://ctdbase.org/detail.go?type=gene&acc=407046,,,407046.0,MIR9-1,10116.0,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [cisplatin results in decreased expression of MIR9-1 mrna]|cisplatin inhibits the reaction [crocin results in increased expression of MIR9-1 mrna]|crocin results in increased expression of MIR9-1 mRNA,,,PMID:32259551,https://www.ncbi.nlm.nih.gov/pubmed/32259551,32259551,,
635,1738435,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116.0,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [ethanol results in increased activity of MPO protein],,,PMID:25637687,https://www.ncbi.nlm.nih.gov/pubmed/25637687,25637687,,
636,1738436,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Crocin results in decreased expression of MYC mRNA,,,PMID:32886819,https://www.ncbi.nlm.nih.gov/pubmed/32886819,32886819,,
637,1738437,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,4613,MYCN,https://ctdbase.org/detail.go?type=gene&acc=4613,,,4613.0,MYCN,9606.0,Homo sapiens (human),Crocin results in decreased expression of MYCN protein|crocin results in decreased expression of and results in decreased stability of MYCN mrna|mycn results in decreased susceptibility to crocin|mycn protein inhibits the reaction [crocin results in increased cleavage of CASP3 protein]|mycn protein inhibits the reaction [crocin results in increased cleavage of PARP1 protein],,,PMID:30672053,https://www.ncbi.nlm.nih.gov/pubmed/30672053,30672053,,
638,1738438,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,10116.0,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [cisplatin results in increased expression of MYD88 protein]|crocin inhibits the reaction [cisplatin results in increased expression of MYD88 mrna],,,PMID:32259551,https://www.ncbi.nlm.nih.gov/pubmed/32259551,32259551,,
639,1738439,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 protein],,,PMID:32920515,https://www.ncbi.nlm.nih.gov/pubmed/32920515,32920515,,
640,1738440,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [cisplatin results in decreased expression of NFE2L2 protein],,,PMID:32259551,https://www.ncbi.nlm.nih.gov/pubmed/32259551,32259551,,
641,1738441,5281233,Comparative Toxicogenomics Database (CTD),Crocin,C029036,crocin,https://ctdbase.org/detail.go?type=chem&acc=C029036,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [arsenic trioxide results in decreased expression of NQO1 protein],,,PMID:32920515,https://www.ncbi.nlm.nih.gov/pubmed/32920515,32920515,,
642,1743055,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Fucoxanthin results in decreased expression of AKT1 mRNA,,,PMID:35266250,https://www.ncbi.nlm.nih.gov/pubmed/35266250,35266250,,
643,1743056,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [carrageenan results in increased phosphorylation of AKT1 protein],,,PMID:26418808,https://www.ncbi.nlm.nih.gov/pubmed/26418808,26418808,,
644,1743057,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,214,ALCAM,https://ctdbase.org/detail.go?type=gene&acc=214,,,214.0,ALCAM,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of ALCAM mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
645,1743058,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,100310846,ANKRD61,https://ctdbase.org/detail.go?type=gene&acc=100310846,,,100310846.0,ANKRD61,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of ANKRD61 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
646,1743059,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,83734,ATG10,https://ctdbase.org/detail.go?type=gene&acc=83734,,,83734.0,ATG10,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of ATG10 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
647,1743060,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,487,ATP2A1,https://ctdbase.org/detail.go?type=gene&acc=487,,,487.0,ATP2A1,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of ATP2A1 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
648,1743061,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,25805,BAMBI,https://ctdbase.org/detail.go?type=gene&acc=25805,,,25805.0,BAMBI,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of BAMBI mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
649,1743062,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of BCHE mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
650,1743063,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Fucoxanthin results in decreased expression of BCL2 mRNA,,,PMID:35266250,https://www.ncbi.nlm.nih.gov/pubmed/35266250,35266250,,
651,1744014,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,2824,GPM6B,https://ctdbase.org/detail.go?type=gene&acc=2824,,,2824.0,GPM6B,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of GPM6B mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
652,1744015,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of GRIN1 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
653,1744016,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of GULO mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
654,1745795,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,7477,WNT7B,https://ctdbase.org/detail.go?type=gene&acc=7477,,,7477.0,WNT7B,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of WNT7B mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
655,1745796,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,225207,ZFP521,https://ctdbase.org/detail.go?type=gene&acc=225207,,,225207.0,Zfp521,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in decreased expression of ZFP521 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
656,1745797,5281239,Comparative Toxicogenomics Database (CTD),Fucoxanthin,C025164,fucoxanthin,https://ctdbase.org/detail.go?type=chem&acc=C025164,72556,ZFP566,https://ctdbase.org/detail.go?type=gene&acc=72556,,,72556.0,Zfp566,10090.0,Mus musculus (house mouse),Fucoxanthin inhibits the reaction [glucose results in increased expression of ZFP566 mrna],,,PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/33448797,33448797,,
657,1739847,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Esculetin results in increased expression of CDKN1A protein,,,PMID:31313495,https://www.ncbi.nlm.nih.gov/pubmed/31313495,31313495,,
658,1739848,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10116.0,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [esculetin results in increased expression of CDKN1A protein]|esculetin results in increased expression of CDKN1A protein|esculetin promotes the reaction [CDKN1A protein binds to CDK2 protein]|esculetin promotes the reaction [CDKN1A protein binds to CDK4 protein],,,PMID:21600278,https://www.ncbi.nlm.nih.gov/pubmed/21600278,21600278,,
659,1739849,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),Esculetin results in increased expression of CDKN1B protein,,,PMID:31313495,https://www.ncbi.nlm.nih.gov/pubmed/31313495,31313495,,
660,1739850,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9606.0,Homo sapiens (human),COMT protein results in increased methylation of esculetin,,,PMID:11160877,https://www.ncbi.nlm.nih.gov/pubmed/11160877,11160877,,
661,1739851,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),[arsenic trioxide co-treated with esculetin] affects the localization of CYCS protein,,,PMID:19428345,https://www.ncbi.nlm.nih.gov/pubmed/19428345,19428345,,
662,1739852,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),[esculetin co-treated with paclitaxel] affects the localization of CYCS protein,,,PMID:16051289,https://www.ncbi.nlm.nih.gov/pubmed/16051289,16051289,,
663,1739853,5281416,Comparative Toxicogenomics Database (CTD),Esculetin,C007628,esculetin,https://ctdbase.org/detail.go?type=chem&acc=C007628,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),[esculetin co-treated with paclitaxel] results in increased expression of FAS protein,,,PMID:16051289,https://www.ncbi.nlm.nih.gov/pubmed/16051289,16051289,,
664,1738915,5281511,Comparative Toxicogenomics Database (CTD),Xanthatin,C022186,xanthatin,https://ctdbase.org/detail.go?type=chem&acc=C022186,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Go 6976 inhibits the reaction [xanthatin results in increased phosphorylation of CDK1 protein]|xanthatin results in increased phosphorylation of CDK1 protein,,,PMID:29074359,https://www.ncbi.nlm.nih.gov/pubmed/29074359,29074359,,
665,1738916,5281511,Comparative Toxicogenomics Database (CTD),Xanthatin,C022186,xanthatin,https://ctdbase.org/detail.go?type=chem&acc=C022186,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Xanthatin results in decreased expression of CDK1 mRNA,,,PMID:21568272,https://www.ncbi.nlm.nih.gov/pubmed/21568272,21568272,,
666,1738917,5281511,Comparative Toxicogenomics Database (CTD),Xanthatin,C022186,xanthatin,https://ctdbase.org/detail.go?type=chem&acc=C022186,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,9606.0,Homo sapiens (human),Xanthatin affects the phosphorylation of CHEK1 protein|tp53 protein promotes the reaction [xanthatin results in decreased phosphorylation of CHEK1 protein]|xanthatin inhibits the reaction [caffeine results in increased phosphorylation of CHEK1 protein]|xanthatin inhibits the reaction [go 6976 results in increased phosphorylation of CHEK1 protein],,,PMID:29074359,https://www.ncbi.nlm.nih.gov/pubmed/29074359,29074359,,
667,1738918,5281511,Comparative Toxicogenomics Database (CTD),Xanthatin,C022186,xanthatin,https://ctdbase.org/detail.go?type=chem&acc=C022186,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [xanthatin results in increased expression of fos]|xanthatin results in increased expression of FOS,,,PMID:23824011,https://www.ncbi.nlm.nih.gov/pubmed/23824011,23824011,,
668,1738919,5281511,Comparative Toxicogenomics Database (CTD),Xanthatin,C022186,xanthatin,https://ctdbase.org/detail.go?type=chem&acc=C022186,10912,GADD45G,https://ctdbase.org/detail.go?type=gene&acc=10912,,,10912.0,GADD45G,9606.0,Homo sapiens (human),Xanthatin results in increased expression of GADD45G protein|acetylcysteine inhibits the reaction [[xanthatin results in increased expression of GADD45G mrna] which results in increased abundance of reactive oxygen species]|acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G protein]|[xanthatin results in increased expression of GADD45G mrna] which results in increased abundance of reactive oxygen species|acetylcysteine inhibits the reaction [xanthatin results in increased expression of GADD45G mrna],,,PMID:23313378,https://www.ncbi.nlm.nih.gov/pubmed/23313378,23313378,,
669,1739124,5281571,BindingDB,Purpurogalline,50088360,"2,3,4,6-tetrahydroxy-5H-benzo[7]annulen-5-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50088360,796,Cyclin-dependent kinase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=796,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),1.7e+4,PMID:22893598|DOI:10.1002/cbic.201200316,https://www.ncbi.nlm.nih.gov/pubmed/22893598|https://doi.org/10.1002/cbic.201200316,22893598,10.1002/cbic.201200316,
670,1739125,5281575,Drug Gene Interaction database (DGIdb),Yangonin,,YANGONIN,https://www.dgidb.org/drugs/chembl:CHEMBL1098658,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
671,1739126,5281575,Drug Gene Interaction database (DGIdb),Yangonin,,YANGONIN,https://www.dgidb.org/drugs/chembl:CHEMBL1098658,,CXCL8,https://www.dgidb.org/genes/hgnc:6025,,,3576.0,CXCL8,9606.0,Homo sapiens (human),,,,,,,,
672,1739127,5281607,Toxin and Toxin Target Database (T3DB),Chrysin,T3D4893,"5,7-Dihydroxyflavone",http://www.t3db.ca/toxins/T3D4893,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,,,PMID:16972788|PMID:9751507|PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/16972788|https://www.ncbi.nlm.nih.gov/pubmed/9751507|https://www.ncbi.nlm.nih.gov/pubmed/23611293,16972788|9751507|23611293,,
673,1746618,5281609,Drug Gene Interaction database (DGIdb),Cupressuflavone,,CUPRESSUFLAVONE,https://www.dgidb.org/drugs/chembl:CHEMBL1208973,,POLH,https://www.dgidb.org/genes/hgnc:9181,,,5429.0,POLH,9606.0,Homo sapiens (human),,,,,,,,
674,1746619,5281614,Drug Gene Interaction database (DGIdb),Fisetin,,FISETIN,https://www.dgidb.org/drugs/ncit:C179571,,KDM4E,https://www.dgidb.org/genes/hgnc:37098,,,390245.0,KDM4E,9606.0,Homo sapiens (human),,,,,,,,
675,1740127,5281621,Comparative Toxicogenomics Database (CTD),Gossypin,C022944,gossypin,https://ctdbase.org/detail.go?type=chem&acc=C022944,6790,AURKA,https://ctdbase.org/detail.go?type=gene&acc=6790,,,6790.0,AURKA,9606.0,Homo sapiens (human),Gossypin binds to and results in decreased activity of AURKA protein,,,PMID:30536456,https://www.ncbi.nlm.nih.gov/pubmed/30536456,30536456,,
676,1740128,5281621,Comparative Toxicogenomics Database (CTD),Gossypin,C022944,gossypin,https://ctdbase.org/detail.go?type=chem&acc=C022944,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Gossypin results in decreased expression of BCL2L1 protein,,,PMID:30536456,https://www.ncbi.nlm.nih.gov/pubmed/30536456,30536456,,
677,1740129,5281621,Comparative Toxicogenomics Database (CTD),Gossypin,C022944,gossypin,https://ctdbase.org/detail.go?type=chem&acc=C022944,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Gossypin results in increased cleavage of CASP3 protein,,,PMID:30536456,https://www.ncbi.nlm.nih.gov/pubmed/30536456,30536456,,
678,1740130,5281621,Comparative Toxicogenomics Database (CTD),Gossypin,C022944,gossypin,https://ctdbase.org/detail.go?type=chem&acc=C022944,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606.0,Homo sapiens (human),Gossypin results in increased cleavage of CASP7 protein,,,PMID:30536456,https://www.ncbi.nlm.nih.gov/pubmed/30536456,30536456,,
679,1740131,5281621,Comparative Toxicogenomics Database (CTD),Gossypin,C022944,gossypin,https://ctdbase.org/detail.go?type=chem&acc=C022944,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Gossypin results in increased cleavage of CASP9 protein,,,PMID:30536456,https://www.ncbi.nlm.nih.gov/pubmed/30536456,30536456,,
680,1746620,5281642,Comparative Toxicogenomics Database (CTD),6-Hydroxyluteolin,C057617,6-hydroxyluteolin,https://ctdbase.org/detail.go?type=chem&acc=C057617,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),CYP1A1 protein results in increased chemical synthesis of 6-hydroxyluteolin|[cyp1a1 protein affects the metabolism of scutellarein] which results in increased chemical synthesis of 6-hydroxyluteolin,,,PMID:19666078,https://www.ncbi.nlm.nih.gov/pubmed/19666078,19666078,,
681,1746621,5281642,Comparative Toxicogenomics Database (CTD),6-Hydroxyluteolin,C057617,6-hydroxyluteolin,https://ctdbase.org/detail.go?type=chem&acc=C057617,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),[CYP1B1 protein affects the metabolism of scutellarein] which results in increased chemical synthesis of 6-hydroxyluteolin|cyp1b1 protein results in increased chemical synthesis of 6-hydroxyluteolin,,,PMID:19666078,https://www.ncbi.nlm.nih.gov/pubmed/19666078,19666078,,
682,1746622,5281643,BindingDB,Hyperoside,429266,CVD-0019904,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=429266,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),99500,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
683,1746623,5281656,Comparative Toxicogenomics Database (CTD),Norathyriol,C069053,norathyriol,https://ctdbase.org/detail.go?type=chem&acc=C069053,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Norathyriol results in increased expression of ABCB1 protein,,,PMID:20513373,https://www.ncbi.nlm.nih.gov/pubmed/20513373,20513373,,
684,1746624,5281656,Comparative Toxicogenomics Database (CTD),Norathyriol,C069053,norathyriol,https://ctdbase.org/detail.go?type=chem&acc=C069053,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Norathyriol results in decreased activity of MAPK1 protein|norathyriol binds to MAPK1 protein,,,PMID:22084399,https://www.ncbi.nlm.nih.gov/pubmed/22084399,22084399,,
685,1746625,5281656,Comparative Toxicogenomics Database (CTD),Norathyriol,C069053,norathyriol,https://ctdbase.org/detail.go?type=chem&acc=C069053,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Norathyriol results in decreased activity of MAPK3 protein,,,PMID:22084399,https://www.ncbi.nlm.nih.gov/pubmed/22084399,22084399,,
686,1746626,5281656,Comparative Toxicogenomics Database (CTD),Norathyriol,C069053,norathyriol,https://ctdbase.org/detail.go?type=chem&acc=C069053,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Norathyriol inhibits the reaction [GW 7647 results in increased activity of PPARA protein],,,PMID:18393431,https://www.ncbi.nlm.nih.gov/pubmed/18393431,18393431,,
687,1746627,5281656,Comparative Toxicogenomics Database (CTD),Norathyriol,C069053,norathyriol,https://ctdbase.org/detail.go?type=chem&acc=C069053,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,9606.0,Homo sapiens (human),"Norathyriol inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid results in increased activity of PPARD protein]",,,PMID:18393431,https://www.ncbi.nlm.nih.gov/pubmed/18393431,18393431,,
688,1746628,5281656,Comparative Toxicogenomics Database (CTD),Norathyriol,C069053,norathyriol,https://ctdbase.org/detail.go?type=chem&acc=C069053,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein],,,PMID:18393431,https://www.ncbi.nlm.nih.gov/pubmed/18393431,18393431,,
689,1746895,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10090.0,Mus musculus (house mouse),Norwogonin analog results in increased expression of ADIPOQ protein|norwogonin results in increased expression of ADIPOQ protein,,,PMID:30445784,https://www.ncbi.nlm.nih.gov/pubmed/30445784,30445784,,
690,1746896,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Norwogonin results in increased expression of BAX protein,,,PMID:32862589,https://www.ncbi.nlm.nih.gov/pubmed/32862589,32862589,,
691,1746897,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Norwogonin inhibits the reaction [oxygen deficiency results in increased expression of BAX protein]|norwogonin inhibits the reaction [oxygen deficiency results in increased expression of BAX mrna],,,PMID:33413359,https://www.ncbi.nlm.nih.gov/pubmed/33413359,33413359,,
692,1746898,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Norwogonin results in decreased expression of BCL2 protein,,,PMID:32862589,https://www.ncbi.nlm.nih.gov/pubmed/32862589,32862589,,
693,1746899,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Norwogonin inhibits the reaction [oxygen deficiency results in decreased expression of BCL2 protein]|norwogonin inhibits the reaction [oxygen deficiency results in decreased expression of BCL2 mrna],,,PMID:33413359,https://www.ncbi.nlm.nih.gov/pubmed/33413359,33413359,,
694,1746900,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Norwogonin inhibits the reaction [oxygen deficiency results in increased cleavage of CASP3 protein]|norwogonin inhibits the reaction [oxygen deficiency results in increased expression of CASP3 mrna],,,PMID:33413359,https://www.ncbi.nlm.nih.gov/pubmed/33413359,33413359,,
695,1746901,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Norwogonin inhibits the reaction [oxygen deficiency results in decreased activity of CAT protein],,,PMID:33413359,https://www.ncbi.nlm.nih.gov/pubmed/33413359,33413359,,
696,1746902,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),Norwogonin results in decreased expression of CCNB1 protein,,,PMID:32862589,https://www.ncbi.nlm.nih.gov/pubmed/32862589,32862589,,
697,1746903,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,10090.0,Mus musculus (house mouse),Norwogonin results in increased expression of CEBPA protein|norwogonin analog results in increased expression of CEBPA protein,,,PMID:30445784,https://www.ncbi.nlm.nih.gov/pubmed/30445784,30445784,,
698,1746904,5281674,Comparative Toxicogenomics Database (CTD),Norwogonin,C055505,norwogonin,https://ctdbase.org/detail.go?type=chem&acc=C055505,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,10116.0,Rattus norvegicus (Norway rat),Norwogonin inhibits the reaction [oxygen deficiency results in increased expression of CYCS protein]|norwogonin inhibits the reaction [oxygen deficiency results in increased expression of CYCS mrna],,,PMID:33413359,https://www.ncbi.nlm.nih.gov/pubmed/33413359,33413359,,
699,1738597,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in decreased expression of JUN mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUN mrna|coumestrol results in decreased expression of JUN mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
700,1741734,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,56180,MOSPD1,https://ctdbase.org/detail.go?type=gene&acc=56180,,,56180.0,MOSPD1,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of MOSPD1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
701,1741735,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,10198,MPHOSPH9,https://ctdbase.org/detail.go?type=gene&acc=10198,,,10198.0,MPHOSPH9,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of MPHOSPH9 mrna|[coumestrol co-treated with resveratrol] results in increased expression of MPHOSPH9 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
702,1741736,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,744,MPPED2,https://ctdbase.org/detail.go?type=gene&acc=744,,,744.0,MPPED2,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of MPPED2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
703,1741737,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4361,MRE11,https://ctdbase.org/detail.go?type=gene&acc=4361,,,4361.0,MRE11,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mrna|[coumestrol co-treated with resveratrol] results in increased expression of MRE11 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
704,1742539,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4070,TACSTD2,https://ctdbase.org/detail.go?type=gene&acc=4070,,,4070.0,TACSTD2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
705,1742540,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,6883,TAF12,https://ctdbase.org/detail.go?type=gene&acc=6883,,,6883.0,TAF12,9606.0,Homo sapiens (human),Coumestrol results in increased expression of TAF12 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
706,1742541,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,6877,TAF5,https://ctdbase.org/detail.go?type=gene&acc=6877,,,6877.0,TAF5,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in increased expression of TAF5 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TAF5 mrna|coumestrol results in increased expression of TAF5 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
707,1742542,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,26115,TANC2,https://ctdbase.org/detail.go?type=gene&acc=26115,,,26115.0,TANC2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TANC2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
708,1742543,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,57551,TAOK1,https://ctdbase.org/detail.go?type=gene&acc=57551,,,57551.0,TAOK1,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of TAOK1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
709,1742544,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,51347,TAOK3,https://ctdbase.org/detail.go?type=gene&acc=51347,,,51347.0,TAOK3,9606.0,Homo sapiens (human),"Coumestrol results in decreased expression of TAOK3 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TAOK3 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
710,1742973,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,55672,NBPF1,https://ctdbase.org/detail.go?type=gene&acc=55672,,,55672.0,NBPF1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NBPF1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
711,1742974,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,200030,NBPF11,https://ctdbase.org/detail.go?type=gene&acc=200030,,,200030.0,NBPF11,9606.0,Homo sapiens (human),Coumestrol results in increased expression of NBPF11 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
712,1743311,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,7078,TIMP3,https://ctdbase.org/detail.go?type=gene&acc=7078,,,7078.0,TIMP3,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in decreased expression of TIMP3 mrna|coumestrol results in decreased expression of TIMP3 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
713,1743312,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,54962,TIPIN,https://ctdbase.org/detail.go?type=gene&acc=54962,,,54962.0,TIPIN,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of TIPIN mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIPIN mrna|[coumestrol co-treated with resveratrol] results in increased expression of TIPIN mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
714,1743313,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,7083,TK1,https://ctdbase.org/detail.go?type=gene&acc=7083,,,7083.0,TK1,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in increased expression of TK1 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TK1 mrna|coumestrol results in increased expression of TK1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
715,1743314,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,26007,TKFC,https://ctdbase.org/detail.go?type=gene&acc=26007,,,26007.0,TKFC,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TKFC mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
716,1743315,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,116238,TLCD1,https://ctdbase.org/detail.go?type=gene&acc=116238,,,116238.0,TLCD1,9606.0,Homo sapiens (human),Coumestrol results in increased expression of TLCD1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
717,1743332,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,55247,NEIL3,https://ctdbase.org/detail.go?type=gene&acc=55247,,,55247.0,NEIL3,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in increased expression of NEIL3 mrna|coumestrol results in increased expression of NEIL3 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEIL3 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
718,1743333,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4751,NEK2,https://ctdbase.org/detail.go?type=gene&acc=4751,,,4751.0,NEK2,9606.0,Homo sapiens (human),ESR2 protein affects the reaction [[coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mrna]|[coumestrol co-treated with ESR1 protein] results in increased expression of NEK2 mRNA,,,PMID:18310284,https://www.ncbi.nlm.nih.gov/pubmed/18310284,18310284,,
719,1743334,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4751,NEK2,https://ctdbase.org/detail.go?type=gene&acc=4751,,,4751.0,NEK2,9606.0,Homo sapiens (human),Coumestrol results in increased expression of NEK2 mrna|[coumestrol co-treated with resveratrol] results in increased expression of NEK2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
720,1743514,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4753,NELL2,https://ctdbase.org/detail.go?type=gene&acc=4753,,,4753.0,NELL2,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of NELL2 mrna|[coumestrol co-treated with resveratrol] results in decreased expression of NELL2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
721,1743515,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,23306,NEMP1,https://ctdbase.org/detail.go?type=gene&acc=23306,,,23306.0,NEMP1,9606.0,Homo sapiens (human),Coumestrol results in increased expression of NEMP1 mrna|[coumestrol co-treated with resveratrol] results in increased expression of NEMP1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
722,1743516,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,81831,NETO2,https://ctdbase.org/detail.go?type=gene&acc=81831,,,81831.0,NETO2,9606.0,Homo sapiens (human),Coumestrol results in increased expression of NETO2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
723,1743517,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4758,NEU1,https://ctdbase.org/detail.go?type=gene&acc=4758,,,4758.0,NEU1,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of NEU1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
724,1743518,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,54492,NEURL1B,https://ctdbase.org/detail.go?type=gene&acc=54492,,,54492.0,NEURL1B,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEURL1B mrna|coumestrol results in increased expression of NEURL1B mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
725,1743519,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,84901,NFATC2IP,https://ctdbase.org/detail.go?type=gene&acc=84901,,,84901.0,NFATC2IP,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of NFATC2IP mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NFATC2IP mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
726,1743520,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NFIL3 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
727,1743521,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of NFKB1 protein,,,PMID:16696175,https://www.ncbi.nlm.nih.gov/pubmed/16696175,16696175,,
728,1743522,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of NFKBIA mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
729,1743523,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,9368,NHERF1,https://ctdbase.org/detail.go?type=gene&acc=9368,,,9368.0,NHERF1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NHERF1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
730,1745663,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575.0,PCDH10,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of PCDH10 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
731,1745664,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5098,PCDHGC3,https://ctdbase.org/detail.go?type=gene&acc=5098,,,5098.0,PCDHGC3,9606.0,Homo sapiens (human),Coumestrol results in increased expression of PCDHGC3 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
732,1745665,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mrna|coumestrol results in increased expression of PCK2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
733,1745666,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,9768,PCLAF,https://ctdbase.org/detail.go?type=gene&acc=9768,,,9768.0,PCLAF,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of PCLAF mrna|[coumestrol co-treated with resveratrol] results in increased expression of PCLAF mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
734,1745667,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,115294,PCMTD1,https://ctdbase.org/detail.go?type=gene&acc=115294,,,115294.0,PCMTD1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCMTD1 mrna|coumestrol results in decreased expression of PCMTD1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
735,1745668,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of PCNA mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNA mrna|[coumestrol co-treated with resveratrol] results in increased expression of PCNA mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
736,1745669,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5116,PCNT,https://ctdbase.org/detail.go?type=gene&acc=5116,,,5116.0,PCNT,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNT mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
737,1745670,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5121,PCP4,https://ctdbase.org/detail.go?type=gene&acc=5121,,,5121.0,PCP4,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of PCP4 mrna|coumestrol results in increased expression of PCP4 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
738,1746002,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,79001,VKORC1,https://ctdbase.org/detail.go?type=gene&acc=79001,,,79001.0,VKORC1,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mrna|[coumestrol co-treated with resveratrol] results in increased expression of VKORC1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
739,1746629,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,11059,WWP1,https://ctdbase.org/detail.go?type=gene&acc=11059,,,11059.0,WWP1,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of WWP1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
740,1746630,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,23039,XPO7,https://ctdbase.org/detail.go?type=gene&acc=23039,,,23039.0,XPO7,9606.0,Homo sapiens (human),Coumestrol results in increased expression of XPO7 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
741,1746631,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,2547,XRCC6,https://ctdbase.org/detail.go?type=gene&acc=2547,,,2547.0,XRCC6,9606.0,Homo sapiens (human),Coumestrol results in increased expression of XRCC6 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
742,1746632,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,4904,YBX1,https://ctdbase.org/detail.go?type=gene&acc=4904,,,4904.0,YBX1,9606.0,Homo sapiens (human),Coumestrol results in increased expression of YBX1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
743,1746633,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,388403,YPEL2,https://ctdbase.org/detail.go?type=gene&acc=388403,,,388403.0,YPEL2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mrna|[coumestrol co-treated with resveratrol] results in decreased expression of YPEL2 mrna|coumestrol results in decreased expression of YPEL2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
744,1746634,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,51646,YPEL5,https://ctdbase.org/detail.go?type=gene&acc=51646,,,51646.0,YPEL5,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in decreased expression of YPEL5 mrna|coumestrol results in decreased expression of YPEL5 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
745,1746635,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,7529,YWHAB,https://ctdbase.org/detail.go?type=gene&acc=7529,,,7529.0,YWHAB,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of YWHAB mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
746,1747170,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,403313,PLPP6,https://ctdbase.org/detail.go?type=gene&acc=403313,,,403313.0,PLPP6,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of PLPP6 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
747,1747171,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,23654,PLXNB2,https://ctdbase.org/detail.go?type=gene&acc=23654,,,23654.0,PLXNB2,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of PLXNB2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
748,1747172,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,23129,PLXND1,https://ctdbase.org/detail.go?type=gene&acc=23129,,,23129.0,PLXND1,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of PLXND1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
749,1747383,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,25886,POC1A,https://ctdbase.org/detail.go?type=gene&acc=25886,,,25886.0,POC1A,9606.0,Homo sapiens (human),Coumestrol results in increased expression of POC1A mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
750,1747384,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5422,POLA1,https://ctdbase.org/detail.go?type=gene&acc=5422,,,5422.0,POLA1,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of POLA1 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mrna|[coumestrol co-treated with resveratrol] results in increased expression of POLA1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
751,1747385,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,23649,POLA2,https://ctdbase.org/detail.go?type=gene&acc=23649,,,23649.0,POLA2,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mrna|coumestrol results in increased expression of POLA2 mrna|[coumestrol co-treated with resveratrol] results in increased expression of POLA2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
752,1747386,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5424,POLD1,https://ctdbase.org/detail.go?type=gene&acc=5424,,,5424.0,POLD1,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in increased expression of POLD1 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD1 mrna|coumestrol results in increased expression of POLD1 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
753,1747387,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5425,POLD2,https://ctdbase.org/detail.go?type=gene&acc=5425,,,5425.0,POLD2,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in increased expression of POLD2 mrna|coumestrol results in increased expression of POLD2 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
754,1747388,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,10714,POLD3,https://ctdbase.org/detail.go?type=gene&acc=10714,,,10714.0,POLD3,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of POLD3 mrna|[coumestrol co-treated with resveratrol] results in increased expression of POLD3 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
755,1747389,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,26073,POLDIP2,https://ctdbase.org/detail.go?type=gene&acc=26073,,,26073.0,POLDIP2,9606.0,Homo sapiens (human),Coumestrol results in increased expression of POLDIP2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
756,1747390,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,5426,POLE,https://ctdbase.org/detail.go?type=gene&acc=5426,,,5426.0,POLE,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of POLE mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
757,1753951,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,23161,SNX13,https://ctdbase.org/detail.go?type=gene&acc=23161,,,23161.0,SNX13,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of SNX13 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
758,1753952,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,28966,SNX24,https://ctdbase.org/detail.go?type=gene&acc=28966,,,28966.0,SNX24,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX24 mrna|coumestrol results in increased expression of SNX24 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
759,1753953,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,83891,SNX25,https://ctdbase.org/detail.go?type=gene&acc=83891,,,83891.0,SNX25,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of SNX25 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
760,1754129,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,6659,SOX4,https://ctdbase.org/detail.go?type=gene&acc=6659,,,6659.0,SOX4,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in decreased expression of SOX4 mrna|coumestrol results in decreased expression of SOX4 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX4 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
761,1754130,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9606.0,Homo sapiens (human),"Coumestrol results in decreased expression of SOX9 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
762,1754131,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,10615,SPAG5,https://ctdbase.org/detail.go?type=gene&acc=10615,,,10615.0,SPAG5,9606.0,Homo sapiens (human),"Coumestrol results in increased expression of SPAG5 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPAG5 mrna|[coumestrol co-treated with resveratrol] results in increased expression of SPAG5 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
763,1754132,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,23111,SPART,https://ctdbase.org/detail.go?type=gene&acc=23111,,,23111.0,SPART,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of SPART mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
764,1754133,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,64847,SPATA20,https://ctdbase.org/detail.go?type=gene&acc=64847,,,64847.0,SPATA20,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in decreased expression of SPATA20 mrna|coumestrol results in decreased expression of SPATA20 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
765,1754134,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,124044,SPATA2L,https://ctdbase.org/detail.go?type=gene&acc=124044,,,124044.0,SPATA2L,9606.0,Homo sapiens (human),Coumestrol results in decreased expression of SPATA2L mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
766,1754135,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,55812,SPATA7,https://ctdbase.org/detail.go?type=gene&acc=55812,,,55812.0,SPATA7,9606.0,Homo sapiens (human),"[coumestrol co-treated with resveratrol] results in decreased expression of SPATA7 mrna|coumestrol results in decreased expression of SPATA7 mrna|[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPATA7 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
767,1754136,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,147841,SPC24,https://ctdbase.org/detail.go?type=gene&acc=147841,,,147841.0,SPC24,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC24 mrna|[coumestrol co-treated with resveratrol] results in increased expression of SPC24 mrna|coumestrol results in increased expression of SPC24 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
768,1754137,5281707,Comparative Toxicogenomics Database (CTD),Coumestrol,D003375,Coumestrol,https://ctdbase.org/detail.go?type=chem&acc=D003375,57405,SPC25,https://ctdbase.org/detail.go?type=gene&acc=57405,,,57405.0,SPC25,9606.0,Homo sapiens (human),"[coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC25 mrna|[coumestrol co-treated with resveratrol] results in increased expression of SPC25 mrna|coumestrol results in increased expression of SPC25 mRNA",,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
769,1741176,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,9606.0,Homo sapiens (human),Polydatin inhibits the reaction [rotenone results in increased phosphorylation of MTOR protein],,,PMID:31926197,https://www.ncbi.nlm.nih.gov/pubmed/31926197,31926197,,
770,1741365,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10116.0,Rattus norvegicus (Norway rat),Polydatin inhibits the reaction [AGT protein modified form results in increased expression of NOX4 protein]|polydatin inhibits the reaction [AGT protein modified form results in increased expression of NOX4 mrna],,,PMID:25488910,https://www.ncbi.nlm.nih.gov/pubmed/25488910,25488910,,
771,1741366,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116.0,Rattus norvegicus (Norway rat),"Polydatin inhibits the reaction [2,2'-dipyridyl disulfide results in increased expression of NPPA protein]|polydatin inhibits the reaction [phenylephrine results in increased expression of NPPA protein]",,,PMID:25449040,https://www.ncbi.nlm.nih.gov/pubmed/25449040,25449040,,
772,1741367,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116.0,Rattus norvegicus (Norway rat),Polydatin inhibits the reaction [AGT protein modified form results in increased expression of NPPA mrna],,,PMID:25488910,https://www.ncbi.nlm.nih.gov/pubmed/25488910,25488910,,
773,1741368,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Polydatin inhibits the reaction [hydrogen peroxide results in decreased expression of NQO1 protein]|polydatin inhibits the reaction [TSHR protein results in decreased expression of NQO1 protein]|nfe2l2 protein affects the reaction [polydatin inhibits the reaction [hydrogen peroxide results in decreased expression of NQO1 protein]],,,PMID:31705858,https://www.ncbi.nlm.nih.gov/pubmed/31705858,31705858,,
774,1741369,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,4922,NTS,https://ctdbase.org/detail.go?type=gene&acc=4922,,,4922.0,NTS,9606.0,Homo sapiens (human),Polydatin binds to NTS protein,,,PMID:16249055,https://www.ncbi.nlm.nih.gov/pubmed/16249055,16249055,,
775,1741370,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,84876,ORAI1,https://ctdbase.org/detail.go?type=gene&acc=84876,,,84876.0,ORAI1,10090.0,Mus musculus (house mouse),ORAI1 protein affects the susceptibility to polydatin,,,PMID:22959927,https://www.ncbi.nlm.nih.gov/pubmed/22959927,22959927,,
776,1741371,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,396058,OVAL,https://ctdbase.org/detail.go?type=gene&acc=396058,,,396058.0,OVAL,10116.0,Rattus norvegicus (Norway rat),Polydatin inhibits the reaction [OVAL protein results in increased secretion of IL4 protein],,,PMID:23840142,https://www.ncbi.nlm.nih.gov/pubmed/23840142,23840142,,
777,1741532,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,40336,PARK,https://ctdbase.org/detail.go?type=gene&acc=40336,,,40336.0,park,7227.0,Drosophila melanogaster (fruit fly),Polydatin inhibits the reaction [PARK gene mutant form results in decreased abundance of dopamine]|polydatin inhibits the reaction [PARK gene mutant form results in decreased abundance of adenosine triphosphate],,,PMID:31926197,https://www.ncbi.nlm.nih.gov/pubmed/31926197,31926197,,
778,1741533,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,11315,PARK7,https://ctdbase.org/detail.go?type=gene&acc=11315,,,11315.0,PARK7,9606.0,Homo sapiens (human),Polydatin inhibits the reaction [rotenone results in increased expression of PARK7 protein]|[prkn protein affects the susceptibility to polydatin] which results in increased expression of PARK7 protein,,,PMID:31926197,https://www.ncbi.nlm.nih.gov/pubmed/31926197,31926197,,
779,1741534,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,9606.0,Homo sapiens (human),Polydatin results in decreased activity of PDE5A protein,,,PMID:15769121,https://www.ncbi.nlm.nih.gov/pubmed/15769121,15769121,,
780,1741535,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,133522,PPARGC1B,https://ctdbase.org/detail.go?type=gene&acc=133522,,,133522.0,PPARGC1B,9606.0,Homo sapiens (human),Polydatin results in decreased expression of PPARGC1B protein,,,PMID:31926197,https://www.ncbi.nlm.nih.gov/pubmed/31926197,31926197,,
781,1741536,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,4659,PPP1R12A,https://ctdbase.org/detail.go?type=gene&acc=4659,,,4659.0,PPP1R12A,10116.0,Rattus norvegicus (Norway rat),"Polydatin inhibits the reaction [phenylephrine results in increased phosphorylation of PPP1R12A protein]|polydatin inhibits the reaction [2,2'-dipyridyl disulfide results in increased phosphorylation of PPP1R12A protein]",,,PMID:25449040,https://www.ncbi.nlm.nih.gov/pubmed/25449040,25449040,,
782,1741873,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606.0,Homo sapiens (human),ESR2 gene mutant form inhibits the reaction [polydatin results in increased expression of SOD2 protein]|fulvestrant inhibits the reaction [polydatin results in increased expression of SOD2 protein]|polydatin results in increased expression of SOD2 protein|polydatin results in increased expression of and results in increased activity of SOD2 protein,,,PMID:24361291,https://www.ncbi.nlm.nih.gov/pubmed/24361291,24361291,,
783,1741874,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),Polydatin promotes the reaction [rotenone results in decreased expression of SQSTM1 protein],,,PMID:31926197,https://www.ncbi.nlm.nih.gov/pubmed/31926197,31926197,,
784,1741875,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,9606.0,Homo sapiens (human),[polydatin co-treated with TGFA protein] results in increased expression of CXCL8 mrna|[polydatin co-treated with TGFA protein] results in increased expression of CXCL10 mRNA,,,PMID:21756928,https://www.ncbi.nlm.nih.gov/pubmed/21756928,21756928,,
785,1741876,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,9606.0,Homo sapiens (human),PD168393 inhibits the reaction [[TGFA protein co-treated with polydatin] results in increased secretion of CXCL8 protein]|polydatin inhibits the reaction [[TGFA protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]|[tgfa protein co-treated with polydatin] results in increased expression of CXCL8 mrna|polydatin promotes the reaction [[TGFA protein co-treated with IFNG protein] results in increased expression of and results in increased secretion of CXCL8 protein]|polydatin inhibits the reaction [TGFA protein affects the localization of EGFR protein]|polydatin promotes the reaction [TGFA protein results in increased expression of CXCL8 protein]|[leptomycin B co-treated with TGFA protein co-treated with polydatin] affects the localization of EGFR protein modified form|[tgfa protein co-treated with polydatin] results in increased secretion of CXCL8 protein|polydatin promotes the reaction [TGFA protein results in increased expression of CXCL8 mrna]|polydatin promotes the reaction [[TGFA protein co-treated with IFNG protein] results in increased expression of CXCL8 mrna]|pd168393 inhibits the reaction [[TGFA protein co-treated with polydatin] results in increased expression of CXCL8 mrna],,,PMID:21967610,https://www.ncbi.nlm.nih.gov/pubmed/21967610,21967610,,
786,1741877,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116.0,Rattus norvegicus (Norway rat),Polydatin inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 protein],,,PMID:25488910,https://www.ncbi.nlm.nih.gov/pubmed/25488910,25488910,,
787,1741878,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Polydatin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]|polydatin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein]|polydatin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]|polydatin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]|polydatin results in decreased expression of TNF mrna|polydatin promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein],,,PMID:21756928,https://www.ncbi.nlm.nih.gov/pubmed/21756928,21756928,,
788,1741879,5281718,Comparative Toxicogenomics Database (CTD),Polydatin,C058229,polydatin,https://ctdbase.org/detail.go?type=chem&acc=C058229,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Polydatin inhibits the reaction [arsenic trioxide results in increased expression of TNF mrna],,,PMID:29130132,https://www.ncbi.nlm.nih.gov/pubmed/29130132,29130132,,
789,1748526,5281780,Comparative Toxicogenomics Database (CTD),"4,5-Dicaffeoylquinic acid",C478100,"3,4-di-O-caffeoylquinic acid",https://ctdbase.org/detail.go?type=chem&acc=C478100,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),"3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in decreased activity of SOD1 protein]",,,PMID:37385299,https://www.ncbi.nlm.nih.gov/pubmed/37385299,37385299,,
790,1742364,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,10142,AKAP9,https://ctdbase.org/detail.go?type=gene&acc=10142,,,10142.0,AKAP9,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of AKAP9 mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
791,1742365,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231.0,AKR1B1,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester results in decreased activity of AKR1B1 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
792,1742366,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester results in decreased activity of AKR1B10 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
793,1742367,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester results in decreased activity of AKR1C1 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
794,1742368,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester results in decreased activity of AKR1C2 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
795,1742369,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester results in decreased activity of AKR1C3 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
796,1742370,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,1109,AKR1C4,https://ctdbase.org/detail.go?type=gene&acc=1109,,,1109.0,AKR1C4,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester results in decreased activity of AKR1C4 protein,,,PMID:27163852,https://www.ncbi.nlm.nih.gov/pubmed/27163852,27163852,,
797,1742371,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Caffeic acid phenethyl ester analog affects the phosphorylation of AKT1 protein,,,PMID:32125059,https://www.ncbi.nlm.nih.gov/pubmed/32125059,32125059,,
798,1743064,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Caffeic acid phenethyl ester inhibits the reaction [bleomycin results in decreased expression of CAT protein],,,PMID:23570914,https://www.ncbi.nlm.nih.gov/pubmed/23570914,23570914,,
799,1743065,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Caffeic acid phenethyl ester inhibits the reaction [carbon tetrachloride results in decreased activity of CAT protein],,,PMID:18436364,https://www.ncbi.nlm.nih.gov/pubmed/18436364,18436364,,
800,1743757,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,53405,CLIC5,https://ctdbase.org/detail.go?type=gene&acc=53405,,,53405.0,CLIC5,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CLIC5 mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
801,1743758,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,9575,CLOCK,https://ctdbase.org/detail.go?type=gene&acc=9575,,,9575.0,CLOCK,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CLOCK mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
802,1743759,5281787,Comparative Toxicogenomics Database (CTD),Caffeic acid phenethyl ester,C055494,caffeic acid phenethyl ester,https://ctdbase.org/detail.go?type=chem&acc=C055494,80781,COL18A1,https://ctdbase.org/detail.go?type=gene&acc=80781,,,80781.0,COL18A1,10090.0,Mus musculus (house mouse),Caffeic acid phenethyl ester results in increased expression of COL18A1 protein,,,PMID:20433813,https://www.ncbi.nlm.nih.gov/pubmed/20433813,20433813,,
803,1748749,5282242,ChEMBL,Ceftibuten,CHEMBL1605,CEFTIBUTEN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1605/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,PMID:2120175,https://www.ncbi.nlm.nih.gov/pubmed/2120175,2120175,,
804,1748750,5282250,Therapeutic Target Database (TTD),"4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid",D0A2UX,SITS,https://idrblab.net/ttd/data/drug/details/D0A2UX,T43531,Chloride channel protein 7 (ClC-7),https://idrblab.net/ttd/data/target/details/T43531,P51798,H(+)/Cl(-) exchange transporter 7,1186.0,CLCN7,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
805,1748751,5282250,Therapeutic Target Database (TTD),"4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid",D0A2UX,SITS,https://idrblab.net/ttd/data/drug/details/D0A2UX,T05089,Calcium-dependent chloride channel anoctamin (ANO),https://idrblab.net/ttd/data/target/details/T05089,Q5XXA6,Anoctamin-1,55107.0,ANO1,9606.0,Homo sapiens (human),Blocker (channel blocker),,,,,,,
806,1748752,5282253,Drug Gene Interaction database (DGIdb),Domoic acid,,DOMOIC ACID,https://www.dgidb.org/drugs/drugbank:DB02852,,KDM4A,https://www.dgidb.org/genes/hgnc:22978,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
807,1749377,5282280,Comparative Toxicogenomics Database (CTD),2-Arachidonoylglycerol,C094503,glyceryl 2-arachidonate,https://ctdbase.org/detail.go?type=chem&acc=C094503,221955,DAGLB,https://ctdbase.org/detail.go?type=gene&acc=221955,,,221955.0,DAGLB,9606.0,Homo sapiens (human),DAGLB protein results in increased chemical synthesis of glyceryl 2-arachidonate,,,PMID:18657971,https://www.ncbi.nlm.nih.gov/pubmed/18657971,18657971,,
808,1749378,5282280,Comparative Toxicogenomics Database (CTD),2-Arachidonoylglycerol,C094503,glyceryl 2-arachidonate,https://ctdbase.org/detail.go?type=chem&acc=C094503,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),Glyceryl 2-arachidonate results in increased expression of DDIT3 mrna|iodopravadoline inhibits the reaction [glyceryl 2-arachidonate results in increased expression of DDIT3 protein]|iodopravadoline inhibits the reaction [glyceryl 2-arachidonate results in increased expression of DDIT3 mrna],,,PMID:32357311,https://www.ncbi.nlm.nih.gov/pubmed/32357311,32357311,,
809,1748753,5282318,Drug Gene Interaction database (DGIdb),Trimipramine Maleate,,TRIMIPRAMINE MALEATE,https://www.dgidb.org/drugs/rxcui:71532,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
810,1748754,5282318,Drug Gene Interaction database (DGIdb),Trimipramine Maleate,,TRIMIPRAMINE MALEATE,https://www.dgidb.org/drugs/rxcui:71532,,HRH1,https://www.dgidb.org/genes/hgnc:5182,,,3269.0,HRH1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
811,1750084,5283349,Drug Gene Interaction database (DGIdb),"2,4-Decadienal",,CHEMBL:CHEMBL443949,https://www.dgidb.org/drugs/chembl:CHEMBL443949,,RORC,https://www.dgidb.org/genes/hgnc:10260,,,6097.0,RORC,9606.0,Homo sapiens (human),,,,,,,,
812,1751685,5283349,Comparative Toxicogenomics Database (CTD),"2,4-Decadienal",C057349,"2,4-decadienal",https://ctdbase.org/detail.go?type=chem&acc=C057349,373441,SM30A,https://ctdbase.org/detail.go?type=gene&acc=373441,,,373441.0,SM30A,7656.0,Paracentrotus lividus (common urchin),"2,4-decadienal results in decreased expression of SM30A mRNA",,,PMID:22363721,https://www.ncbi.nlm.nih.gov/pubmed/22363721,22363721,,
813,1751686,5283349,Comparative Toxicogenomics Database (CTD),"2,4-Decadienal",C057349,"2,4-decadienal",https://ctdbase.org/detail.go?type=chem&acc=C057349,373464,SM50,https://ctdbase.org/detail.go?type=gene&acc=373464,,,373464.0,,7656.0,Paracentrotus lividus (common urchin),"2,4-decadienal results in decreased expression of SM50 mRNA",,,PMID:22363721,https://www.ncbi.nlm.nih.gov/pubmed/22363721,22363721,,
814,1751687,5283349,Comparative Toxicogenomics Database (CTD),"2,4-Decadienal",C057349,"2,4-decadienal",https://ctdbase.org/detail.go?type=chem&acc=C057349,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,7656.0,Paracentrotus lividus (common urchin),"2,4-decadienal results in decreased expression of SOX9 mRNA",,,PMID:22363721,https://www.ncbi.nlm.nih.gov/pubmed/22363721,22363721,,
815,1751688,5283349,Comparative Toxicogenomics Database (CTD),"2,4-Decadienal",C057349,"2,4-decadienal",https://ctdbase.org/detail.go?type=chem&acc=C057349,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),"Acetylcysteine inhibits the reaction [2,4-decadienal results in increased expression of and results in increased secretion of TNF protein]|2,4-decadienal results in increased expression of and results in increased secretion of TNF protein",,,PMID:16014734,https://www.ncbi.nlm.nih.gov/pubmed/16014734,16014734,,
816,1750085,5283387,Therapeutic Target Database (TTD),Oleamide,D03AHJ,Elaidoylamide,https://idrblab.net/ttd/data/drug/details/D03AHJ,T19160,Group IIA phospholipase A2 (GIIA sPLA2),https://idrblab.net/ttd/data/target/details/T19160,P14555,"Phospholipase A2, membrane associated",5320.0,PLA2G2A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
817,1750086,5284329,IUPHAR/BPS Guide to PHARMACOLOGY,Purmorphamine,10356,purmorphamine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10356,239,SMO,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=239,Q99835,Smoothened homolog,6608.0,SMO,9606.0,Homo sapiens (human),Agonist,pEC50,6,PMID:16408088,https://www.ncbi.nlm.nih.gov/pubmed/16408088,16408088,,
818,1738297,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,557565,NRD1B,https://ctdbase.org/detail.go?type=gene&acc=557565,,,557565.0,nrd1b,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of NRD1B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
819,1738298,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of NREP mRNA,,,PMID:20106945|PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25596134,20106945|25596134,,
820,1738299,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of NREP promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
821,1738300,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,9606.0,Homo sapiens (human),Cyclosporine results in increased methylation of NRF1 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
822,1738301,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,3084,NRG1,https://ctdbase.org/detail.go?type=gene&acc=3084,,,3084.0,NRG1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of NRG1 mRNA,,,PMID:20106945|PMID:22147139|PMID:33631201,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/22147139|https://www.ncbi.nlm.nih.gov/pubmed/33631201,20106945|22147139|33631201,,
823,1738302,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9542,NRG2,https://ctdbase.org/detail.go?type=gene&acc=9542,,,9542.0,NRG2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of NRG2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
824,1738303,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8204,NRIP1,https://ctdbase.org/detail.go?type=gene&acc=8204,,,8204.0,NRIP1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of NRIP1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
825,1738304,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11270,NRM,https://ctdbase.org/detail.go?type=gene&acc=11270,,,11270.0,NRM,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of NRM mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
826,1738909,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9322,TRIP10,https://ctdbase.org/detail.go?type=gene&acc=9322,,,9322.0,TRIP10,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of TRIP10 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
827,1738910,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9321,TRIP11,https://ctdbase.org/detail.go?type=gene&acc=9321,,,9321.0,TRIP11,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of TRIP11 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
828,1738911,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9321,TRIP11,https://ctdbase.org/detail.go?type=gene&acc=9321,,,9321.0,TRIP11,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of TRIP11 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
829,1738912,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9320,TRIP12,https://ctdbase.org/detail.go?type=gene&acc=9320,,,9320.0,TRIP12,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of TRIP12 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
830,1738913,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9319,TRIP13,https://ctdbase.org/detail.go?type=gene&acc=9319,,,9319.0,TRIP13,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of TRIP13 mRNA,,,PMID:19159671|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/19159671|https://www.ncbi.nlm.nih.gov/pubmed/25562108,19159671|25562108,,
831,1738914,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9325,TRIP4,https://ctdbase.org/detail.go?type=gene&acc=9325,,,9325.0,TRIP4,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of TRIP4 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
832,1739990,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11165,NUDT3,https://ctdbase.org/detail.go?type=gene&acc=11165,,,11165.0,NUDT3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of NUDT3 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
833,1739991,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11163,NUDT4,https://ctdbase.org/detail.go?type=gene&acc=11163,,,11163.0,NUDT4,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of NUDT4 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
834,1739992,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11163,NUDT4,https://ctdbase.org/detail.go?type=gene&acc=11163,,,11163.0,NUDT4,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of NUDT4 mRNA,,,PMID:17942131,https://www.ncbi.nlm.nih.gov/pubmed/17942131,17942131,,
835,1739993,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11164,NUDT5,https://ctdbase.org/detail.go?type=gene&acc=11164,,,11164.0,NUDT5,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of NUDT5 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
836,1739994,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11162,NUDT6,https://ctdbase.org/detail.go?type=gene&acc=11162,,,11162.0,NUDT6,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of NUDT6 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
837,1739995,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,283927,NUDT7,https://ctdbase.org/detail.go?type=gene&acc=283927,,,283927.0,NUDT7,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of NUDT7 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
838,1739996,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,283927,NUDT7,https://ctdbase.org/detail.go?type=gene&acc=283927,,,283927.0,NUDT7,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of NUDT7 mRNA,,,PMID:25047351,https://www.ncbi.nlm.nih.gov/pubmed/25047351,25047351,,
839,1739997,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,283927,NUDT7,https://ctdbase.org/detail.go?type=gene&acc=283927,,,283927.0,NUDT7,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of NUDT7 protein,,,PMID:23308384|PMID:25047351,https://www.ncbi.nlm.nih.gov/pubmed/23308384|https://www.ncbi.nlm.nih.gov/pubmed/25047351,23308384|25047351,,
840,1740824,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8458,TTF2,https://ctdbase.org/detail.go?type=gene&acc=8458,,,8458.0,TTF2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of TTF2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
841,1740825,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9675,TTI1,https://ctdbase.org/detail.go?type=gene&acc=9675,,,9675.0,TTI1,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of TTI1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
842,1740826,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9675,TTI1,https://ctdbase.org/detail.go?type=gene&acc=9675,,,9675.0,TTI1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of TTI1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
843,1740827,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7272,TTK,https://ctdbase.org/detail.go?type=gene&acc=7272,,,7272.0,TTK,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of TTK mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
844,1740828,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,150465,TTL,https://ctdbase.org/detail.go?type=gene&acc=150465,,,150465.0,TTL,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of TTL mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
845,1740829,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,254173,TTLL10,https://ctdbase.org/detail.go?type=gene&acc=254173,,,254173.0,TTLL10,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of TTLL10 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
846,1740830,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,158135,TTLL11,https://ctdbase.org/detail.go?type=gene&acc=158135,,,158135.0,TTLL11,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of TTLL11 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
847,1740831,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,158135,TTLL11,https://ctdbase.org/detail.go?type=gene&acc=158135,,,158135.0,TTLL11,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of TTLL11 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
848,1740832,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,158135,TTLL11,https://ctdbase.org/detail.go?type=gene&acc=158135,,,158135.0,TTLL11,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of TTLL11 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
849,1740833,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9654,TTLL4,https://ctdbase.org/detail.go?type=gene&acc=9654,,,9654.0,TTLL4,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of TTLL4 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
850,1740834,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23093,TTLL5,https://ctdbase.org/detail.go?type=gene&acc=23093,,,23093.0,TTLL5,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of TTLL5 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
851,1742016,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,564474,SLC1A8B,https://ctdbase.org/detail.go?type=gene&acc=564474,,,564474.0,slc1a8b,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of SLC1A8B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
852,1742017,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,100463516,SLC1A9,https://ctdbase.org/detail.go?type=gene&acc=100463516,,,100463516.0,slc1a9,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of SLC1A9 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
853,1742018,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6574,SLC20A1,https://ctdbase.org/detail.go?type=gene&acc=6574,,,6574.0,SLC20A1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of SLC20A1 mRNA,,,PMID:24907557|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/24907557|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,24907557|25562108|27989131,,
854,1742019,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6574,SLC20A1,https://ctdbase.org/detail.go?type=gene&acc=6574,,,6574.0,SLC20A1,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of SLC20A1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
855,1742020,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6575,SLC20A2,https://ctdbase.org/detail.go?type=gene&acc=6575,,,6575.0,SLC20A2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC20A2 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
856,1742021,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6580,SLC22A1,https://ctdbase.org/detail.go?type=gene&acc=6580,,,6580.0,SLC22A1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of SLC22A1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
857,1742022,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,6580,SLC22A1,https://ctdbase.org/detail.go?type=gene&acc=6580,,,6580.0,SLC22A1,9606.0,Homo sapiens (human),[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with cyclosporine] results in decreased expression of SLC22A1 mRNA,,,PMID:33819548,https://www.ncbi.nlm.nih.gov/pubmed/33819548,33819548,,
858,1742023,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9390,SLC22A13,https://ctdbase.org/detail.go?type=gene&acc=9390,,,9390.0,SLC22A13,10116.0,Rattus norvegicus (Norway rat),Cyclosporine results in decreased expression of SLC22A13 mRNA,,,PMID:21865292,https://www.ncbi.nlm.nih.gov/pubmed/21865292,21865292,,
859,1742024,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9389,SLC22A14,https://ctdbase.org/detail.go?type=gene&acc=9389,,,9389.0,SLC22A14,9606.0,Homo sapiens (human),Cyclosporine results in increased methylation of SLC22A14 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
860,1743316,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,26986,PABPC1,https://ctdbase.org/detail.go?type=gene&acc=26986,,,26986.0,PABPC1,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PABPC1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
861,1743317,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,393856,PABPC1B,https://ctdbase.org/detail.go?type=gene&acc=393856,,,393856.0,pabpc1b,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of PABPC1B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
862,1743318,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,80336,PABPC1L,https://ctdbase.org/detail.go?type=gene&acc=80336,,,80336.0,PABPC1L,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PABPC1L mRNA,,,PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|21632981|25562108|27989131,,
863,1743319,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5042,PABPC3,https://ctdbase.org/detail.go?type=gene&acc=5042,,,5042.0,PABPC3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PABPC3 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
864,1743320,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,132430,PABPC4L,https://ctdbase.org/detail.go?type=gene&acc=132430,,,132430.0,PABPC4L,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PABPC4L mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
865,1743321,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8106,PABPN1,https://ctdbase.org/detail.go?type=gene&acc=8106,,,8106.0,PABPN1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PABPN1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
866,1743749,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55757,UGGT2,https://ctdbase.org/detail.go?type=gene&acc=55757,,,55757.0,UGGT2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of UGGT2 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
867,1743750,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360.0,UGP2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of UGP2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
868,1743751,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360.0,UGP2,9606.0,Homo sapiens (human),[glycochenodeoxycholic acid co-treated with deoxycholic acid co-treated with chenodeoxycholic acid co-treated with glycodeoxycholic acid co-treated with glycocholic acid co-treated with cyclosporine] results in decreased expression of UGP2 mRNA,,,PMID:33819548,https://www.ncbi.nlm.nih.gov/pubmed/33819548,33819548,,
869,1743752,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360.0,UGP2,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of UGP2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
870,1743753,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UGT1A1 mRNA,,,PMID:32253466,https://www.ncbi.nlm.nih.gov/pubmed/32253466,32253466,,
871,1743754,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UGT1A6 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
872,1743755,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,10116.0,Rattus norvegicus (Norway rat),Cyclosporine results in increased expression of UGT1A6 mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
873,1743756,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,94284,UGT1A6A,https://ctdbase.org/detail.go?type=gene&acc=94284,,,94284.0,Ugt1a6a,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of UGT1A6A mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
874,1744443,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7372,UMPS,https://ctdbase.org/detail.go?type=gene&acc=7372,,,7372.0,UMPS,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UMPS mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
875,1744444,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84747,UNC119B,https://ctdbase.org/detail.go?type=gene&acc=84747,,,84747.0,UNC119B,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UNC119B mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
876,1744445,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,201294,UNC13D,https://ctdbase.org/detail.go?type=gene&acc=201294,,,201294.0,UNC13D,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of UNC13D mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
877,1744446,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,146862,UNC45B,https://ctdbase.org/detail.go?type=gene&acc=146862,,,146862.0,UNC45B,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of UNC45B promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
878,1744447,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,25972,UNC50,https://ctdbase.org/detail.go?type=gene&acc=25972,,,25972.0,UNC50,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UNC50 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
879,1744448,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,25972,UNC50,https://ctdbase.org/detail.go?type=gene&acc=25972,,,25972.0,UNC50,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of UNC50 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
880,1744449,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,219699,UNC5B,https://ctdbase.org/detail.go?type=gene&acc=219699,,,219699.0,UNC5B,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of UNC5B mRNA,,,PMID:20106945|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|25562108|27989131,,
881,1744450,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,222643,UNC5CL,https://ctdbase.org/detail.go?type=gene&acc=222643,,,222643.0,UNC5CL,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UNC5CL mRNA,,,PMID:20106945|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|25562108|27989131,,
882,1744451,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7374,UNG,https://ctdbase.org/detail.go?type=gene&acc=7374,,,7374.0,UNG,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UNG mRNA,,,PMID:21632981|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108,21632981|25562108,,
883,1744452,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7374,UNG,https://ctdbase.org/detail.go?type=gene&acc=7374,,,7374.0,UNG,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of UNG mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
884,1744812,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,27089,UQCRQ,https://ctdbase.org/detail.go?type=gene&acc=27089,,,27089.0,UQCRQ,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of UQCRQ mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
885,1744813,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84996,URB1-AS1,https://ctdbase.org/detail.go?type=gene&acc=84996,,,84996.0,URB1-AS1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of URB1-AS1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
886,1745363,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5096,PCCB,https://ctdbase.org/detail.go?type=gene&acc=5096,,,5096.0,PCCB,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCCB mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
887,1745364,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,64881,PCDH20,https://ctdbase.org/detail.go?type=gene&acc=64881,,,64881.0,PCDH20,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDH20 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
888,1745365,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5099,PCDH7,https://ctdbase.org/detail.go?type=gene&acc=5099,,,5099.0,PCDH7,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDH7 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
889,1745366,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5101,PCDH9,https://ctdbase.org/detail.go?type=gene&acc=5101,,,5101.0,PCDH9,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDH9 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
890,1745367,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,56134,PCDHAC2,https://ctdbase.org/detail.go?type=gene&acc=56134,,,56134.0,PCDHAC2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PCDHAC2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
891,1745368,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,56125,PCDHB11,https://ctdbase.org/detail.go?type=gene&acc=56125,,,56125.0,PCDHB11,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDHB11 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
892,1745369,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,56122,PCDHB14,https://ctdbase.org/detail.go?type=gene&acc=56122,,,56122.0,PCDHB14,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDHB14 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
893,1745370,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,57717,PCDHB16,https://ctdbase.org/detail.go?type=gene&acc=57717,,,57717.0,PCDHB16,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDHB16 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
894,1745371,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,56133,PCDHB2,https://ctdbase.org/detail.go?type=gene&acc=56133,,,56133.0,PCDHB2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDHB2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
895,1745372,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,56131,PCDHB4,https://ctdbase.org/detail.go?type=gene&acc=56131,,,56131.0,PCDHB4,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PCDHB4 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
896,1746791,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54832,VPS13C,https://ctdbase.org/detail.go?type=gene&acc=54832,,,54832.0,VPS13C,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of VPS13C mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
897,1746792,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55187,VPS13D,https://ctdbase.org/detail.go?type=gene&acc=55187,,,55187.0,VPS13D,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of VPS13D mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
898,1746793,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,51028,VPS36,https://ctdbase.org/detail.go?type=gene&acc=51028,,,51028.0,VPS36,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of VPS36 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
899,1746794,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,137492,VPS37A,https://ctdbase.org/detail.go?type=gene&acc=137492,,,137492.0,VPS37A,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of VPS37A mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
900,1746795,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,79720,VPS37B,https://ctdbase.org/detail.go?type=gene&acc=79720,,,79720.0,VPS37B,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of VPS37B mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
901,1746796,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55048,VPS37C,https://ctdbase.org/detail.go?type=gene&acc=55048,,,55048.0,VPS37C,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of VPS37C mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
902,1746797,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,27072,VPS41,https://ctdbase.org/detail.go?type=gene&acc=27072,,,27072.0,VPS41,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of VPS41 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
903,1746798,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11311,VPS45,https://ctdbase.org/detail.go?type=gene&acc=11311,,,11311.0,VPS45,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of VPS45 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
904,1746799,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9525,VPS4B,https://ctdbase.org/detail.go?type=gene&acc=9525,,,9525.0,VPS4B,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of VPS4B mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
905,1747391,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9601,PDIA4,https://ctdbase.org/detail.go?type=gene&acc=9601,,,9601.0,PDIA4,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PDIA4 mRNA,,,PMID:20106945|PMID:21163907|PMID:21632981|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21163907|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|21163907|21632981|25562108|27989131,,
906,1747392,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9601,PDIA4,https://ctdbase.org/detail.go?type=gene&acc=9601,,,9601.0,PDIA4,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PDIA4 protein|cyclosporine results in increased expression of PDIA4 mRNA,,,PMID:23308384|PMID:25047351,https://www.ncbi.nlm.nih.gov/pubmed/23308384|https://www.ncbi.nlm.nih.gov/pubmed/25047351,23308384|25047351,,
907,1747393,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10954,PDIA5,https://ctdbase.org/detail.go?type=gene&acc=10954,,,10954.0,PDIA5,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PDIA5 mrna|cyclosporine results in increased expression of PDIA5 mRNA,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
908,1747827,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23244,PDS5A,https://ctdbase.org/detail.go?type=gene&acc=23244,,,23244.0,PDS5A,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PDS5A mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
909,1747828,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PDS5B mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
910,1747829,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23590,PDSS1,https://ctdbase.org/detail.go?type=gene&acc=23590,,,23590.0,PDSS1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PDSS1 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
911,1748185,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of WWOX mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
912,1748186,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,11059,WWP1,https://ctdbase.org/detail.go?type=gene&acc=11059,,,11059.0,WWP1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of WWP1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
913,1748187,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,25937,WWTR1,https://ctdbase.org/detail.go?type=gene&acc=25937,,,25937.0,WWTR1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of WWTR1 mRNA,,,PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,25562108|27989131,,
914,1748188,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,56949,XAB2,https://ctdbase.org/detail.go?type=gene&acc=56949,,,56949.0,XAB2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of XAB2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
915,1748189,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54739,XAF1,https://ctdbase.org/detail.go?type=gene&acc=54739,,,54739.0,XAF1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of XAF1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
916,1748190,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54739,XAF1,https://ctdbase.org/detail.go?type=gene&acc=54739,,,54739.0,XAF1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of XAF1 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
917,1748191,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9502,XAGE2,https://ctdbase.org/detail.go?type=gene&acc=9502,,,9502.0,XAGE2,9606.0,Homo sapiens (human),Cyclosporine results in increased methylation of XAGE2 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
918,1748192,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,170626,XAGE3,https://ctdbase.org/detail.go?type=gene&acc=170626,,,170626.0,XAGE3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of XAGE3 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
919,1748193,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,9606.0,Homo sapiens (human),ATF6 protein affects the reaction [cyclosporine results in increased expression of XBP1 protein alternative form]|cyclosporine results in increased splicing of XBP1 mrna|cyclosporine results in increased expression of XBP1 protein alternative form,,,PMID:35033536,https://www.ncbi.nlm.nih.gov/pubmed/35033536,35033536,,
920,1748194,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of XBP1 mrna|cyclosporine results in increased expression of XBP1 mrna|cyclosporine affects the activity of XBP1 protein,,,PMID:25596134,https://www.ncbi.nlm.nih.gov/pubmed/25596134,25596134,,
921,1750087,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,79844,ZDHHC11,https://ctdbase.org/detail.go?type=gene&acc=79844,,,79844.0,ZDHHC11,9606.0,Homo sapiens (human),Cyclosporine results in increased methylation of ZDHHC11 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
922,1750088,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84885,ZDHHC12,https://ctdbase.org/detail.go?type=gene&acc=84885,,,84885.0,ZDHHC12,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZDHHC12 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
923,1750089,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54503,ZDHHC13,https://ctdbase.org/detail.go?type=gene&acc=54503,,,54503.0,ZDHHC13,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZDHHC13 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
924,1750090,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,79683,ZDHHC14,https://ctdbase.org/detail.go?type=gene&acc=79683,,,79683.0,ZDHHC14,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of ZDHHC14 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
925,1750091,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84287,ZDHHC16,https://ctdbase.org/detail.go?type=gene&acc=84287,,,84287.0,ZDHHC16,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZDHHC16 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
926,1750092,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84243,ZDHHC18,https://ctdbase.org/detail.go?type=gene&acc=84243,,,84243.0,ZDHHC18,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZDHHC18 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
927,1750093,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84243,ZDHHC18,https://ctdbase.org/detail.go?type=gene&acc=84243,,,84243.0,ZDHHC18,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of ZDHHC18 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
928,1750094,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,51201,ZDHHC2,https://ctdbase.org/detail.go?type=gene&acc=51201,,,51201.0,ZDHHC2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZDHHC2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
929,1751123,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5279,PIGC,https://ctdbase.org/detail.go?type=gene&acc=5279,,,5279.0,PIGC,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PIGC mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
930,1751124,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5281,PIGF,https://ctdbase.org/detail.go?type=gene&acc=5281,,,5281.0,PIGF,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PIGF mRNA,,,PMID:20106945|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|25562108|27989131,,
931,1751125,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10026,PIGK,https://ctdbase.org/detail.go?type=gene&acc=10026,,,10026.0,PIGK,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PIGK mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
932,1751126,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10026,PIGK,https://ctdbase.org/detail.go?type=gene&acc=10026,,,10026.0,PIGK,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PIGK mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
933,1751127,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,9487,PIGL,https://ctdbase.org/detail.go?type=gene&acc=9487,,,9487.0,PIGL,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PIGL mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
934,1751128,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,93183,PIGM,https://ctdbase.org/detail.go?type=gene&acc=93183,,,93183.0,PIGM,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PIGM mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
935,1751129,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,93183,PIGM,https://ctdbase.org/detail.go?type=gene&acc=93183,,,93183.0,PIGM,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PIGM mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
936,1751130,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23556,PIGN,https://ctdbase.org/detail.go?type=gene&acc=23556,,,23556.0,PIGN,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PIGN mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
937,1751987,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,65018,PINK1,https://ctdbase.org/detail.go?type=gene&acc=65018,,,65018.0,PINK1,9606.0,Homo sapiens (human),Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 protein]|cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 mrna],,,PMID:29567065,https://www.ncbi.nlm.nih.gov/pubmed/29567065,29567065,,
938,1751988,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,65018,PINK1,https://ctdbase.org/detail.go?type=gene&acc=65018,,,65018.0,PINK1,10090.0,Mus musculus (house mouse),Cyclosporine inhibits the reaction [cadmium results in increased expression of PINK1],,,PMID:25464205,https://www.ncbi.nlm.nih.gov/pubmed/25464205,25464205,,
939,1751989,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5305,PIP4K2A,https://ctdbase.org/detail.go?type=gene&acc=5305,,,5305.0,PIP4K2A,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PIP4K2A mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
940,1751990,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8396,PIP4K2B,https://ctdbase.org/detail.go?type=gene&acc=8396,,,8396.0,PIP4K2B,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PIP4K2B mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
941,1751991,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8396,PIP4K2B,https://ctdbase.org/detail.go?type=gene&acc=8396,,,8396.0,PIP4K2B,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of PIP4K2B mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
942,1751992,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,79837,PIP4K2C,https://ctdbase.org/detail.go?type=gene&acc=79837,,,79837.0,PIP4K2C,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PIP4K2C mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
943,1752346,5284373,DrugBank,cyclosporin A,DB00091,Cyclosporine,https://www.drugbank.ca/drugs/DB00091,BE0001066,Solute carrier family 22 member 6,https://www.drugbank.ca/bio_entities/BE0001066,Q4U2R8,Solute carrier family 22 member 6,9356.0,SLC22A6,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:9374486|PMID:27290622|PMID:29051147|PMID:25860376,https://www.ncbi.nlm.nih.gov/pubmed/9374486|https://www.ncbi.nlm.nih.gov/pubmed/27290622|https://www.ncbi.nlm.nih.gov/pubmed/29051147|https://www.ncbi.nlm.nih.gov/pubmed/25860376,9374486|27290622|29051147|25860376,,
944,1752347,5284373,DrugBank,cyclosporin A,DB00091,Cyclosporine,https://www.drugbank.ca/drugs/DB00091,BE0003651,Multidrug resistance-associated protein 7,https://www.drugbank.ca/bio_entities/BE0003651,Q5T3U5,ATP-binding cassette sub-family C member 10,89845.0,ABCC10,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:12527806,https://www.ncbi.nlm.nih.gov/pubmed/12527806,12527806,,
945,1752348,5284373,DrugBank,cyclosporin A,DB00091,Cyclosporine,https://www.drugbank.ca/drugs/DB00091,BE0001069,Canalicular multispecific organic anion transporter 1,https://www.drugbank.ca/bio_entities/BE0001069,Q92887,Canalicular multispecific organic anion transporter 1,1244.0,ABCC2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15816878|PMID:12967592,https://www.ncbi.nlm.nih.gov/pubmed/15816878|https://www.ncbi.nlm.nih.gov/pubmed/12967592,15816878|12967592,,
946,1752349,5284373,DrugBank,cyclosporin A,DB00091,Cyclosporine,https://www.drugbank.ca/drugs/DB00091,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11437380|PMID:25860376,https://www.ncbi.nlm.nih.gov/pubmed/11437380|https://www.ncbi.nlm.nih.gov/pubmed/25860376,11437380|25860376,,
947,1752350,5284373,DrugBank,cyclosporin A,DB00091,Cyclosporine,https://www.drugbank.ca/drugs/DB00091,BE0001004,Solute carrier organic anion transporter family member 1B1,https://www.drugbank.ca/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:12538813|PMID:14530907|PMID:23179780,https://www.ncbi.nlm.nih.gov/pubmed/12538813|https://www.ncbi.nlm.nih.gov/pubmed/14530907|https://www.ncbi.nlm.nih.gov/pubmed/23179780,12538813|14530907|23179780,,
948,1752351,5284373,DrugBank,cyclosporin A,DB00091,Cyclosporine,https://www.drugbank.ca/drugs/DB00091,BE0003659,Solute carrier organic anion transporter family member 1B3,https://www.drugbank.ca/bio_entities/BE0003659,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:25860376|PMID:22240838|PMID:23179780,https://www.ncbi.nlm.nih.gov/pubmed/25860376|https://www.ncbi.nlm.nih.gov/pubmed/22240838|https://www.ncbi.nlm.nih.gov/pubmed/23179780,25860376|22240838|23179780,,
949,1752352,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1184,CLCN5,https://ctdbase.org/detail.go?type=gene&acc=1184,,,1184.0,CLCN5,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of CLCN5 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
950,1752526,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,171017,ZNF384,https://ctdbase.org/detail.go?type=gene&acc=171017,,,171017.0,ZNF384,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF384 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
951,1752527,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,151126,ZNF385B,https://ctdbase.org/detail.go?type=gene&acc=151126,,,151126.0,ZNF385B,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZNF385B mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
952,1752528,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55893,ZNF395,https://ctdbase.org/detail.go?type=gene&acc=55893,,,55893.0,ZNF395,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZNF395 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
953,1752529,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,342908,ZNF404,https://ctdbase.org/detail.go?type=gene&acc=342908,,,342908.0,ZNF404,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF404 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
954,1752530,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,57862,ZNF410,https://ctdbase.org/detail.go?type=gene&acc=57862,,,57862.0,ZNF410,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF410 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
955,1752531,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55786,ZNF415,https://ctdbase.org/detail.go?type=gene&acc=55786,,,55786.0,ZNF415,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF415 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
956,1752532,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,80264,ZNF430,https://ctdbase.org/detail.go?type=gene&acc=80264,,,80264.0,ZNF430,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF430 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
957,1753310,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,114991,ZNF618,https://ctdbase.org/detail.go?type=gene&acc=114991,,,114991.0,ZNF618,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZNF618 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
958,1753311,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,114991,ZNF618,https://ctdbase.org/detail.go?type=gene&acc=114991,,,114991.0,ZNF618,9606.0,Homo sapiens (human),Cyclosporine results in increased methylation of ZNF618 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
959,1753312,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,253639,ZNF620,https://ctdbase.org/detail.go?type=gene&acc=253639,,,253639.0,ZNF620,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZNF620 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
960,1753494,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,285268,ZNF621,https://ctdbase.org/detail.go?type=gene&acc=285268,,,285268.0,ZNF621,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF621 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
961,1753495,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,90441,ZNF622,https://ctdbase.org/detail.go?type=gene&acc=90441,,,90441.0,ZNF622,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF622 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
962,1753496,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,199692,ZNF627,https://ctdbase.org/detail.go?type=gene&acc=199692,,,199692.0,ZNF627,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF627 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
963,1753497,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,89887,ZNF628,https://ctdbase.org/detail.go?type=gene&acc=89887,,,89887.0,ZNF628,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF628 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
964,1753498,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,23361,ZNF629,https://ctdbase.org/detail.go?type=gene&acc=23361,,,23361.0,ZNF629,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZNF629 mRNA,,,PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,25562108|27989131,,
965,1753499,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,51193,ZNF639,https://ctdbase.org/detail.go?type=gene&acc=51193,,,51193.0,ZNF639,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZNF639 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
966,1753624,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,59339,PLEKHA2,https://ctdbase.org/detail.go?type=gene&acc=59339,,,59339.0,PLEKHA2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLEKHA2 mRNA,,,PMID:20106945|PMID:21632981|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|21632981|25562108,,
967,1753625,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,65977,PLEKHA3,https://ctdbase.org/detail.go?type=gene&acc=65977,,,65977.0,PLEKHA3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLEKHA3 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
968,1753626,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,22874,PLEKHA6,https://ctdbase.org/detail.go?type=gene&acc=22874,,,22874.0,PLEKHA6,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLEKHA6 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
969,1753627,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,144100,PLEKHA7,https://ctdbase.org/detail.go?type=gene&acc=144100,,,144100.0,PLEKHA7,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLEKHA7 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
970,1753628,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,144100,PLEKHA7,https://ctdbase.org/detail.go?type=gene&acc=144100,,,144100.0,PLEKHA7,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLEKHA7 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
971,1754249,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,440503,PLIN5,https://ctdbase.org/detail.go?type=gene&acc=440503,,,440503.0,PLIN5,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of PLIN5 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
972,1754250,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5347,PLK1,https://ctdbase.org/detail.go?type=gene&acc=5347,,,5347.0,PLK1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLK1 mRNA,,,PMID:20106945|PMID:21632981|PMID:22147139|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22147139|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|21632981|22147139|25562108,,
973,1754251,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10769,PLK2,https://ctdbase.org/detail.go?type=gene&acc=10769,,,10769.0,PLK2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLK2 mRNA,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
974,1754252,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10769,PLK2,https://ctdbase.org/detail.go?type=gene&acc=10769,,,10769.0,PLK2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLK2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
975,1754253,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLK3 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
976,1754254,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10733,PLK4,https://ctdbase.org/detail.go?type=gene&acc=10733,,,10733.0,PLK4,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLK4 mRNA,,,PMID:20106945|PMID:21632981|PMID:22147139,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22147139,20106945|21632981|22147139,,
977,1754255,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,51090,PLLP,https://ctdbase.org/detail.go?type=gene&acc=51090,,,51090.0,PLLP,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLLP mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
978,1754256,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5351,PLOD1,https://ctdbase.org/detail.go?type=gene&acc=5351,,,5351.0,PLOD1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLOD1 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
979,1754257,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5352,PLOD2,https://ctdbase.org/detail.go?type=gene&acc=5352,,,5352.0,PLOD2,9606.0,Homo sapiens (human),Cyclosporine affects the expression of PLOD2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
980,1754258,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5352,PLOD2,https://ctdbase.org/detail.go?type=gene&acc=5352,,,5352.0,PLOD2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLOD2 mRNA,,,PMID:21632981|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,21632981|25562108|27989131,,
981,1754437,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5352,PLOD2,https://ctdbase.org/detail.go?type=gene&acc=5352,,,5352.0,PLOD2,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of PLOD2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
982,1754438,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8985,PLOD3,https://ctdbase.org/detail.go?type=gene&acc=8985,,,8985.0,PLOD3,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of PLOD3 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
983,1754439,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8985,PLOD3,https://ctdbase.org/detail.go?type=gene&acc=8985,,,8985.0,PLOD3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLOD3 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
984,1754440,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,368234,PLP1B,https://ctdbase.org/detail.go?type=gene&acc=368234,,,368234.0,plp1b,7955.0,Danio rerio (zebrafish),Cyclosporine affects the expression of PLP1B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
985,1754441,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5355,PLP2,https://ctdbase.org/detail.go?type=gene&acc=5355,,,5355.0,PLP2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLP2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
986,1754442,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,8613,PLPP3,https://ctdbase.org/detail.go?type=gene&acc=8613,,,8613.0,PLPP3,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLPP3 mRNA,,,PMID:20106945|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|25562108|27989131,,
987,1754443,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84513,PLPP5,https://ctdbase.org/detail.go?type=gene&acc=84513,,,84513.0,PLPP5,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLPP5 mRNA,,,PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|21632981|25562108|27989131,,
988,1754444,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,84513,PLPP5,https://ctdbase.org/detail.go?type=gene&acc=84513,,,84513.0,PLPP5,10090.0,Mus musculus (house mouse),Cyclosporine results in increased expression of PLPP5 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
989,1754445,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,403313,PLPP6,https://ctdbase.org/detail.go?type=gene&acc=403313,,,403313.0,PLPP6,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLPP6 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
990,1754446,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,54886,PLPPR1,https://ctdbase.org/detail.go?type=gene&acc=54886,,,54886.0,PLPPR1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLPPR1 mRNA,,,PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|21632981|25562108|27989131,,
991,1754745,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,79699,ZYG11B,https://ctdbase.org/detail.go?type=gene&acc=79699,,,79699.0,ZYG11B,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of ZYG11B mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
992,1754746,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,7791,ZYX,https://ctdbase.org/detail.go?type=gene&acc=7791,,,7791.0,ZYX,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZYX mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
993,1754747,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,26009,ZZZ3,https://ctdbase.org/detail.go?type=gene&acc=26009,,,26009.0,ZZZ3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of ZZZ3 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
994,1754841,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLXNA2 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
995,1754842,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,55558,PLXNA3,https://ctdbase.org/detail.go?type=gene&acc=55558,,,55558.0,PLXNA3,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PLXNA3 mRNA,,,PMID:20106945|PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/25562108,20106945|25562108,,
996,1754843,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5364,PLXNB1,https://ctdbase.org/detail.go?type=gene&acc=5364,,,5364.0,PLXNB1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLXNB1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
997,1754844,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10154,PLXNC1,https://ctdbase.org/detail.go?type=gene&acc=10154,,,10154.0,PLXNC1,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PLXNC1 mRNA,,,PMID:20106945|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|27989131,,
998,1754845,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,10154,PLXNC1,https://ctdbase.org/detail.go?type=gene&acc=10154,,,10154.0,PLXNC1,9606.0,Homo sapiens (human),Cyclosporine results in decreased methylation of PLXNC1 promoter,,,PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/27989131,27989131,,
999,1754846,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,148811,PM20D1,https://ctdbase.org/detail.go?type=gene&acc=148811,,,148811.0,PM20D1,10090.0,Mus musculus (house mouse),Cyclosporine results in decreased expression of PM20D1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1000,1754847,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,135293,PM20D2,https://ctdbase.org/detail.go?type=gene&acc=135293,,,135293.0,PM20D2,9606.0,Homo sapiens (human),Cyclosporine results in decreased expression of PM20D2 mRNA,,,PMID:25562108,https://www.ncbi.nlm.nih.gov/pubmed/25562108,25562108,,
1001,1754848,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,135293,PM20D2,https://ctdbase.org/detail.go?type=gene&acc=135293,,,135293.0,PM20D2,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PM20D2 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1002,1754849,5284373,Comparative Toxicogenomics Database (CTD),cyclosporin A,D016572,Cyclosporine,https://ctdbase.org/detail.go?type=chem&acc=D016572,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606.0,Homo sapiens (human),Cyclosporine results in increased expression of PMAIP1 mRNA,,,PMID:20106945|PMID:21632981|PMID:25562108|PMID:25596134|PMID:26260164|PMID:27989131,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/25562108|https://www.ncbi.nlm.nih.gov/pubmed/25596134|https://www.ncbi.nlm.nih.gov/pubmed/26260164|https://www.ncbi.nlm.nih.gov/pubmed/27989131,20106945|21632981|25562108|25596134|26260164|27989131,,
1003,1754748,5284389,Comparative Toxicogenomics Database (CTD),Meptyldinocap,C007500,dinocap,https://ctdbase.org/detail.go?type=chem&acc=C007500,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,9606.0,Homo sapiens (human),Dinocap results in decreased activity of DIO1 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
1004,1754749,5284389,Comparative Toxicogenomics Database (CTD),Meptyldinocap,C007500,dinocap,https://ctdbase.org/detail.go?type=chem&acc=C007500,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,9606.0,Homo sapiens (human),Dinocap results in decreased activity of DIO2 protein,,,PMID:30561685,https://www.ncbi.nlm.nih.gov/pubmed/30561685,30561685,,
1005,1750205,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,79697,RIOX1,https://ctdbase.org/detail.go?type=gene&acc=79697,,,79697.0,RIOX1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of RIOX1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1006,1750206,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,29919,RMC1,https://ctdbase.org/detail.go?type=gene&acc=29919,,,29919.0,RMC1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of RMC1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1007,1750207,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,6117,RPA1,https://ctdbase.org/detail.go?type=gene&acc=6117,,,6117.0,RPA1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of RPA1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1008,1750208,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,6173,RPL36A,https://ctdbase.org/detail.go?type=gene&acc=6173,,,6173.0,RPL36A,123683.0,Oryzias javanicus (javanese ricefish),Toxaphene results in decreased expression of RPL36A mRNA,,,PMID:21220043,https://www.ncbi.nlm.nih.gov/pubmed/21220043,21220043,,
1009,1750209,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,6184,RPN1,https://ctdbase.org/detail.go?type=gene&acc=6184,,,6184.0,RPN1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of RPN1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1010,1750210,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,6185,RPN2,https://ctdbase.org/detail.go?type=gene&acc=6185,,,6185.0,RPN2,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of RPN2 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1011,1750211,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,6207,RPS13,https://ctdbase.org/detail.go?type=gene&acc=6207,,,6207.0,RPS13,123683.0,Oryzias javanicus (javanese ricefish),Toxaphene results in decreased expression of RPS13 mrna|toxaphene results in increased expression of RPS13 mRNA,,,PMID:21220043,https://www.ncbi.nlm.nih.gov/pubmed/21220043,21220043,,
1012,1750212,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,100000325,RRAGCB,https://ctdbase.org/detail.go?type=gene&acc=100000325,,,100000325.0,rragcb,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of RRAGCB mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1013,1750213,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,23223,RRP12,https://ctdbase.org/detail.go?type=gene&acc=23223,,,23223.0,RRP12,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of RRP12 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1014,1754739,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,2801,GOLGA2,https://ctdbase.org/detail.go?type=gene&acc=2801,,,2801.0,GOLGA2,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of GOLGA2 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1015,1754740,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,64689,GORASP1,https://ctdbase.org/detail.go?type=gene&acc=64689,,,64689.0,GORASP1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of GORASP1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1016,1754741,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,54762,GRAMD1C,https://ctdbase.org/detail.go?type=gene&acc=54762,,,54762.0,GRAMD1C,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in decreased expression of GRAMD1C mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1017,1754742,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,9606.0,Homo sapiens (human),Toxaphene results in increased degradation of GSN protein|cat protein inhibits the reaction [toxaphene results in increased degradation of GSN protein],,,PMID:12139946,https://www.ncbi.nlm.nih.gov/pubmed/12139946,12139946,,
1018,1754743,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,325284,GSPT1L,https://ctdbase.org/detail.go?type=gene&acc=325284,,,325284.0,gspt1l,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of GSPT1L mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1019,1754744,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,2959,GTF2B,https://ctdbase.org/detail.go?type=gene&acc=2959,,,2959.0,GTF2B,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in decreased expression of GTF2B mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1020,1755094,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,10525,HYOU1,https://ctdbase.org/detail.go?type=gene&acc=10525,,,10525.0,HYOU1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of HYOU1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1021,1755095,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,3376,IARS1,https://ctdbase.org/detail.go?type=gene&acc=3376,,,3376.0,IARS1,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of IARS1 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1022,1755096,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,336503,IFI30A,https://ctdbase.org/detail.go?type=gene&acc=336503,,,336503.0,ifi30a,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in increased expression of IFI30A mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1023,1755097,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in decreased expression of IKBKB mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1024,1755098,5284469,Comparative Toxicogenomics Database (CTD),"1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane",D014112,Toxaphene,https://ctdbase.org/detail.go?type=chem&acc=D014112,80895,ILKAP,https://ctdbase.org/detail.go?type=gene&acc=80895,,,80895.0,ILKAP,8049.0,Gadus morhua (Atlantic cod),"[aroclors co-treated with hydrocarbons, chlorinated co-treated with hexachlorocyclohexane co-treated with toxaphene co-treated with chlordan] results in decreased expression of ILKAP mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1025,1744442,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10116.0,Rattus norvegicus (Norway rat),"[naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to clonidine|[naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to N(6)-cyclopentyladenosine|[naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to enkephalin, ala(2)-mephe(4)-gly(5)-",,,PMID:8987795,https://www.ncbi.nlm.nih.gov/pubmed/8987795,8987795,,
1026,1744606,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,9606.0,Homo sapiens (human),Naloxone inhibits the reaction [fentanyl results in increased activity of OPRM1 protein],,,PMID:35072756,https://www.ncbi.nlm.nih.gov/pubmed/35072756,35072756,,
1027,1744607,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,9606.0,Homo sapiens (human),Naloxone results in decreased activity of OPRM1 protein,,,PMID:10070497,https://www.ncbi.nlm.nih.gov/pubmed/10070497,10070497,,
1028,1744608,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,5009,OTC,https://ctdbase.org/detail.go?type=gene&acc=5009,,,5009.0,OTC,10116.0,Rattus norvegicus (Norway rat),Naloxone results in decreased expression of OTC mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
1029,1744609,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,5020,OXT,https://ctdbase.org/detail.go?type=gene&acc=5020,,,5020.0,OXT,9606.0,Homo sapiens (human),Naloxone inhibits the reaction [morphine inhibits the reaction [OXT protein results in increased abundance of nitrates]]|naloxone inhibits the reaction [morphine inhibits the reaction [OXT protein results in increased abundance of nitrites]],,,PMID:9151298,https://www.ncbi.nlm.nih.gov/pubmed/9151298,9151298,,
1030,1744610,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,5020,OXT,https://ctdbase.org/detail.go?type=gene&acc=5020,,,5020.0,OXT,9606.0,Homo sapiens (human),Naloxone inhibits the reaction [morphine results in decreased susceptibility to OXT protein],,,PMID:1315136,https://www.ncbi.nlm.nih.gov/pubmed/1315136,1315136,,
1031,1744611,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,5313,PKLR,https://ctdbase.org/detail.go?type=gene&acc=5313,,,5313.0,PKLR,10116.0,Rattus norvegicus (Norway rat),Naloxone results in decreased expression of PKLR mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
1032,1744612,5284596,Comparative Toxicogenomics Database (CTD),Naloxone,D009270,Naloxone,https://ctdbase.org/detail.go?type=chem&acc=D009270,5327,PLAT,https://ctdbase.org/detail.go?type=gene&acc=5327,,,5327.0,PLAT,9606.0,Homo sapiens (human),Naloxone affects the reaction [morphine results in increased expression of PLAT protein]|naloxone affects the reaction [morphine results in increased expression of PLAT mrna],,,PMID:16619846,https://www.ncbi.nlm.nih.gov/pubmed/16619846,16619846,,
1033,1745224,5284603,Drug Gene Interaction database (DGIdb),Oxycodone,,OXYCODONE,https://www.dgidb.org/drugs/rxcui:7804,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
1034,1745225,5284603,Drug Gene Interaction database (DGIdb),Oxycodone,,OXYCODONE,https://www.dgidb.org/drugs/rxcui:7804,,NR1I3,https://www.dgidb.org/genes/hgnc:7969,,,9970.0,NR1I3,9606.0,Homo sapiens (human),,,,,,,,
1035,1745226,5284604,Toxin and Toxin Target Database (T3DB),Oxymorphone,T3D3015,Oxymorphone,http://www.t3db.ca/toxins/T3D3015,BE0000770,Mu-type opioid receptor,http://www.t3db.ca/biodb/bio_entities/BE0000770,P35372,Mu-type opioid receptor,4988.0,OPRM1,9606.0,Homo sapiens (human),"Oxymorphone interacts predominantly with the opioid mu-receptor. these mu-binding sites are discretely distributed in the human brain, with high densities in the posterior amygdala, hypothalamus, thalamus, nucleus caudatus, putamen, and certain cortical areas. they are also found on the terminal axons of primary afferents within laminae I and II (substantia gelatinosa) of the spinal cord and in the spinal nucleus of the trigeminal nerve.",,,PMID:9712193|PMID:17006080|PMID:17595308|PMID:10854833|PMID:16343768|PMID:1335078|PMID:2409281,https://www.ncbi.nlm.nih.gov/pubmed/9712193|https://www.ncbi.nlm.nih.gov/pubmed/17006080|https://www.ncbi.nlm.nih.gov/pubmed/17595308|https://www.ncbi.nlm.nih.gov/pubmed/10854833|https://www.ncbi.nlm.nih.gov/pubmed/16343768|https://www.ncbi.nlm.nih.gov/pubmed/1335078|https://www.ncbi.nlm.nih.gov/pubmed/2409281,9712193|17006080|17595308|10854833|16343768|1335078|2409281,,
1036,1745227,5284604,Toxin and Toxin Target Database (T3DB),Oxymorphone,T3D3015,Oxymorphone,http://www.t3db.ca/toxins/T3D3015,BE0000420,Delta-type opioid receptor,http://www.t3db.ca/biodb/bio_entities/BE0000420,P41143,Delta-type opioid receptor,4985.0,OPRD1,9606.0,Homo sapiens (human),,,,PMID:17595308|PMID:14998329,https://www.ncbi.nlm.nih.gov/pubmed/17595308|https://www.ncbi.nlm.nih.gov/pubmed/14998329,17595308|14998329,,
1037,1745228,5284604,Toxin and Toxin Target Database (T3DB),Oxymorphone,T3D3015,Oxymorphone,http://www.t3db.ca/toxins/T3D3015,BE0000632,Kappa-type opioid receptor,http://www.t3db.ca/biodb/bio_entities/BE0000632,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606.0,Homo sapiens (human),,,,PMID:1335078|PMID:2409281,https://www.ncbi.nlm.nih.gov/pubmed/1335078|https://www.ncbi.nlm.nih.gov/pubmed/2409281,1335078|2409281,,
1038,1745229,5284607,BindingDB,Phytonadione,24782,"2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1,4-dihydronaphthalene-1,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=24782,2230,"Indoleamine 2,3-dioxygenase 1",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2230,P14902,"Indoleamine 2,3-dioxygenase 1",3620.0,IDO1,9606.0,Homo sapiens (human),,,,PMID:18318466|DOI:10.1021/jm7014155,https://www.ncbi.nlm.nih.gov/pubmed/18318466|https://doi.org/10.1021/jm7014155,18318466,10.1021/jm7014155,
1039,1740653,5284613,Comparative Toxicogenomics Database (CTD),Proscillaridin,D011442,Proscillaridin,https://ctdbase.org/detail.go?type=chem&acc=D011442,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Proscillaridin results in decreased expression of CCL2 protein,,,PMID:20116850,https://www.ncbi.nlm.nih.gov/pubmed/20116850,20116850,,
1040,1740654,5284613,Comparative Toxicogenomics Database (CTD),Proscillaridin,D011442,Proscillaridin,https://ctdbase.org/detail.go?type=chem&acc=D011442,6351,CCL4,https://ctdbase.org/detail.go?type=gene&acc=6351,,,6351.0,CCL4,9606.0,Homo sapiens (human),Proscillaridin results in decreased expression of CCL4 protein,,,PMID:20116850,https://www.ncbi.nlm.nih.gov/pubmed/20116850,20116850,,
1041,1740655,5284613,Comparative Toxicogenomics Database (CTD),Proscillaridin,D011442,Proscillaridin,https://ctdbase.org/detail.go?type=chem&acc=D011442,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,9606.0,Homo sapiens (human),Proscillaridin results in decreased expression of CCL5 protein,,,PMID:20116850,https://www.ncbi.nlm.nih.gov/pubmed/20116850,20116850,,
1042,1740656,5284613,Comparative Toxicogenomics Database (CTD),Proscillaridin,D011442,Proscillaridin,https://ctdbase.org/detail.go?type=chem&acc=D011442,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Proscillaridin results in decreased expression of CXCL8 protein,,,PMID:20116850,https://www.ncbi.nlm.nih.gov/pubmed/20116850,20116850,,
1043,1740657,5284613,Comparative Toxicogenomics Database (CTD),Proscillaridin,D011442,Proscillaridin,https://ctdbase.org/detail.go?type=chem&acc=D011442,3570,IL6R,https://ctdbase.org/detail.go?type=gene&acc=3570,,,3570.0,IL6R,9606.0,Homo sapiens (human),Proscillaridin results in decreased expression of IL6R protein modified form,,,PMID:20116850,https://www.ncbi.nlm.nih.gov/pubmed/20116850,20116850,,
1044,1740658,5284613,Comparative Toxicogenomics Database (CTD),Proscillaridin,D011442,Proscillaridin,https://ctdbase.org/detail.go?type=chem&acc=D011442,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,9606.0,Homo sapiens (human),Proscillaridin inhibits the reaction [TARDBP protein binds to TARDBP protein],,,PMID:23891805,https://www.ncbi.nlm.nih.gov/pubmed/23891805,23891805,,
1045,1745230,5284616,Drug Gene Interaction database (DGIdb),Sirolimus,,SIROLIMUS,https://www.dgidb.org/drugs/rxcui:35302,,MTOR,https://www.dgidb.org/genes/hgnc:3942,,,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1046,1745231,5284616,DrugBank,Sirolimus,DB00877,Sirolimus,https://www.drugbank.ca/drugs/DB00877,BE0002386,Serine/threonine-protein kinase mTOR,https://www.drugbank.ca/bio_entities/BE0002386,P42345,Serine/threonine-protein kinase mTOR,2475.0,MTOR,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20005306|PMID:19620795|PMID:12742462|PMID:11752352|PMID:15365568|PMID:33141044,https://www.ncbi.nlm.nih.gov/pubmed/20005306|https://www.ncbi.nlm.nih.gov/pubmed/19620795|https://www.ncbi.nlm.nih.gov/pubmed/12742462|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/15365568|https://www.ncbi.nlm.nih.gov/pubmed/33141044,20005306|19620795|12742462|11752352|15365568|33141044,,
1047,1745232,5284616,DrugBank,Sirolimus,DB00877,Sirolimus,https://www.drugbank.ca/drugs/DB00877,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,PMID:10490933|PMID:15686733,https://www.ncbi.nlm.nih.gov/pubmed/10490933|https://www.ncbi.nlm.nih.gov/pubmed/15686733,10490933|15686733,,
1048,1750918,5284627,IUPHAR/BPS Guide to PHARMACOLOGY,Topiramate,6849,topiramate,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6849,2597,carbonic anhydrase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2597,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),Inhibition,pKi,6.6,PMID:15686894,https://www.ncbi.nlm.nih.gov/pubmed/15686894,15686894,,
1049,1750919,5284627,Drug Gene Interaction database (DGIdb),Topiramate,,TOPIRAMATE,https://www.dgidb.org/drugs/rxcui:38404,,GABRB3,https://www.dgidb.org/genes/hgnc:4083,,,2562.0,GABRB3,9606.0,Homo sapiens (human),Positive modulator,,,,,,,
1050,1755099,5284627,DrugBank,Topiramate,DB00273,Topiramate,https://www.drugbank.ca/drugs/DB00273,BE0009738,Sodium channel protein type 1 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,P35498,Sodium channel protein type 1 subunit alpha,6323.0,SCN1A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11948006|PMID:15526956|PMID:12861512,https://www.ncbi.nlm.nih.gov/pubmed/11948006|https://www.ncbi.nlm.nih.gov/pubmed/15526956|https://www.ncbi.nlm.nih.gov/pubmed/12861512,11948006|15526956|12861512,,
1051,1755100,5284627,DrugBank,Topiramate,DB00273,Topiramate,https://www.drugbank.ca/drugs/DB00273,BE0009738,Sodium channel protein type 10 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,6336.0,SCN10A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11948006|PMID:15526956|PMID:12861512,https://www.ncbi.nlm.nih.gov/pubmed/11948006|https://www.ncbi.nlm.nih.gov/pubmed/15526956|https://www.ncbi.nlm.nih.gov/pubmed/12861512,11948006|15526956|12861512,,
1052,1755101,5284627,DrugBank,Topiramate,DB00273,Topiramate,https://www.drugbank.ca/drugs/DB00273,BE0009738,Sodium channel protein type 11 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,Q9UI33,Sodium channel protein type 11 subunit alpha,11280.0,SCN11A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11948006|PMID:15526956|PMID:12861512,https://www.ncbi.nlm.nih.gov/pubmed/11948006|https://www.ncbi.nlm.nih.gov/pubmed/15526956|https://www.ncbi.nlm.nih.gov/pubmed/12861512,11948006|15526956|12861512,,
1053,1755102,5284627,DrugBank,Topiramate,DB00273,Topiramate,https://www.drugbank.ca/drugs/DB00273,BE0009738,Sodium channel protein type 2 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,Q99250,Sodium channel protein type 2 subunit alpha,6326.0,SCN2A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11948006|PMID:15526956|PMID:12861512,https://www.ncbi.nlm.nih.gov/pubmed/11948006|https://www.ncbi.nlm.nih.gov/pubmed/15526956|https://www.ncbi.nlm.nih.gov/pubmed/12861512,11948006|15526956|12861512,,
1054,1755103,5284627,DrugBank,Topiramate,DB00273,Topiramate,https://www.drugbank.ca/drugs/DB00273,BE0009738,Sodium channel protein type 3 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,Q9NY46,Sodium channel protein type 3 subunit alpha,6328.0,SCN3A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11948006|PMID:15526956|PMID:12861512,https://www.ncbi.nlm.nih.gov/pubmed/11948006|https://www.ncbi.nlm.nih.gov/pubmed/15526956|https://www.ncbi.nlm.nih.gov/pubmed/12861512,11948006|15526956|12861512,,
1055,1751295,5284904,BindingDB,,12024,"4-Arylazo-3,5-diamino-1H-pyrazole 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12024,95,Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=95,P06493,Cyclin-dependent kinase 1,983.0,CDK1,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17064068|DOI:10.1021/jm0605740,https://www.ncbi.nlm.nih.gov/pubmed/17064068|https://doi.org/10.1021/jm0605740,17064068,10.1021/jm0605740,
1056,1751296,5284904,BindingDB,,12024,"4-Arylazo-3,5-diamino-1H-pyrazole 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12024,81,Cyclin-dependent kinase 2/G1/S-specific cyclin-E1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=81,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),100000,PMID:17064068|DOI:10.1021/jm0605740,https://www.ncbi.nlm.nih.gov/pubmed/17064068|https://doi.org/10.1021/jm0605740,17064068,10.1021/jm0605740,
1057,1751297,5284904,BindingDB,,12024,"4-Arylazo-3,5-diamino-1H-pyrazole 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12024,93,Cyclin-dependent kinase 4/G1/S-specific cyclin-D1,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=93,P11802,Cyclin-dependent kinase 4,1019.0,CDK4,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17064068|DOI:10.1021/jm0605740,https://www.ncbi.nlm.nih.gov/pubmed/17064068|https://doi.org/10.1021/jm0605740,17064068,10.1021/jm0605740,
1058,1751298,5284904,BindingDB,,12024,"4-Arylazo-3,5-diamino-1H-pyrazole 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12024,97,Cyclin-A2/Cyclin-dependent kinase 2,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=97,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17064068|DOI:10.1021/jm0605740,https://www.ncbi.nlm.nih.gov/pubmed/17064068|https://doi.org/10.1021/jm0605740,17064068,10.1021/jm0605740,
1059,1751299,5284904,BindingDB,,12024,"4-Arylazo-3,5-diamino-1H-pyrazole 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12024,112,Cyclin-H/Cyclin-dependent kinase 7,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=112,P51946,Cyclin-H,902.0,CCNH,9606.0,Homo sapiens (human),,IC50 (nM),>100000,PMID:17064068|DOI:10.1021/jm0605740,https://www.ncbi.nlm.nih.gov/pubmed/17064068|https://doi.org/10.1021/jm0605740,17064068,10.1021/jm0605740,
1060,1751300,5284904,BindingDB,,12024,"4-Arylazo-3,5-diamino-1H-pyrazole 1b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12024,113,Cyclin-T1/Cyclin-dependent kinase 9,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=113,O60563,Cyclin-T1,904.0,CCNT1,9606.0,Homo sapiens (human),,IC50 (nM),15000,PMID:17064068|DOI:10.1021/jm0605740,https://www.ncbi.nlm.nih.gov/pubmed/17064068|https://doi.org/10.1021/jm0605740,17064068,10.1021/jm0605740,
1061,1747936,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,2791,GNG11,https://ctdbase.org/detail.go?type=gene&acc=2791,,,2791.0,GNG11,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of GNG11 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1062,1747937,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,55970,GNG12,https://ctdbase.org/detail.go?type=gene&acc=55970,,,55970.0,GNG12,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of GNG12 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1063,1747938,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,2785,GNG3,https://ctdbase.org/detail.go?type=gene&acc=2785,,,2785.0,GNG3,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of GNG3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1064,1750400,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of HMGB2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1065,1750401,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,3149,HMGB3,https://ctdbase.org/detail.go?type=gene&acc=3149,,,3149.0,HMGB3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of HMGB3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1066,1753313,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,51447,IP6K2,https://ctdbase.org/detail.go?type=gene&acc=51447,,,51447.0,IP6K2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IP6K2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1067,1753314,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,253430,IPMK,https://ctdbase.org/detail.go?type=gene&acc=253430,,,253430.0,IPMK,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IPMK mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1068,1753315,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,79781,IQCA1,https://ctdbase.org/detail.go?type=gene&acc=79781,,,79781.0,IQCA1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IQCA1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1069,1753316,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,115811,IQCD,https://ctdbase.org/detail.go?type=gene&acc=115811,,,115811.0,IQCD,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IQCD mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1070,1753317,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10788,IQGAP2,https://ctdbase.org/detail.go?type=gene&acc=10788,,,10788.0,IQGAP2,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IQGAP2 mrna|fenretinide results in decreased expression of IQGAP2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1071,1753318,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,23096,IQSEC2,https://ctdbase.org/detail.go?type=gene&acc=23096,,,23096.0,IQSEC2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of IQSEC2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1072,1753319,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,10335,IRAG1,https://ctdbase.org/detail.go?type=gene&acc=10335,,,10335.0,IRAG1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IRAG1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1073,1753320,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,4033,IRAG2,https://ctdbase.org/detail.go?type=gene&acc=4033,,,4033.0,IRAG2,10090.0,Mus musculus (house mouse),Fenretinide results in decreased expression of IRAG2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1074,1753321,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,11213,IRAK3,https://ctdbase.org/detail.go?type=gene&acc=11213,,,11213.0,IRAK3,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IRAK3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1075,1753322,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,3659,IRF1,https://ctdbase.org/detail.go?type=gene&acc=3659,,,3659.0,IRF1,9606.0,Homo sapiens (human),Fenretinide results in increased expression of IRF1 mRNA,,,PMID:15958647,https://www.ncbi.nlm.nih.gov/pubmed/15958647,15958647,,
1076,1753323,5288209,Comparative Toxicogenomics Database (CTD),Fenretinide,D017313,Fenretinide,https://ctdbase.org/detail.go?type=chem&acc=D017313,3659,IRF1,https://ctdbase.org/detail.go?type=gene&acc=3659,,,3659.0,IRF1,10090.0,Mus musculus (house mouse),Fenretinide results in increased expression of IRF1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
1077,1752632,5288320,DrugBank,Topiroxostat,DB01685,Topiroxostat,https://www.drugbank.ca/drugs/DB01685,BE0003543,Cytochrome P450 1A1,https://www.drugbank.ca/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543.0,CYP1A1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1078,1752792,5288320,DrugBank,Topiroxostat,DB01685,Topiroxostat,https://www.drugbank.ca/drugs/DB01685,BE0003645,Solute carrier family 22 member 8,https://www.drugbank.ca/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1079,1752793,5288320,DrugBank,Topiroxostat,DB01685,Topiroxostat,https://www.drugbank.ca/drugs/DB01685,BE0001066,Solute carrier family 22 member 6,https://www.drugbank.ca/bio_entities/BE0001066,Q4U2R8,Solute carrier family 22 member 6,9356.0,SLC22A6,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1080,1752794,5288320,DrugBank,Topiroxostat,DB01685,Topiroxostat,https://www.drugbank.ca/drugs/DB01685,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Binder,,,,,,,
1081,1752795,5288320,DrugBank,Topiroxostat,DB01685,Topiroxostat,https://www.drugbank.ca/drugs/DB01685,BE0000925,Alpha-1-acid glycoprotein 1,https://www.drugbank.ca/bio_entities/BE0000925,P02763,Alpha-1-acid glycoprotein 1,5004.0,ORM1,9606.0,Homo sapiens (human),Binder,,,,,,,
1082,1752796,5288324,Therapeutic Target Database (TTD),2-deoxy-2-fluoro-beta-D-glucopyranose,D0X4EB,2-Deoxy-2fluoro-Glucose,https://idrblab.net/ttd/data/drug/details/D0X4EB,T26617,Lactase-phlorizin hydrolase (LCT),https://idrblab.net/ttd/data/target/details/T26617,P09848,Lactase-phlorizin hydrolase,3938.0,LCT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1083,1752797,5288329,Therapeutic Target Database (TTD),"4-Chloro-3',3''-dibromophenol-1,8-naphthalein",D02MUO,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",https://idrblab.net/ttd/data/drug/details/D02MUO,T52227,Candida Thymidylate synthase (Candi TMP1),https://idrblab.net/ttd/data/target/details/T52227,P12461,Thymidylate synthase,3643463.0,CDC21,237561.0,Candida albicans SC5314,Inhibitor,,,,,,,
1084,1752798,5288382,Drug Gene Interaction database (DGIdb),Geldanamycin,,GELDANAMYCIN,https://www.dgidb.org/drugs/ncit:C1112,,FCGR3B,https://www.dgidb.org/genes/hgnc:3620,,,2215.0,FCGR3B,9606.0,Homo sapiens (human),,,,,,,,
1085,1752799,5288382,Drug Gene Interaction database (DGIdb),Geldanamycin,,GELDANAMYCIN,https://www.dgidb.org/drugs/ncit:C1112,,MYOD1,https://www.dgidb.org/genes/hgnc:7611,,,4654.0,MYOD1,9606.0,Homo sapiens (human),,,,,,,,
1086,1752800,5288385,Therapeutic Target Database (TTD),(4E)-4-Aminohex-4-enoic acid,D05TEW,(4e)-4-Aminohex-4-Enoic Acid,https://idrblab.net/ttd/data/drug/details/D05TEW,T59045,GABA transaminase (ABAT),https://idrblab.net/ttd/data/target/details/T59045,P80404,"4-aminobutyrate aminotransferase, mitochondrial",18.0,ABAT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1087,1752801,5288385,DrugBank,(4E)-4-Aminohex-4-enoic acid,DB01699,(4e)-4-Aminohex-4-Enoic Acid,https://www.drugbank.ca/drugs/DB01699,BE0000253,"4-aminobutyrate aminotransferase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0000253,P80404,"4-aminobutyrate aminotransferase, mitochondrial",18.0,ABAT,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1088,1752802,5288437,DrugBank,"4,6-Dideoxyglucose",DB01841,"4,6-Dideoxyglucose",https://www.drugbank.ca/drugs/DB01841,BE0001393,Neopullulanase 1,https://www.drugbank.ca/bio_entities/BE0001393,Q60053,Neopullulanase 1,,,2026.0,Thermoactinomyces vulgaris,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1089,1753830,5289294,Therapeutic Target Database (TTD),(3S)-3-hydroxy-4-[[(2S)-1-(3-methylbutylamino)-1-oxo-4-phenylbutan-2-yl]amino]-4-oxobutanoic acid,D0T0IX,WRR-112,https://idrblab.net/ttd/data/drug/details/D0T0IX,T77236,Cathepsin F (CTSF),https://idrblab.net/ttd/data/target/details/T77236,Q9UBX1,Cathepsin F,8722.0,CTSF,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1090,1753831,5289295,Therapeutic Target Database (TTD),N-Methyl-N-propargyl-1(R)-aminoindan,D0A2AF,N-Methyl-N-Propargyl-1(R)-Aminoindan,https://idrblab.net/ttd/data/drug/details/D0A2AF,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1091,1753832,5289299,Therapeutic Target Database (TTD),"[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",D05FBL,1-Deoxy-Ribofuranose-5'-Phosphate,https://idrblab.net/ttd/data/drug/details/D05FBL,T23688,Bacterial Deoxy-D-manno-octulosonate 8-phosphate synthase (Bact kdsA),https://idrblab.net/ttd/data/target/details/T23688,P0A715,2-dehydro-3-deoxyphosphooctonate aldolase,945785.0,kdsA,83333.0,Escherichia coli K-12,Inhibitor,,,,,,,
1092,1753833,5289310,Therapeutic Target Database (TTD),N-Propargyl-1(S)-aminoindan,D0K5LJ,N-Propargyl-1(S)-Aminoindan,https://idrblab.net/ttd/data/drug/details/D0K5LJ,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1093,1753834,5289343,Therapeutic Target Database (TTD),N-(Sulfanylacetyl)tyrosylprolylmethioninamide,D01MBG,N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,https://idrblab.net/ttd/data/drug/details/D01MBG,T72335,Bacterial Lethal factor (Bact lef),https://idrblab.net/ttd/data/target/details/T72335,P15917,Lethal factor,45025515.0,lef,1392.0,Bacillus anthracis,Inhibitor,,,,,,,
1094,1754504,5311042,IUPHAR/BPS Guide to PHARMACOLOGY,"[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl]-(phenylmethyl)phosphinic acid",1088,CGP 55845,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1088,242,GABAB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=242,Q96CX2,BTB/POZ domain-containing protein KCTD12,,,9606.0,Homo sapiens (human),Antagonist,pKi,7.8,PMID:11082110,https://www.ncbi.nlm.nih.gov/pubmed/11082110,11082110,,
1095,1754505,5311042,IUPHAR/BPS Guide to PHARMACOLOGY,"[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl]-(phenylmethyl)phosphinic acid",1088,CGP 55845,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1088,242,GABAB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=242,Q68DU8,BTB/POZ domain-containing protein KCTD16,,,9606.0,Homo sapiens (human),Antagonist,pKi,7.8,PMID:11082110,https://www.ncbi.nlm.nih.gov/pubmed/11082110,11082110,,
1096,1742218,5311053,IUPHAR/BPS Guide to PHARMACOLOGY,Cloprostenol,1894,cloprostenol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1894,344,FP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344,P43088,Prostaglandin F2-alpha receptor,5737.0,PTGFR,9606.0,Homo sapiens (human),Full agonist,pKi,9.3,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1097,1742219,5311053,IUPHAR/BPS Guide to PHARMACOLOGY,Cloprostenol,1894,cloprostenol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1894,346,TP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346,P21731,Thromboxane A2 receptor ,6915.0,TBXA2R,9606.0,Homo sapiens (human),Full agonist,pKi,5.2,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1098,1742372,5311104,Therapeutic Target Database (TTD),"6-(2,6-Dichlorophenyl)-2-[(4-Fluoro-3-Methylphenyl)amino]-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One",D0D5EW,HKI-9924129,https://idrblab.net/ttd/data/drug/details/D0D5EW,T85943,Proto-oncogene c-Src (SRC),https://idrblab.net/ttd/data/target/details/T85943,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1099,1742373,5311104,Therapeutic Target Database (TTD),"6-(2,6-Dichlorophenyl)-2-[(4-Fluoro-3-Methylphenyl)amino]-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One",D0D5EW,HKI-9924129,https://idrblab.net/ttd/data/drug/details/D0D5EW,T12499,LCK tyrosine protein kinase (LCK),https://idrblab.net/ttd/data/target/details/T12499,P06239,Tyrosine-protein kinase Lck,3932.0,LCK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1100,1742374,5311104,Therapeutic Target Database (TTD),"6-(2,6-Dichlorophenyl)-2-[(4-Fluoro-3-Methylphenyl)amino]-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One",D0D5EW,HKI-9924129,https://idrblab.net/ttd/data/drug/details/D0D5EW,T59328,Epidermal growth factor receptor (EGFR),https://idrblab.net/ttd/data/target/details/T59328,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1101,1742964,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,341,EP2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,Q62928,Prostaglandin E2 receptor EP2 subtype,81752.0,Ptger2,10116.0,Rattus norvegicus (Norway rat),Full agonist,pKi,5.9,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
1102,1742965,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,341,EP2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,P43116,Prostaglandin E2 receptor EP2 subtype,5732.0,PTGER2,9606.0,Homo sapiens (human),Full agonist,pKi,5.3 - 6,PMID:10634944|PMID:10462542,https://www.ncbi.nlm.nih.gov/pubmed/10634944|https://www.ncbi.nlm.nih.gov/pubmed/10462542,10634944|10462542,,
1103,1742966,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,340,EP1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=340,P70597,Prostaglandin E2 receptor EP1 subtype,25637.0,Ptger1,10116.0,Rattus norvegicus (Norway rat),Full agonist,pKi,6.3,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
1104,1742967,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,342,EP3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342,P34980,Prostaglandin E2 receptor EP3 subtype,24929.0,Ptger3,10116.0,Rattus norvegicus (Norway rat),Full agonist,pEC50,9.26,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
1105,1742968,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,343,EP4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343,P35408,Prostaglandin E2 receptor EP4 subtype,5734.0,PTGER4,9606.0,Homo sapiens (human),Full agonist,pEC50,7.75,PMID:19584306,https://www.ncbi.nlm.nih.gov/pubmed/19584306,19584306,,
1106,1742969,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,343,EP4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343,P35408,Prostaglandin E2 receptor EP4 subtype,5734.0,PTGER4,9606.0,Homo sapiens (human),Full agonist,pKi,7.5 - 8,PMID:10634944|PMID:10462542,https://www.ncbi.nlm.nih.gov/pubmed/10634944|https://www.ncbi.nlm.nih.gov/pubmed/10462542,10634944|10462542,,
1107,1742970,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,343,EP4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343,P32240,Prostaglandin E2 receptor EP4 subtype,19219.0,Ptger4,10090.0,Mus musculus (house mouse),Full agonist,pKi,6.3,PMID:9313928,https://www.ncbi.nlm.nih.gov/pubmed/9313928,9313928,,
1108,1742971,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,343,EP4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343,P43114,Prostaglandin E2 receptor EP4 subtype,84023.0,Ptger4,10116.0,Rattus norvegicus (Norway rat),Full agonist,pKi,7.6,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
1109,1742972,5311223,IUPHAR/BPS Guide to PHARMACOLOGY,Dpt-prostaglandin E1,1913,MB-28767,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1913,344,FP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344,P43088,Prostaglandin F2-alpha receptor,5737.0,PTGFR,9606.0,Homo sapiens (human),Full agonist,pKi,6.3,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1110,1744814,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,341,EP2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,Q62928,Prostaglandin E2 receptor EP2 subtype,81752.0,Ptger2,10116.0,Rattus norvegicus (Norway rat),Full agonist,pKi,5.1,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
1111,1744815,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,340,EP1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=340,P70597,Prostaglandin E2 receptor EP1 subtype,25637.0,Ptger1,10116.0,Rattus norvegicus (Norway rat),Full agonist,pKi,5.2,PMID:9537820,https://www.ncbi.nlm.nih.gov/pubmed/9537820,9537820,,
1112,1744816,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,341,EP2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341,P43116,Prostaglandin E2 receptor EP2 subtype,5732.0,PTGER2,9606.0,Homo sapiens (human),Full agonist,pKi,4.9,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1113,1744817,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,342,EP3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342,P43115,Prostaglandin E2 receptor EP3 subtype,5733.0,PTGER3,9606.0,Homo sapiens (human),Full agonist,pKi,4.9,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1114,1744818,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,346,TP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346,P30987,Thromboxane A2 receptor,21390.0,Tbxa2r,10090.0,Mus musculus (house mouse),Full agonist,pKi,7.2,PMID:9313928,https://www.ncbi.nlm.nih.gov/pubmed/9313928,9313928,,
1115,1744819,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,346,TP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346,P21731,Thromboxane A2 receptor ,6915.0,TBXA2R,9606.0,Homo sapiens (human),Full agonist,pKi,7.5,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1116,1744820,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1974,[3H]U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1974,346,TP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346,P21731,Thromboxane A2 receptor ,6915.0,TBXA2R,9606.0,Homo sapiens (human),Full agonist,pKd,7.8,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1117,1744821,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,345,IP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345,P43119,Prostacyclin receptor,5739.0,PTGIR,9606.0,Homo sapiens (human),Full agonist,pKi,4.2,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1118,1744822,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,344,FP receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344,P43088,Prostaglandin F2-alpha receptor,5737.0,PTGFR,9606.0,Homo sapiens (human),Full agonist,pKi,6.6,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1119,1744976,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,339,DP2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=339,Q9Y5Y4,Prostaglandin D2 receptor 2,11251.0,PTGDR2,9606.0,Homo sapiens (human),Full agonist,pKi,5.5,PMID:12466225,https://www.ncbi.nlm.nih.gov/pubmed/12466225,12466225,,
1120,1744977,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,340,EP1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=340,P34995,Prostaglandin E2 receptor EP1 subtype,5731.0,PTGER1,9606.0,Homo sapiens (human),Full agonist,pKi,4.5,PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/10634944,10634944,,
1121,1744978,5311493,IUPHAR/BPS Guide to PHARMACOLOGY,"9,11-Methanoepoxy PGH2",1888,U46619,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1888,338,DP1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=338,Q13258,Prostaglandin D2 receptor,5729.0,PTGDR,9606.0,Homo sapiens (human),Full agonist,pKi,5.4 - 5.9,PMID:9579725|PMID:10634944,https://www.ncbi.nlm.nih.gov/pubmed/9579725|https://www.ncbi.nlm.nih.gov/pubmed/10634944,9579725|10634944,,
1122,1744979,5311494,IUPHAR/BPS Guide to PHARMACOLOGY,UTPgammaS,1735,UTPγS,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1735,324,P2Y2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=324,P41231,P2Y purinoceptor 2,5029.0,P2RY2,9606.0,Homo sapiens (human),Full agonist,pEC50,5.8,PMID:8564228,https://www.ncbi.nlm.nih.gov/pubmed/8564228,8564228,,
1123,1744980,5311501,BindingDB,"(2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate",21281,"(11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalen-1-ylcarbonyl)-9-oxa-1-azatricyclo[6.3.1.0^{4,12}]dodeca-2,4(12),5,7-tetraene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21281,2136,Cannabinoid receptor 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2136,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606.0,Homo sapiens (human),,Ki (nM),7.5,PMID:24831513|DOI:10.1021/cb500177c,https://www.ncbi.nlm.nih.gov/pubmed/24831513|https://doi.org/10.1021/cb500177c,24831513,10.1021/cb500177c,
1124,1744981,5311501,BindingDB,"(2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate",21281,"(11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalen-1-ylcarbonyl)-9-oxa-1-azatricyclo[6.3.1.0^{4,12}]dodeca-2,4(12),5,7-tetraene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21281,2137,Cannabinoid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2137,P34972,Cannabinoid receptor 2 ,1269.0,CNR2,9606.0,Homo sapiens (human),,Ki (nM),0.45,PMID:24831513|DOI:10.1021/cb500177c,https://www.ncbi.nlm.nih.gov/pubmed/24831513|https://doi.org/10.1021/cb500177c,24831513,10.1021/cb500177c,
1125,1744982,5311503,IUPHAR/BPS Guide to PHARMACOLOGY,"(Z)-7-[(2R,3R,5R)-5-chloro-2-[(E,3S)-3-cyclohexyl-3-hydroxyprop-1-enyl]-3-hydroxycyclopentyl]hept-5-enoic acid",1889,ZK110841,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1889,338,DP1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=338,Q13258,Prostaglandin D2 receptor,5729.0,PTGDR,9606.0,Homo sapiens (human),Full agonist,pKi,9.5,PMID:9579725,https://www.ncbi.nlm.nih.gov/pubmed/9579725,9579725,,
1126,1747574,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein]",,,PMID:26694894,https://www.ncbi.nlm.nih.gov/pubmed/26694894,26694894,,
1127,1747575,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in increased degradation of PARP1 protein",,,PMID:19135124,https://www.ncbi.nlm.nih.gov/pubmed/19135124,19135124,,
1128,1747576,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [ethanol results in decreased expression of PPARA protein]|hif1a protein inhibits the reaction [5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [ethanol results in decreased expression of PPARA protein]]",,,PMID:29476730,https://www.ncbi.nlm.nih.gov/pubmed/29476730,29476730,,
1129,1747577,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCD protein]",,,PMID:22245252,https://www.ncbi.nlm.nih.gov/pubmed/22245252,22245252,,
1130,1747578,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna]|5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 protein]|5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [[lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of dinoprostone]",,,PMID:22101131,https://www.ncbi.nlm.nih.gov/pubmed/22101131,22101131,,
1131,1747579,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [lipopolysaccharides results in increased localization of RELA protein]",,,PMID:22101131,https://www.ncbi.nlm.nih.gov/pubmed/22101131,22101131,,
1132,1747580,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [lipopolysaccharides results in increased phosphorylation of RELA protein]",,,PMID:26694894,https://www.ncbi.nlm.nih.gov/pubmed/26694894,26694894,,
1133,1747581,5320315,Comparative Toxicogenomics Database (CTD),Oroxylin A,C080669,"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one",https://ctdbase.org/detail.go?type=chem&acc=C080669,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10116.0,Rattus norvegicus (Norway rat),"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [lipopolysaccharides results in decreased expression of and results in decreased activity of RHOA protein]",,,PMID:26694894,https://www.ncbi.nlm.nih.gov/pubmed/26694894,26694894,,
1134,1738423,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,51514,DTL,https://ctdbase.org/detail.go?type=gene&acc=51514,,,51514.0,DTL,9606.0,Homo sapiens (human),Lead affects the expression of DTL mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1135,1738424,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,1837,DTNA,https://ctdbase.org/detail.go?type=gene&acc=1837,,,1837.0,DTNA,9606.0,Homo sapiens (human),Lead affects the expression of DTNA mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1136,1738425,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,23220,DTX4,https://ctdbase.org/detail.go?type=gene&acc=23220,,,23220.0,DTX4,9606.0,Homo sapiens (human),Lead results in decreased expression of DTX4 mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1137,1738426,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,10116.0,Rattus norvegicus (Norway rat),[lead acetate results in increased abundance of lead] which results in increased expression of DUSP1 mRNA,,,PMID:36642386,https://www.ncbi.nlm.nih.gov/pubmed/36642386,36642386,,
1138,1738427,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,285193,DUSP28,https://ctdbase.org/detail.go?type=gene&acc=285193,,,285193.0,DUSP28,9606.0,Homo sapiens (human),Lead results in increased expression of DUSP28 mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1139,1738428,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,1852,DUSP9,https://ctdbase.org/detail.go?type=gene&acc=1852,,,1852.0,DUSP9,9606.0,Homo sapiens (human),Lead affects the expression of DUSP9 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1140,1738429,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,1797,DXO,https://ctdbase.org/detail.go?type=gene&acc=1797,,,1797.0,DXO,9606.0,Homo sapiens (human),Lead results in decreased expression of DXO mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1141,1738430,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,1780,DYNC1I1,https://ctdbase.org/detail.go?type=gene&acc=1780,,,1780.0,DYNC1I1,9606.0,Homo sapiens (human),Lead affects the expression of DYNC1I1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1142,1738431,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,8655,DYNLL1,https://ctdbase.org/detail.go?type=gene&acc=8655,,,8655.0,DYNLL1,9606.0,Homo sapiens (human),Lead affects the expression of DYNLL1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1143,1739413,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,55520,ELAC1,https://ctdbase.org/detail.go?type=gene&acc=55520,,,55520.0,ELAC1,9606.0,Homo sapiens (human),Lead affects the expression of ELAC1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1144,1739414,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,222223,ELAPOR2,https://ctdbase.org/detail.go?type=gene&acc=222223,,,222223.0,ELAPOR2,9606.0,Homo sapiens (human),Lead affects the expression of ELAPOR2 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1145,1739415,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,1993,ELAVL2,https://ctdbase.org/detail.go?type=gene&acc=1993,,,1993.0,ELAVL2,9606.0,Homo sapiens (human),Lead affects the splicing of ELAVL2 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1146,1739416,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,114794,ELFN2,https://ctdbase.org/detail.go?type=gene&acc=114794,,,114794.0,ELFN2,9606.0,Homo sapiens (human),Lead affects the expression of ELFN2 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1147,1739417,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,255520,ELMOD2,https://ctdbase.org/detail.go?type=gene&acc=255520,,,255520.0,ELMOD2,9606.0,Homo sapiens (human),Lead affects the expression of ELMOD2 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1148,1739418,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,2006,ELN,https://ctdbase.org/detail.go?type=gene&acc=2006,,,2006.0,ELN,9606.0,Homo sapiens (human),Lead affects the expression of ELN mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1149,1739419,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,2006,ELN,https://ctdbase.org/detail.go?type=gene&acc=2006,,,2006.0,ELN,9606.0,Homo sapiens (human),Lead affects the methylation of ELN gene,,,PMID:31636367,https://www.ncbi.nlm.nih.gov/pubmed/31636367,31636367,,
1150,1739420,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,6921,ELOC,https://ctdbase.org/detail.go?type=gene&acc=6921,,,6921.0,ELOC,9606.0,Homo sapiens (human),Lead affects the splicing of ELOC mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1151,1739421,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,54898,ELOVL2,https://ctdbase.org/detail.go?type=gene&acc=54898,,,54898.0,ELOVL2,9606.0,Homo sapiens (human),Lead affects the expression of ELOVL2 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1152,1739422,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,55140,ELP3,https://ctdbase.org/detail.go?type=gene&acc=55140,,,55140.0,ELP3,9606.0,Homo sapiens (human),Lead results in decreased expression of ELP3 mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1153,1739423,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,54859,ELP6,https://ctdbase.org/detail.go?type=gene&acc=54859,,,54859.0,ELP6,9606.0,Homo sapiens (human),Lead affects the expression of ELP6 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1154,1740270,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,30001,ERO1A,https://ctdbase.org/detail.go?type=gene&acc=30001,,,30001.0,ERO1A,9606.0,Homo sapiens (human),Lead affects the expression of ERO1A mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1155,1740271,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,2098,ESD,https://ctdbase.org/detail.go?type=gene&acc=2098,,,2098.0,ESD,9606.0,Homo sapiens (human),Lead affects the expression of ESD mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1156,1740272,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,9700,ESPL1,https://ctdbase.org/detail.go?type=gene&acc=9700,,,9700.0,ESPL1,9606.0,Homo sapiens (human),Lead affects the expression of ESPL1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1157,1740273,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,83715,ESPN,https://ctdbase.org/detail.go?type=gene&acc=83715,,,83715.0,ESPN,9606.0,Homo sapiens (human),Lead affects the expression of ESPN mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1158,1740274,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,2101,ESRRA,https://ctdbase.org/detail.go?type=gene&acc=2101,,,2101.0,ESRRA,9606.0,Homo sapiens (human),Lead results in increased expression of ESRRA mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1159,1740275,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,2103,ESRRB,https://ctdbase.org/detail.go?type=gene&acc=2103,,,2103.0,ESRRB,9606.0,Homo sapiens (human),Lead affects the methylation of ESRRB gene,,,PMID:31636367,https://www.ncbi.nlm.nih.gov/pubmed/31636367,31636367,,
1160,1740276,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,8220,ESS2,https://ctdbase.org/detail.go?type=gene&acc=8220,,,8220.0,ESS2,9606.0,Homo sapiens (human),Lead results in decreased expression of ESS2 mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1161,1740277,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,23344,ESYT1,https://ctdbase.org/detail.go?type=gene&acc=23344,,,23344.0,ESYT1,9606.0,Homo sapiens (human),Lead affects the expression of ESYT1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1162,1740278,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,55224,ETNK2,https://ctdbase.org/detail.go?type=gene&acc=55224,,,55224.0,ETNK2,9606.0,Homo sapiens (human),Lead affects the expression of ETNK2 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1163,1740933,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,708966,FAM127C,https://ctdbase.org/detail.go?type=gene&acc=708966,,,708966.0,,9606.0,Homo sapiens (human),Lead affects the expression of FAM127C mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1164,1740934,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,131408,FAM131A,https://ctdbase.org/detail.go?type=gene&acc=131408,,,131408.0,FAM131A,9606.0,Homo sapiens (human),Lead affects the splicing of FAM131A mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1165,1740935,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,348487,FAM131C,https://ctdbase.org/detail.go?type=gene&acc=348487,,,348487.0,FAM131C,9606.0,Homo sapiens (human),Lead affects the expression of FAM131C mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1166,1740936,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,286499,FAM133A,https://ctdbase.org/detail.go?type=gene&acc=286499,,,286499.0,FAM133A,9606.0,Homo sapiens (human),Lead affects the expression of FAM133A mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1167,1742671,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,282969,FUOM,https://ctdbase.org/detail.go?type=gene&acc=282969,,,282969.0,FUOM,9606.0,Homo sapiens (human),Lead affects the methylation of FUOM gene,,,PMID:31636367,https://www.ncbi.nlm.nih.gov/pubmed/31636367,31636367,,
1168,1742834,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,2521,FUS,https://ctdbase.org/detail.go?type=gene&acc=2521,,,2521.0,FUS,9606.0,Homo sapiens (human),Lead results in increased expression of FUS mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1169,1742835,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,10690,FUT9,https://ctdbase.org/detail.go?type=gene&acc=10690,,,10690.0,FUT9,9606.0,Homo sapiens (human),Lead affects the expression of FUT9 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1170,1742836,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,5348,FXYD1,https://ctdbase.org/detail.go?type=gene&acc=5348,,,5348.0,FXYD1,9606.0,Homo sapiens (human),Lead affects the expression of FXYD1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1171,1742837,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,53827,FXYD5,https://ctdbase.org/detail.go?type=gene&acc=53827,,,53827.0,FXYD5,9606.0,Homo sapiens (human),Lead affects the expression of FXYD5 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1172,1743184,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,55568,GALNT10,https://ctdbase.org/detail.go?type=gene&acc=55568,,,55568.0,GALNT10,9606.0,Homo sapiens (human),Lead results in decreased expression of GALNT10 mRNA,,,PMID:19921347,https://www.ncbi.nlm.nih.gov/pubmed/19921347,19921347,,
1173,1743185,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,63917,GALNT11,https://ctdbase.org/detail.go?type=gene&acc=63917,,,63917.0,GALNT11,9606.0,Homo sapiens (human),Lead affects the expression of GALNT11 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1174,1743186,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,114805,GALNT13,https://ctdbase.org/detail.go?type=gene&acc=114805,,,114805.0,GALNT13,9606.0,Homo sapiens (human),Lead affects the expression of GALNT13 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1175,1749779,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,10116.0,Rattus norvegicus (Norway rat),[lead acetate results in increased abundance of lead] which results in decreased expression of IGF1R protein|[lead acetate results in increased abundance of lead] which results in decreased expression of IGF1R mRNA,,,PMID:36652739,https://www.ncbi.nlm.nih.gov/pubmed/36652739,36652739,,
1176,1749780,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3481,IGF2,https://ctdbase.org/detail.go?type=gene&acc=3481,,,3481.0,IGF2,9606.0,Homo sapiens (human),Lead results in decreased methylation of IGF2 gene,,,PMID:26115033,https://www.ncbi.nlm.nih.gov/pubmed/26115033,26115033,,
1177,1749781,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,10642,IGF2BP1,https://ctdbase.org/detail.go?type=gene&acc=10642,,,10642.0,IGF2BP1,9606.0,Homo sapiens (human),Lead affects the expression of IGF2BP1 mRNA,,,PMID:28903495,https://www.ncbi.nlm.nih.gov/pubmed/28903495,28903495,,
1178,1749782,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,10644,IGF2BP2,https://ctdbase.org/detail.go?type=gene&acc=10644,,,10644.0,IGF2BP2,9606.0,Homo sapiens (human),Lead affects the methylation of IGF2BP2 gene,,,PMID:31636367,https://www.ncbi.nlm.nih.gov/pubmed/31636367,31636367,,
1179,1750581,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Decabromobiphenyl ether promotes the reaction [[lead chloride results in increased abundance of lead] which results in increased expression of IL4 protein]|[lead chloride results in increased abundance of lead] which results in increased expression of IL4 protein,,,PMID:30836164,https://www.ncbi.nlm.nih.gov/pubmed/30836164,30836164,,
1180,1750582,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),[lead acetate results in increased abundance of lead] promotes the reaction [[IL4 protein co-treated with IFNG protein] results in increased expression of MRC1 protein]|[[lead acetate results in increased abundance of lead] co-treated with [IL4 protein co-treated with IL13 protein]] results in increased expression of TGFB1 protein,,,PMID:34352350,https://www.ncbi.nlm.nih.gov/pubmed/34352350,34352350,,
1181,1750583,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Lead results in increased expression of and results in increased secretion of IL4 protein,,,PMID:28973681,https://www.ncbi.nlm.nih.gov/pubmed/28973681,28973681,,
1182,1750584,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3566,IL4R,https://ctdbase.org/detail.go?type=gene&acc=3566,,,3566.0,IL4R,9606.0,Homo sapiens (human),Lead affects the methylation of IL4R gene,,,PMID:31636367,https://www.ncbi.nlm.nih.gov/pubmed/31636367,31636367,,
1183,1750585,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3567,IL5,https://ctdbase.org/detail.go?type=gene&acc=3567,,,3567.0,IL5,10090.0,Mus musculus (house mouse),Lead results in increased expression of and results in increased secretion of IL5 protein,,,PMID:28973681,https://www.ncbi.nlm.nih.gov/pubmed/28973681,28973681,,
1184,1750586,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Lead results in increased expression of IL6,,,PMID:28395533,https://www.ncbi.nlm.nih.gov/pubmed/28395533,28395533,,
1185,1750587,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),[lead chloride results in increased abundance of lead] which results in increased expression of IL6 protein|decabromobiphenyl ether promotes the reaction [[lead chloride results in increased abundance of lead] which results in increased expression of IL6 protein],,,PMID:30836164,https://www.ncbi.nlm.nih.gov/pubmed/30836164,30836164,,
1186,1750588,5352425,Comparative Toxicogenomics Database (CTD),Lead,D007854,Lead,https://ctdbase.org/detail.go?type=chem&acc=D007854,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Lead results in increased expression of IL6 protein|fisetin inhibits the reaction [lead results in increased expression of IL6 protein],,,PMID:31539617,https://www.ncbi.nlm.nih.gov/pubmed/31539617,31539617,,
1187,1754610,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,116285,ACSM1,https://ctdbase.org/detail.go?type=gene&acc=116285,,,116285.0,ACSM1,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of ACSM1 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1188,1754611,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,123876,ACSM2A,https://ctdbase.org/detail.go?type=gene&acc=123876,,,123876.0,ACSM2A,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of ACSM2A mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1189,1754612,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,348158,ACSM2B,https://ctdbase.org/detail.go?type=gene&acc=348158,,,348158.0,ACSM2B,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of ACSM2B mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1190,1754613,5371560,Comparative Toxicogenomics Database (CTD),Dicrotophos,C000944,dicrotophos,https://ctdbase.org/detail.go?type=chem&acc=C000944,6296,ACSM3,https://ctdbase.org/detail.go?type=gene&acc=6296,,,6296.0,ACSM3,9606.0,Homo sapiens (human),Dicrotophos results in decreased expression of ACSM3 mRNA,,,PMID:28302478,https://www.ncbi.nlm.nih.gov/pubmed/28302478,28302478,,
1191,1750910,5393152,BindingDB,"3,7-Dihydroxyflavone",26660,"3,7-dihydroxy-2-phenyl-4H-chromen-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26660,5007,Dipeptidyl peptidase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5007,Q9NY33,Dipeptidyl peptidase 3,10072.0,DPP3,9606.0,Homo sapiens (human),,IC50 (nM),9.80e+4,PMID:27754592|DOI:10.1111/cbdd.12887,https://www.ncbi.nlm.nih.gov/pubmed/27754592|https://doi.org/10.1111/cbdd.12887,27754592,10.1111/cbdd.12887,
1192,1750911,5416975,BindingDB,rac-3-Hydroxy-N-methyl-isomorphinan,224023,Dextrorphan,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=224023,9579,Mas-related G-protein coupled receptor member X2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9579,Q96LB1,Mas-related G-protein coupled receptor member X2,117194.0,MRGPRX2,9606.0,Homo sapiens (human),,,,PMID:28288109|DOI:10.1038/nchembio.2334,https://www.ncbi.nlm.nih.gov/pubmed/28288109|https://doi.org/10.1038/nchembio.2334,28288109,10.1038/nchembio.2334,
1193,1750912,5416975,BindingDB,rac-3-Hydroxy-N-methyl-isomorphinan,224023,Dextrorphan,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=224023,9579,Mas-related G-protein coupled receptor member X2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9579,Q96LB1,Mas-related G-protein coupled receptor member X2,117194.0,MRGPRX2,9606.0,Homo sapiens (human),,,,PMID:28288109|DOI:10.1038/nchembio.2334,https://www.ncbi.nlm.nih.gov/pubmed/28288109|https://doi.org/10.1038/nchembio.2334,28288109,10.1038/nchembio.2334,
1194,1750913,5458565,Drug Gene Interaction database (DGIdb),"3-(6-chloro-1,1-dioxo-7-sulfamoyl-4H-1lambda6,2,4-benzothiadiazin-3-yl)propanoic acid",,CHEMBL:CHEMBL2003658,https://www.dgidb.org/drugs/chembl:CHEMBL2003658,,CDC25B,https://www.dgidb.org/genes/hgnc:1726,,,994.0,CDC25B,9606.0,Homo sapiens (human),,,,,,,,
1195,1750914,5459308,BindingDB,Sinomenine,224031,Sinomenine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=224031,9579,Mas-related G-protein coupled receptor member X2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9579,Q96LB1,Mas-related G-protein coupled receptor member X2,117194.0,MRGPRX2,9606.0,Homo sapiens (human),,,,PMID:28288109|DOI:10.1038/nchembio.2334,https://www.ncbi.nlm.nih.gov/pubmed/28288109|https://doi.org/10.1038/nchembio.2334,28288109,10.1038/nchembio.2334,
1196,1750915,5459308,BindingDB,Sinomenine,224031,Sinomenine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=224031,9579,Mas-related G-protein coupled receptor member X2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9579,Q96LB1,Mas-related G-protein coupled receptor member X2,117194.0,MRGPRX2,9606.0,Homo sapiens (human),,,,PMID:28288109|DOI:10.1038/nchembio.2334,https://www.ncbi.nlm.nih.gov/pubmed/28288109|https://doi.org/10.1038/nchembio.2334,28288109,10.1038/nchembio.2334,
1197,1738754,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5549,PRELP,https://ctdbase.org/detail.go?type=gene&acc=5549,,,5549.0,PRELP,10090.0,Mus musculus (house mouse),Soot results in decreased expression of PRELP mRNA,,,PMID:22461453,https://www.ncbi.nlm.nih.gov/pubmed/22461453,22461453,,
1198,1738755,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,57580,PREX1,https://ctdbase.org/detail.go?type=gene&acc=57580,,,57580.0,PREX1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PREX1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1199,1738756,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,80243,PREX2,https://ctdbase.org/detail.go?type=gene&acc=80243,,,80243.0,PREX2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PREX2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1200,1738757,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,80243,PREX2,https://ctdbase.org/detail.go?type=gene&acc=80243,,,80243.0,PREX2,10090.0,Mus musculus (house mouse),Soot affects the expression of PREX2 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1201,1738758,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10216,PRG4,https://ctdbase.org/detail.go?type=gene&acc=10216,,,10216.0,PRG4,10090.0,Mus musculus (house mouse),Soot results in increased expression of PRG4 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1202,1738759,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PRICKLE1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1203,1738760,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,10090.0,Mus musculus (house mouse),Soot results in decreased expression of PRICKLE1 mRNA,,,PMID:22461453|PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/22461453|https://www.ncbi.nlm.nih.gov/pubmed/26551751,22461453|26551751,,
1204,1739128,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5588,PRKCQ,https://ctdbase.org/detail.go?type=gene&acc=5588,,,5588.0,PRKCQ,10090.0,Mus musculus (house mouse),Soot results in decreased expression of PRKCQ mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1205,1739129,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5587,PRKD1,https://ctdbase.org/detail.go?type=gene&acc=5587,,,5587.0,PRKD1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PRKD1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1206,1739130,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,25865,PRKD2,https://ctdbase.org/detail.go?type=gene&acc=25865,,,25865.0,PRKD2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PRKD2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1207,1739131,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5591,PRKDC,https://ctdbase.org/detail.go?type=gene&acc=5591,,,5591.0,PRKDC,9606.0,Homo sapiens (human),Soot analog results in increased expression of PRKDC protein,,,PMID:30240709,https://www.ncbi.nlm.nih.gov/pubmed/30240709,30240709,,
1208,1739132,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5592,PRKG1,https://ctdbase.org/detail.go?type=gene&acc=5592,,,5592.0,PRKG1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PRKG1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1209,1739133,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5071,PRKN,https://ctdbase.org/detail.go?type=gene&acc=5071,,,5071.0,PRKN,10090.0,Mus musculus (house mouse),Soot results in decreased expression of PRKN mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1210,1739134,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,107849,PRL2C5,https://ctdbase.org/detail.go?type=gene&acc=107849,,,107849.0,Prl2c5,10090.0,Mus musculus (house mouse),Soot results in increased expression of PRL2C5 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1211,1741045,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10981,RAB32,https://ctdbase.org/detail.go?type=gene&acc=10981,,,10981.0,RAB32,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of RAB32 mrna|[air pollutants results in increased abundance of soot] which results in increased expression of RAB32 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1212,1741046,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,23682,RAB38,https://ctdbase.org/detail.go?type=gene&acc=23682,,,23682.0,RAB38,10090.0,Mus musculus (house mouse),Soot results in decreased expression of RAB38 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1213,1741047,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5864,RAB3A,https://ctdbase.org/detail.go?type=gene&acc=5864,,,5864.0,RAB3A,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RAB3A mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1214,1741048,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,115827,RAB3C,https://ctdbase.org/detail.go?type=gene&acc=115827,,,115827.0,RAB3C,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of RAB3C mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1215,1741049,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,401258,RAB44,https://ctdbase.org/detail.go?type=gene&acc=401258,,,401258.0,RAB44,10090.0,Mus musculus (house mouse),Soot results in decreased expression of RAB44 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1216,1741050,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,51560,RAB6B,https://ctdbase.org/detail.go?type=gene&acc=51560,,,51560.0,RAB6B,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RAB6B mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1217,1741051,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,51762,RAB8B,https://ctdbase.org/detail.go?type=gene&acc=51762,,,51762.0,RAB8B,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of soot] which results in increased expression of RAB8B mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1218,1741052,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,23637,RABGAP1,https://ctdbase.org/detail.go?type=gene&acc=23637,,,23637.0,RABGAP1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of soot] which results in increased expression of RABGAP1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1219,1741738,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5912,RAP2B,https://ctdbase.org/detail.go?type=gene&acc=5912,,,5912.0,RAP2B,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of RAP2B mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1220,1741739,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,2889,RAPGEF1,https://ctdbase.org/detail.go?type=gene&acc=2889,,,2889.0,RAPGEF1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RAPGEF1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1221,1741740,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10411,RAPGEF3,https://ctdbase.org/detail.go?type=gene&acc=10411,,,10411.0,RAPGEF3,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RAPGEF3 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1222,1741741,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,10411,RAPGEF3,https://ctdbase.org/detail.go?type=gene&acc=10411,,,10411.0,RAPGEF3,10090.0,Mus musculus (house mouse),Soot results in increased expression of RAPGEF3 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1223,1741742,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,11069,RAPGEF4,https://ctdbase.org/detail.go?type=gene&acc=11069,,,11069.0,RAPGEF4,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RAPGEF4 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1224,1741743,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,9771,RAPGEF5,https://ctdbase.org/detail.go?type=gene&acc=9771,,,9771.0,RAPGEF5,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RAPGEF5 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1225,1741744,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,9771,RAPGEF5,https://ctdbase.org/detail.go?type=gene&acc=9771,,,9771.0,RAPGEF5,10090.0,Mus musculus (house mouse),Soot results in increased expression of RAPGEF5 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1226,1742209,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of soot] which results in increased expression of RB1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1227,1742210,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5931,RBBP7,https://ctdbase.org/detail.go?type=gene&acc=5931,,,5931.0,RBBP7,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of RBBP7 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1228,1742211,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,146713,RBFOX3,https://ctdbase.org/detail.go?type=gene&acc=146713,,,146713.0,RBFOX3,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RBFOX3 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1229,1742212,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,146713,RBFOX3,https://ctdbase.org/detail.go?type=gene&acc=146713,,,146713.0,RBFOX3,10090.0,Mus musculus (house mouse),Soot results in increased expression of RBFOX3 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1230,1742213,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5933,RBL1,https://ctdbase.org/detail.go?type=gene&acc=5933,,,5933.0,RBL1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of RBL1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1231,1742214,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5933,RBL1,https://ctdbase.org/detail.go?type=gene&acc=5933,,,5933.0,RBL1,10090.0,Mus musculus (house mouse),Soot results in increased expression of RBL1 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1232,1742215,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,5934,RBL2,https://ctdbase.org/detail.go?type=gene&acc=5934,,,5934.0,RBL2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of soot] which results in increased expression of RBL2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1233,1742216,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,72397,RBM12B1,https://ctdbase.org/detail.go?type=gene&acc=72397,,,72397.0,Rbm12b1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RBM12B1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
1234,1742217,5462310,Comparative Toxicogenomics Database (CTD),Carbon,D053260,Soot,https://ctdbase.org/detail.go?type=chem&acc=D053260,77604,RBM12B2,https://ctdbase.org/detail.go?type=gene&acc=77604,,,77604.0,Rbm12b2,10090.0,Mus musculus (house mouse),Soot results in decreased expression of RBM12B2 mRNA,,,PMID:26551751,https://www.ncbi.nlm.nih.gov/pubmed/26551751,26551751,,
1235,1750916,5462471,BindingDB,Damgo,21015,(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]-N-methylacetamido}-N-(2-hydroxyethyl)-3-phenylpropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21015,2101,Mu-type opioid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2101,P33535,Mu-type opioid receptor,25601.0,Oprm1,10116.0,Rattus norvegicus (Norway rat),,,,PMID:18266313|DOI:10.1021/jm070332f,https://www.ncbi.nlm.nih.gov/pubmed/18266313|https://doi.org/10.1021/jm070332f,18266313,10.1021/jm070332f,
1236,1750917,5462471,BindingDB,Damgo,21015,(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]-N-methylacetamido}-N-(2-hydroxyethyl)-3-phenylpropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21015,2101,Mu-type opioid receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2101,P33535,Mu-type opioid receptor,25601.0,Oprm1,10116.0,Rattus norvegicus (Norway rat),,,,PMID:16686530|DOI:10.1021/jm050921q,https://www.ncbi.nlm.nih.gov/pubmed/16686530|https://doi.org/10.1021/jm050921q,16686530,10.1021/jm050921q,
1237,1748519,5463523,Toxin and Toxin Target Database (T3DB),Barium(2+) difluoride,T3D1107,Barium fluoride,http://www.t3db.ca/toxins/T3D1107,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q9UNX9,ATP-sensitive inward rectifier potassium channel 14,3770.0,KCNJ14,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1238,1748520,5463523,Toxin and Toxin Target Database (T3DB),Barium(2+) difluoride,T3D1107,Barium fluoride,http://www.t3db.ca/toxins/T3D1107,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q99712,ATP-sensitive inward rectifier potassium channel 15,3772.0,KCNJ15,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1239,1748521,5463523,Toxin and Toxin Target Database (T3DB),Barium(2+) difluoride,T3D1107,Barium fluoride,http://www.t3db.ca/toxins/T3D1107,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q15842,ATP-sensitive inward rectifier potassium channel 8,3764.0,KCNJ8,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1240,1748522,5463523,Toxin and Toxin Target Database (T3DB),Barium(2+) difluoride,T3D1107,Barium fluoride,http://www.t3db.ca/toxins/T3D1107,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P48048,ATP-sensitive inward rectifier potassium channel 1,3758.0,KCNJ1,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1241,1748523,5463523,Toxin and Toxin Target Database (T3DB),Barium(2+) difluoride,T3D1107,Barium fluoride,http://www.t3db.ca/toxins/T3D1107,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,P78508,ATP-sensitive inward rectifier potassium channel 10,3766.0,KCNJ10,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1242,1748524,5463523,Toxin and Toxin Target Database (T3DB),Barium(2+) difluoride,T3D1107,Barium fluoride,http://www.t3db.ca/toxins/T3D1107,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14654,ATP-sensitive inward rectifier potassium channel 11,3767.0,KCNJ11,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1243,1748525,5463523,Toxin and Toxin Target Database (T3DB),Barium(2+) difluoride,T3D1107,Barium fluoride,http://www.t3db.ca/toxins/T3D1107,BE0004905,ATP-sensitive potassium channel,http://www.t3db.ca/biodb/bio_entities/BE0004905,Q14500,ATP-sensitive inward rectifier potassium channel 12,3768.0,KCNJ12,9606.0,Homo sapiens (human),"Barium is a competitive antagonist at inward rectifier potassium channels and blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A150)",,,PMID:11454958,https://www.ncbi.nlm.nih.gov/pubmed/11454958,11454958,,
1244,1750214,5469424,Comparative Toxicogenomics Database (CTD),Demethoxycurcumin,C050229,demethoxycurcumin,https://ctdbase.org/detail.go?type=chem&acc=C050229,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Demethoxycurcumin results in increased cleavage of PARP1 protein|wortmannin promotes the reaction [demethoxycurcumin results in increased cleavage of PARP1 protein],,,PMID:34291863,https://www.ncbi.nlm.nih.gov/pubmed/34291863,34291863,,
1245,1750215,5469424,Comparative Toxicogenomics Database (CTD),Demethoxycurcumin,C050229,demethoxycurcumin,https://ctdbase.org/detail.go?type=chem&acc=C050229,5175,PECAM1,https://ctdbase.org/detail.go?type=gene&acc=5175,,,5175.0,PECAM1,10116.0,Rattus norvegicus (Norway rat),Demethoxycurcumin results in increased expression of PECAM1 protein,,,PMID:17960570,https://www.ncbi.nlm.nih.gov/pubmed/17960570,17960570,,
1246,1750402,5469424,Comparative Toxicogenomics Database (CTD),Demethoxycurcumin,C050229,demethoxycurcumin,https://ctdbase.org/detail.go?type=chem&acc=C050229,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),Demethoxycurcumin affects the expression of VEGFA mRNA,,,PMID:17960570,https://www.ncbi.nlm.nih.gov/pubmed/17960570,17960570,,
1247,1750403,5469424,Comparative Toxicogenomics Database (CTD),Demethoxycurcumin,C050229,demethoxycurcumin,https://ctdbase.org/detail.go?type=chem&acc=C050229,7490,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490.0,WT1,9606.0,Homo sapiens (human),Demethoxycurcumin results in decreased expression of WT1 protein|demethoxycurcumin results in decreased expression of WT1 mRNA,,,PMID:18034345,https://www.ncbi.nlm.nih.gov/pubmed/18034345,18034345,,
1248,1750404,5469424,Comparative Toxicogenomics Database (CTD),Demethoxycurcumin,C050229,demethoxycurcumin,https://ctdbase.org/detail.go?type=chem&acc=C050229,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,9606.0,Homo sapiens (human),Demethoxycurcumin results in decreased expression of XIAP protein,,,PMID:34291863,https://www.ncbi.nlm.nih.gov/pubmed/34291863,34291863,,
1249,1750405,5469634,BindingDB,2-(10-Heptadecenyl)-6-hydroxybenzoic acid,50259930,6-(10'Z-heptadecenyl)-salicylicacid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50259930,9980,Fatty acid synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9980,P12276,Fatty acid synthase,,,9031.0,Gallus gallus (chicken),,IC50 (nM),1.05e+4,PMID:22380770|DOI:10.3109/14756366.2012.658786,https://www.ncbi.nlm.nih.gov/pubmed/22380770|https://doi.org/10.3109/14756366.2012.658786,22380770,10.3109/14756366.2012.658786,
1250,1750406,5472867,Comparative Toxicogenomics Database (CTD),"1,5-Bis(2-hydroxyphenyl)penta-1,4-dien-3-one",C518535,bis(2-hydroxybenzylidene)acetone,https://ctdbase.org/detail.go?type=chem&acc=C518535,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Bis(2-hydroxybenzylidene)acetone inhibits the reaction [lipopolysaccharides results in increased activity of NOS2 protein],,,PMID:18838692,https://www.ncbi.nlm.nih.gov/pubmed/18838692,18838692,,
1251,1750407,5472867,Comparative Toxicogenomics Database (CTD),"1,5-Bis(2-hydroxyphenyl)penta-1,4-dien-3-one",C518535,bis(2-hydroxybenzylidene)acetone,https://ctdbase.org/detail.go?type=chem&acc=C518535,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),Bis(2-hydroxybenzylidene)acetone results in increased activity of NQO1 protein,,,PMID:18838692,https://www.ncbi.nlm.nih.gov/pubmed/18838692,18838692,,
1252,1750408,5473208,Drug Gene Interaction database (DGIdb),(3E)-5-methoxy-3-[[6-[(E)-(5-methoxy-2-oxo-1H-indol-3-ylidene)methyl]pyridin-2-yl]methylidene]-1H-indol-2-one,,CHEMBL:CHEMBL515617,https://www.dgidb.org/drugs/chembl:CHEMBL515617,,ATXN2,https://www.dgidb.org/genes/hgnc:10555,,,6311.0,ATXN2,9606.0,Homo sapiens (human),,,,,,,,
1253,1750409,5473208,Drug Gene Interaction database (DGIdb),(3E)-5-methoxy-3-[[6-[(E)-(5-methoxy-2-oxo-1H-indol-3-ylidene)methyl]pyridin-2-yl]methylidene]-1H-indol-2-one,,CHEMBL:CHEMBL515617,https://www.dgidb.org/drugs/chembl:CHEMBL515617,,SMAD3,https://www.dgidb.org/genes/hgnc:6769,,,4088.0,SMAD3,9606.0,Homo sapiens (human),,,,,,,,
1254,1750410,5478003,Comparative Toxicogenomics Database (CTD),Apocarotenal,C004984,apocarotenal,https://ctdbase.org/detail.go?type=chem&acc=C004984,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,9606.0,Homo sapiens (human),Apocarotenal results in increased expression of ACADM mRNA,,,PMID:17034753,https://www.ncbi.nlm.nih.gov/pubmed/17034753,17034753,,
1255,1752263,5484402,Comparative Toxicogenomics Database (CTD),7-Hydroxymethotrexate,C011864,7-hydroxymethotrexate,https://ctdbase.org/detail.go?type=chem&acc=C011864,8836,GGH,https://ctdbase.org/detail.go?type=gene&acc=8836,,,8836.0,GGH,9606.0,Homo sapiens (human),GGH mRNA results in decreased susceptibility to 7-hydroxymethotrexate,,,PMID:19426680,https://www.ncbi.nlm.nih.gov/pubmed/19426680,19426680,,
1256,1752264,5484402,Comparative Toxicogenomics Database (CTD),7-Hydroxymethotrexate,C011864,7-hydroxymethotrexate,https://ctdbase.org/detail.go?type=chem&acc=C011864,4524,MTHFR,https://ctdbase.org/detail.go?type=gene&acc=4524,,,4524.0,MTHFR,9606.0,Homo sapiens (human),MTHFR mRNA results in decreased susceptibility to 7-hydroxymethotrexate,,,PMID:19426680,https://www.ncbi.nlm.nih.gov/pubmed/19426680,19426680,,
1257,1752265,5484402,Comparative Toxicogenomics Database (CTD),7-Hydroxymethotrexate,C011864,7-hydroxymethotrexate,https://ctdbase.org/detail.go?type=chem&acc=C011864,6579,SLCO1A2,https://ctdbase.org/detail.go?type=gene&acc=6579,,,6579.0,SLCO1A2,9606.0,Homo sapiens (human),7-hydroxymethotrexate inhibits the reaction [SLCO1A2 mRNA results in increased import of estrone sulfate],,,PMID:16702441,https://www.ncbi.nlm.nih.gov/pubmed/16702441,16702441,,
1258,1752266,5486971,Drug Gene Interaction database (DGIdb),Pregabalin,,PREGABALIN,https://www.dgidb.org/drugs/rxcui:187832,,CACNA1C,https://www.dgidb.org/genes/hgnc:1390,,,775.0,CACNA1C,9606.0,Homo sapiens (human),Modulator,,,,,,,
1259,1752267,5486971,Drug Gene Interaction database (DGIdb),Pregabalin,,PREGABALIN,https://www.dgidb.org/drugs/rxcui:187832,,CACNB3,https://www.dgidb.org/genes/hgnc:1403,,,784.0,CACNB3,9606.0,Homo sapiens (human),Modulator,,,,,,,
1260,1752268,5486971,Drug Gene Interaction database (DGIdb),Pregabalin,,PREGABALIN,https://www.dgidb.org/drugs/rxcui:187832,,CACNG1,https://www.dgidb.org/genes/hgnc:1405,,,786.0,CACNG1,9606.0,Homo sapiens (human),Modulator,,,,,,,
1261,1752269,5486971,Drug Gene Interaction database (DGIdb),Pregabalin,,PREGABALIN,https://www.dgidb.org/drugs/rxcui:187832,,CACNA2D4,https://www.dgidb.org/genes/hgnc:20202,,,93589.0,CACNA2D4,9606.0,Homo sapiens (human),Modulator,,,,,,,
1262,1752270,5486971,Drug Gene Interaction database (DGIdb),Pregabalin,,PREGABALIN,https://www.dgidb.org/drugs/rxcui:187832,,CACNB1,https://www.dgidb.org/genes/hgnc:1401,,,782.0,CACNB1,9606.0,Homo sapiens (human),Modulator,,,,,,,
1263,1752271,5487313,DrugBank,[[1-[N-Hydroxy-acetamidyl]-3-methyl-butyl]-carbonyl-leucinyl]-alanine ethyl ester,DB08482,[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,https://www.drugbank.ca/drugs/DB08482,BE0000920,Interstitial collagenase,https://www.drugbank.ca/bio_entities/BE0000920,P03956,Interstitial collagenase,4312.0,MMP1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
1264,1752272,5490334,Comparative Toxicogenomics Database (CTD),Hibifolin,C087346,hibifolin,https://ctdbase.org/detail.go?type=chem&acc=C087346,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116.0,Rattus norvegicus (Norway rat),Hibifolin inhibits the reaction [APP protein binds to APP protein],,,PMID:17323972,https://www.ncbi.nlm.nih.gov/pubmed/17323972,17323972,,
1265,1752262,5497163,Comparative Toxicogenomics Database (CTD),Glyceryl Trioleate,D014304,Triolein,https://ctdbase.org/detail.go?type=chem&acc=D014304,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090.0,Mus musculus (house mouse),Triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [fructose results in increased abundance of triglycerides]]|triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [fructose results in increased expression of SREBF1 protein]]|triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [fructose results in increased expression of ACACA mrna]]|triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [fructose results in increased expression of SREBF1 mrna]]|triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [fructose results in increased expression of FASN mrna]],,,PMID:15066988,https://www.ncbi.nlm.nih.gov/pubmed/15066988,15066988,,
1266,1754506,5702546,Comparative Toxicogenomics Database (CTD),Resiniferatoxin,C024353,resiniferatoxin,https://ctdbase.org/detail.go?type=chem&acc=C024353,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,9606.0,Homo sapiens (human),Resiniferatoxin binds to and results in increased activity of TRPV1 protein,,,PMID:17698245|PMID:18460982|PMID:19926130,https://www.ncbi.nlm.nih.gov/pubmed/17698245|https://www.ncbi.nlm.nih.gov/pubmed/18460982|https://www.ncbi.nlm.nih.gov/pubmed/19926130,17698245|18460982|19926130,,
1267,1754507,5702546,Comparative Toxicogenomics Database (CTD),Resiniferatoxin,C024353,resiniferatoxin,https://ctdbase.org/detail.go?type=chem&acc=C024353,7345,UCHL1,https://ctdbase.org/detail.go?type=gene&acc=7345,,,7345.0,UCHL1,10090.0,Mus musculus (house mouse),4-methylcatechol inhibits the reaction [resiniferatoxin results in decreased expression of UCHL1 protein]|resiniferatoxin results in decreased expression of UCHL1 protein,,,PMID:18219259,https://www.ncbi.nlm.nih.gov/pubmed/18219259,18219259,,
1268,1754508,5719371,Drug Gene Interaction database (DGIdb),"6-Chloro-1,3-diethyl-2-[2-(methyl-phenyl-amino)-vinyl]-3H-benzoimidazol-1-ium",,CHEMBL:CHEMBL579957,https://www.dgidb.org/drugs/chembl:CHEMBL579957,,HTT,https://www.dgidb.org/genes/hgnc:4851,,,3064.0,HTT,9606.0,Homo sapiens (human),,,,,,,,
1269,1753489,5720188,Comparative Toxicogenomics Database (CTD),"2-[(5Z)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-methylbutanoic acid",C503945,5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid,https://ctdbase.org/detail.go?type=chem&acc=C503945,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid results in decreased expression of CASP3 protein,,,PMID:30031050,https://www.ncbi.nlm.nih.gov/pubmed/30031050,30031050,,
1270,1753490,5720188,Comparative Toxicogenomics Database (CTD),"2-[(5Z)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-methylbutanoic acid",C503945,5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid,https://ctdbase.org/detail.go?type=chem&acc=C503945,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,10090.0,Mus musculus (house mouse),DNM1L protein affects the reaction [5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid results in increased expression of HMOX1 protein],,,PMID:30031050,https://www.ncbi.nlm.nih.gov/pubmed/30031050,30031050,,
1271,1753491,5722076,Drug Gene Interaction database (DGIdb),1-methyl-2-[(E)-2-(4-nitrophenyl)vinyl]pyridinium,,CHEMBL:CHEMBL591630,https://www.dgidb.org/drugs/chembl:CHEMBL591630,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
1272,1754509,5723450,BindingDB,,241958,"5-(2-(4-Hydroxyphenyl)hydrazono)-dihydro-2-thioxopyrimidine-4,6(1H,5H)-dione (14)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=241958,2740,Ribosomal protein S6 kinase alpha-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2740,P51812,Ribosomal protein S6 kinase alpha-3,6197.0,RPS6KA3,9606.0,Homo sapiens (human),,IC50 (nM),2.19e+3,PMID:22545939|DOI:10.3109/14756366.2012.681651,https://www.ncbi.nlm.nih.gov/pubmed/22545939|https://doi.org/10.3109/14756366.2012.681651,22545939,10.3109/14756366.2012.681651,
1273,1753492,5731684,Drug Gene Interaction database (DGIdb),2-[(E)-2-(2-bromophenyl)vinyl]quinolin-8-ol,,CHEMBL:CHEMBL590184,https://www.dgidb.org/drugs/chembl:CHEMBL590184,,HSP90AA1,https://www.dgidb.org/genes/hgnc:5253,,,3320.0,HSP90AA1,9606.0,Homo sapiens (human),,,,,,,,
1274,1754510,5742832,ChEMBL,Aztreonam,CHEMBL158,AZTREONAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL158/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P02919,Penicillin-binding protein 1B,944843.0,mrcB,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
1275,1754511,5742832,ChEMBL,Aztreonam,CHEMBL158,AZTREONAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL158/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P08506,D-alanyl-D-alanine carboxypeptidase DacC,945455.0,dacC,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
1276,1754512,5742832,ChEMBL,Aztreonam,CHEMBL158,AZTREONAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL158/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AD65,"Peptidoglycan D,D-transpeptidase MrdA",945240.0,mrdA,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
1277,1754513,5742832,ChEMBL,Aztreonam,CHEMBL158,AZTREONAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL158/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P0AEB2,D-alanyl-D-alanine carboxypeptidase DacA,944799.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
1278,1754514,5742832,ChEMBL,Aztreonam,CHEMBL158,AZTREONAM,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL158/,CHEMBL2354204,Bacterial penicillin-binding protein,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2354204/,P24228,D-alanyl-D-alanine carboxypeptidase DacB,75202099.0,ftsI,2.0,Bacteria (eubacteria),Bacterial penicillin-binding protein inhibitor,,,,,,,
1279,1753493,5743568,Comparative Toxicogenomics Database (CTD),5-Hydroxythalidomide,C544471,5-hydroxythalidomide,https://ctdbase.org/detail.go?type=chem&acc=C544471,1562,CYP2C18,https://ctdbase.org/detail.go?type=gene&acc=1562,,,1562.0,CYP2C18,9606.0,Homo sapiens (human),CYP2C18 protein results in increased metabolism of 5-hydroxythalidomide,,,PMID:24350712,https://www.ncbi.nlm.nih.gov/pubmed/24350712,24350712,,
